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Properly calibrated, a spectroscopic x-ray computed tomography (CT) machine can perform 
quantitative chemistry.  The MARS scanner is built around the Medipix family of photon counting, 
energy discriminating x-ray detectors.  A MARS image is a material representation of a volume 
reconstructed from spectral x-ray projections.  I used atherosclerosis and cancer models to show that 
MARS images can be used to identify spatial and material traits of disease.  For atherosclerosis, I 
simulated clinical human scans using photons from ~30 to 120 keV.  I scanned excised carotid 
plaques and produced MARS images of a necrotic lipid core with spotty calcifications, which are 
indicative of plaques vulnerable to rupture.  These images were confirmed with histological analysis.  
Plaques submerged in gadolinium contrast agent, to mimic contrast enhanced angiography, showed 
that the lipid and calcium signals were maintained.  In mice, I demonstrated the simultaneous 
identification of lipid, calcium, and three contrast agents, gold, iodine and gadolinium.  This opens the 
possibility of targeting three different traits of interest while maintaining the intrinsic material 
information.  I also demonstrated tumour detection using intravascular injection of 15 nm gold 
nanoparticles in a mouse infected with a sub-dermal Lewis lung carcinoma. 
Both the detector and the machine are young technologies requiring extensive testing and adjustment.  
So, to achieve the results described above, I spent great effort on machine and protocol optimization. 
I developed automated pixel masking software and the associated graphical user interface (GUI) that 
identifies unreliable pixels and inhibits them on the MARS camera.  This system was modified and 
adapted for pixel masking of raw data before reconstruction by other MARS team members and a 
patent application has been submitted.  I helped develop a technique to measure the energy offset of 
each counter from the global energy threshold chosen by the user.  This produces more precise energy 
discrimination and may be used to improve material reconstruction in future MARS versions.  I also 
lead the initial attempt to develop an automated foil fluorescence energy calibration technique.  This 
work lead to a model to estimate the optimal foil thickness needed for each calibration material and 
the number of fluorescence photons emitted. 
Material calibration is also required.  I helped develop and manufactured the current commercial 
versions of the MARS calibration phantoms.  I tested material decomposition using these phantoms 
and helped develop a simple system for optimizing protocol energy thresholds for simultaneous 
identification of multiple k-edge containing materials. 
I have contributed software and hardware that is included in the commercial release of the MARS 
scanner.  My work appears in 16 journal or conference publications, with two more currently in 
preparation.  I have presented posters or given talks at domestic and international conferences. 
I have improved the function and understanding of MARS scanners through pixel masking, energy 
and material calibration analyses, and threshold and protocol optimization.  My work helps show that 
MARS images will provide a new valuable tool for clinicians in assessing disease, injury and the 
treatment of both.  Quantitative location of materials can help to identify atherosclerosis and cancer.  
As targeted contrast agents are developed, physiological, histological and biochemical traits will be 





Glossary and Abbreviations 
 ART:  Algebraic Reconstruction Technique.  Used in CT reconstruction. 
 Atherosclerosis:  a disease in which fatty lesions called plaques develop in the innermost 
layer of artery walls.   
 ASIC:  Application specific integrated circuit.  A circuit built for a specific purpose.  The 
Medipix chip is an ASIC for spectral imaging 
 AuNPs:  Gold Nanoparticles 
 Cancer:  Cancer is the uncontrolled proliferation of native cells that can spread to 
neighbouring tissues, sometimes metastasising to varied locations throughout the body 
 CdTe:  Cadmium telluride.  A semiconductor used as an X-ray sensor 
 CZT:  Cadmium zinc telluride.  A semiconductor used as an X-ray sensor 
 CERN:  European Organization for Nuclear Research. 
 Contrast to noise ratio:  a measure of image quality using contrast between two regions and 
the noise 
 CSM:  Charge Summing Mode.  A mode of operation available in the Medipix3RX that 
corrects for charge sharing across pixels. 
 CT:  Computed Tomography.  A mathematical technique used in X-ray imaging to 
reconstruct cross sections of a sample 
 CVD:  Cardiovascular Disease.  Any disease that affects the cardiovascular system.  
Atherosclerosis is a form of CVD. 
 DAC:  Digital-to-Analog Converter.  An electrical device that turns a digital number into an 
analog value 
 Dual Energy CT:  a CT technique that creates two datasets, each representing a different 
energy regime for the input beam.  It can use two different sources, or two different detectors 
or the same source with rapid kVp switching 
 FWHM:  Full Width Half Maximum.  A measure of the spread of a function that gives the 
difference between the values of the independent variable on either side of the function at a 
value of the dependent variable that is half of its maximum value 
 GaAs:  Gallium arsenide.  A semiconductor used as an X-ray sensor 
 GUI:  Graphical User Interface.   
 HU:  Hounsfield Unit.  A linear transformation of measured linear attenuation coefficients in 
a CT scan.  The transformation forces water’s attenuation value to be 0 HU and air’s 




 K-edge:  a sudden increase in X-ray attenuation of an atom occurring when increasing X-ray 
energy matches the binding energy of the K shell electrons 
 kVp:  Peak Kilovoltage.  The maximum voltage across the anode and cathode of an X-ray 
tube.  It determines the maximum photon energy emitted by the tube. 
 Linear Attenuation Coefficient:  The fraction of an incident beam of photons that is 
absorbed or scattered per unit thickness of the absorber 
 MARS:  Medipix All Resolution System.  MARS Bioimaging Ltd. is a company based in 
Christchurch dedicated to producing medical imaging technologies with the Medipix chip 
 MD:  Material Decomposition.  A process of turning spectral X-ray attenuation data into 
material images. 
 NIST:  National Institute of Standards and Technology 
 Noise Floor:  A DAC value for the global low threshold DAC below which a counter begins 
to count even with no X-ray input.  The DAC value corresponds to a photon energy below 
which the counter low thresholds cannot be set. 
 ODD:  Object to Detector Distance.  The distance from the centre of rotation of the rotating 
gantry to the surface of the X-ray sensor layer in the camera 
 SDD:  Source to Detector Distance.  The distance from the focal spot on the X-ray tube anode 
to the surface of the X-ray sensor layer in the camera.  It is the sum of  the ODD and the SOD. 
 SOD:  Source to Object Distance.  The distance from the focal spot on the X-ray tube anode 
(the source of X-rays) to the centre of rotation of the rotating gantry. 
  SNR:  Signal to Noise Ratio.  A measure of the signal quality of a data set 
 Spectral Imaging/CT:  Energy differentiated X-ray attenuation measurements in more than 
two energy bins, acquired simultaneously. 
 SPM:  Single Pixel Mode.  A mode of operation in Medipix3RX in which each pixel operates 
independently.  Therefore, there is no correction for charge sharing as in CSM. 
 ST:  Soft Tissue.  In this thesis, a soft tissue voxel has only water and lipid components in the 
material decomposition. 
 Threshold Equalization:  The process of adjusting each pixel in the Medipix3RX chip to 
respond to energy in the same way. 
 Voxel:  A voxel, or volume element, is the three dimensional image counterpart of a pixel in a 
two dimensional image. 
 XRF:  X-ray Fluorescence.  An X-ray photon emitted when an electron falls from a higher 




 Z:  Atomic Number.  The number of protons in the nucleus of an atom.  For this thesis, a high 
Z voxel in the material decomposition receives a concentration for two materials:  water and 








1)  Camera pixel inhibition masking algorithm and the associated software and GUI interface for the 
MARS scanner. 
 Inventors:  JL Healy, A Atharifard, ST Bell 
 The algorithm quickly establishes the reliability of pixels and creates a mask to inhibit (turn 
off) unreliable pixels on the camera.  The GUI allowed users to run the protocol and examine 
the mask created before saving it for scanner use.  The basic framework of function and GUI 
were retained for the much expanded second generation masking software [1, 2] 
 I contributed to all aspects of the pixel masking protocol:  algorithm, data collection and 
analysis, software and GUI design 
 This work is presented in Chapter 5 
 
2)  Developed and manufactured standardized material phantoms for use in automated material 
calibration of the MARS scanner. 
 The phantoms consist of water based solutions of salts containing the elements of most 
interest in material decomposition.  Concentrations range from easily detected to just below 
the current detection limit.  Vials are arranged in a set geometric pattern to allow automation. 
 I contributed to phantom design, choice of concentrations and was mainly responsible for 
manufacture 








3)  RK Panta, CJ Bateman, J Healy, JL Mohr, N de Ruiter, AP Butler, NG Anderson, 
SP Gieseg. Simultaneous discrimination of multiple intrinsic bio-markers in excised 
atheroma with spectral molecular imaging. New Zealand Medical Journal 2013, 126(1375): 
3. 
 This work demonstrated the detection of lipid-, water- and calcium-like materials in phantoms 
and excised atherosclerotic plaques at photon energies relevant to human scanning (30 – 120 
keV) using a Medipix3RX camera with GaAs sensor layer operating in Single Pixel Mode 
 I contributed to all phases of the work:  experimental design, data collection, data analysis, 
abstract preparation, slide layout for talk by Panta. 
 This work is presented in Chapter 3 
 
4)  Raj Kumar Panta, Christopher Bateman, Joe Healy, Alex Chernoglazov, Steven P. 
Gieseg, Anthony Butler, Phil Butler, Nigel G Anderson. Implementing spectral molecular 
imaging (spectral CT) in soft tissue. Conference Proceeding of 34th National 
Conference of Association of Medical Physicist in India (AMPICON-2013, November 




 This work demonstrated the detection of lipid-, water- and calcium-like materials in 
atherosclerotic plaque and lamb tissue samples using a MARS scanner with a Medipix3RX 
camera and GaAs or CdTe sensor layer.  Atheroma data was collected using 30 – 120 keV 
photon range while lamb data was collected using the 10 to 50 keV range. 
 I contributed to the all aspects of this work, experimental design, data collection, data 
analysis, abstract preparation, slide preparation. 
 This work is presented in Chapter 3 
5)  R. Aamir, A. Chernoglazov, C.J. Bateman, A.P.H. Butler, P.H. Butler, N.G. Anderson, S.T. Bell, 
R.K. Panta, J.L. Healy, J.L. Mohr, K. Rajendran, M.F. Walsh, N. de Ruiter, S.P. Gieseg, T. 
Woodfield, P.F. Renaud, L. Brooke, S. Abdul-Majid, M. Clyne, R. Glendenning, P.J. Bones, M. 
Billinghurst, C. Bartneck, H. Mandalika, R. Grasset, N. Schleich, N. Scott, S.J. Nik, A. Opie, T. 
Janmale, D.N. Tang, D. Kim, R.M. Doesburg, R. Zainon, J.P. Ronaldson, N.J. Cook, D.J. Smithies, 
K. Hodge MARS Spectral Molecular Imaging of Lamb Tissue: Data Collection and Image Analysis.  
Journal of Instrumentation 9, no. 02 (February 17, 2014): P02005–P02005. doi:10.1088/1748-
0221/9/02/P02005. 
 This work demonstrates material decomposition of lipid-, water- and calcium-like materials in 
a lamb chop using photon energies from approximately 10 to 50 keV.  The study was 
conducted for the purpose of making a quality data set available online which included raw, 
reconstructed and material reconstructed data 
 I contributed to protocol development and manuscript preparation. 
 This work is presented in Chapter 3 
 
6)  K. Rajendran, M.F. Walsh, N.J.A. de Ruiter, A.I. Chernoglazov, R.K. Panta, A.P.H. Butler, P.H. 
Butler, S.T. Bell, N.G. Anderson, T.B.F. Woodfield, S.J. Tredinnick, J.L. Healy, C.J. Bateman, R. 
Aamir, R.M.N. Doesburg, P.F. Renaud, S.P. Gieseg, D.J. Smithies, J.L. Mohr, V.B.H. Mandalika, 
A.M.T. Opie, N.J. Cook, J.P. Ronaldson, S.J. Nik, A. Atharifard, M. Clyne, P.J. Bones, C. Bartneck, 
R. Grasset, N. Schleich and M. Billinghurst.  Reducing beam hardening effects and metal artefacts in 
spectral CT using Medipix3RX.  2014 JINST 9 P03015 
 This work describes the reduced artefacts and increased contrast in narrower and/or higher 
energy bins for spectral reconstruction of scans of metal scaffolds.  It discusses the 
implications for scanning protocols used to scan tissues with embedded metal.  All raw and 
reconstructed data are available online 
 I contributed to protocol development and manuscript editing.  I was responsible for training 
the first author in use of the scanner 
 This work is not discussed in this thesis as I was primarily involved as a sounding board for 
ideas and then in significant editing, but not in the work that was actually done, except to 
make phantoms. 
 
7)  RK Panta, R. Aamir, JL. Healy, K. Rajendran, NJA. de Ruiter, M. Moghiseh, APH. 
Butler, NG. Anderson, SP. Gieseg and PH. Butler. Multiple K-edges imaging with 
MARS-CT: proof of concept. The Annual Conference of the New Zealand Branch of 
the Australasian College of Physical Scientists and Engineers in Medicine (November 
20-21, 2014, Christchurch, New Zealand), 63. 
 This was a phantom study using human relevant photon energies (30 – 120 keV) to 
demonstrate simultaneous differentiation of four high atomic number materials (Gold, 
Gadolinium, Iodine, Calcium) based on spectral patterns revealing K-edge effects. 
 This study used phantoms of my construction.  I contributed to experimental design, data 




 This work is presented in Chapter 4 
 
8)  JL Healy, RK Panta, R Aamir, K Rajendran, NJA de Ruiter, CJ Bateman, AI Chernaglozov, MF 
Walsh, ST Bell, NG Anderson, APH Butler, PH Butler, SP Gieseg.  Differentiating lipid, water and 
calcium-rich regions within atherosclerotic plaques using multi-energy CT.  (2015) New Zealand 
Medical Journal 128(No. 1421):96. 
 This work demonstrated spatial histologic correlation of lipid and calcification in an 
atherosclerotic plaque with the material decomposition of plaque scans at human relevant 
photon energies (30 – 120 keV).  It is the first time a MARS scanner equipped with a 
Medipix3RX camera operating in Charge Summing Mode was confirmed to correctly identify 
traits of plaque vulnerable to rupture (a necrotic lipid core and spotty calcifications) while 
excluding low energy photons (below 30 keV) from the data set. 
 I was primarily responsible for all aspects of this work:  experimental design, protocol 
development, scanning samples, histologic processing, image correlation and abstract writing. 
See reference in Oral Presentations. 
 This work is presented in Chapter 3 
 
9)  A Lindsay, J Healy, W Mills, JG Lewis, N Gill, N Draper, SP Gieseg.  Impact-induced muscle 
damage contributes to oxidative stress in professional rugby union (2015) New Zealand Medical 
Journal 128(No. 1421):96. 
 See contribution 12 for description 
 
10)  M. Moghiseh, R. Aamir, R.K. Panta, N. de Ruiter, C.J. Bateman, A. Chernoglazov,       J.L. 
Healy, A.P.H. Butler, N.G. Anderson.  Multi-energy spectral data of multiple high-Z materials – a 
phantom study.  (2016) JSM Biomed Imaging Data Pap 3(1): 1007 
 This work shows simultaneous material decomposition of gold, iodine, gadolinium, calcium, 
lipid and water in a phantom.  The full raw, reconstructed and material reconstructed data sets 
are available online.  The paper illustrates K-edge detection and the degree of material mis-
identification as a function of concentration. 
 This study used phantoms of my construction.  I contributed to experimental design and 
manuscript preparation. 
 This work is presented in Chapter 4 
 
11)  L. Vanden Broeke, A. Atharifard, B. P. Goulter, J. L. Healy, M. Ramyar, R. K. Panta, M. 
Anjomrouz, M. Shamshad, A. Largeau, K. Mueller, M. F. Walsh, R. Aamir, D. J. Smithies, R. 
Doesburg, K. Rajendran, N. J. A. de Ruiter, D. Knight, A. Chernoglazov, H. Mandalik, C. J. Bateman, 
S. T. Bell, A. P. H. Butler, and P. H. Butler. Oblique fluorescence in a MARS scanner with a CdTe-
Medipix3RX.  2016 JINST 11 C12063 
 This work describes a model for using off-axis X-ray fluorescence from monoatomic foils to 
perform per-pixel energy calibration of MARS scanners in situ.  The model calculates the X-
ray fluorescence intensity across the detectors field of view to enable positioning the camera 
in the ideal location for maximum fluorescence and minimum scatter from the primary beam.  
Initial experimental comparisons with the model are presented 
 I participated in all aspects of this work including model development, experimental design, 
data collection and analysis. 





12)  A. Lindsay, J. Healy, W. Mills, J. Lewis , N. Gill, N. Draper, S. P. Gieseg.  Impact-induced 
muscle damage and urinary pterins in professional rugby: 7,8-dihydroneopterin oxidation by 
myoglobin.  Scandinavian Journal of Medicine & Science in Sports [2016, 26(3):329-337] 
 This work examines the possible reactions of myoglobin and iron released from injured 
muscles with pterins  produced in humans (some of which are thought to serve as anti-
oxidants during oxidative stress).  Products of reactions between myoglobin or iron and 7,8-
dihydroneopterin were studied in vitro and then measured  in urine samples from rugby 
players before and after games.  Impact muscle injury had positive correlations with the 
reactants and reaction products. 
 I participated in sample collection, data analysis and ran the enzyme-linked immunosorbent 
assay for myoglobin concentration in the urine samples.  I also helped edit the manuscript. 
 This work was not part of my proposal and is not discussed further in this thesis.  It represents 
a contribution I was able to make to a fellow student’s work because of the skills I developed 
working in Steven Gieseg’s lab. 
 
13)  Gieseg SP, Healy JL, Prebble HM, Panta RK, Aamir R, de Ruiter NJA, Bateman CJ, Walsh MF, 
Bell ST, Anderson NG, Butler APH, Butler PH, White V, Roak J.  Spectral Imaging of Unstable 
Atherosclerotic plaque by MARS-Scanning. Internal publication of the European Organization for 
Nuclear Research, CERN. 
 This work is an overall review of progress in imaging of atherosclerotic plaque with MARS 
scanners.  It includes material decomposition of intrinsic markers of vulnerable plaque in 
excised plaques in air and in a solution of gadolinium contrast agent.  It also demonstrates the 
use of Calcium measurements from MARS scanning of plaque sections to correct metabolic  
measurements on live plaque sections for the amount of calcification present.  We also 
demonstrated the ability of human macrophages to uptake gold nanoparticles in quantities 
sufficient to allow imaging with MARS which is a first step in developing spectral CT 
contrasts for imaging atherosclerosis. 
 I was involved in all aspects of research presented in this overview:  design and execution of 
experiments and scanner protocols, data analysis, image creation, training of Hannah Prebble 
in use of the MARS scanner, cell culture, and abstract preparation 
 This work is covered in Chapters 3 and 4 
 
14)  Ali Atharifard, Joe L. Healy, Brian P. Goulter, Mohsen Ramyar, Lieza Vanden Broeke, Michael 
F. Walsh, Chikezie C. Onyema, Raj K. Panta, Raja Aamir, Derek J. Smithies, Robert Doesburg, 
Marzieh Anjomrouz, Muhammad Shamshad, Kishore Rajendran, Niels J. A. de Ruiter, David Knight, 
Alex Chernoglazov, Harish Mandalik, Stephen T. Bell, Christopher J. Bateman, Anthony P. H. Butler 
and Philip H. Butler. Per-pixel Energy Calibration of Photon Counting Detectors. 2017 JINST 12 
C03085 
 This work describes a technique for finding the energy offset of each counter on each pixel in 
the MARS camera from the global energy calibration of the counter thresholds.  The 
technique will allow future MARS reconstruction software versions to correct for the 
variations in energy response between pixels that cannot be adjusted for using hardware 
settings.  This will enable more accurate material identification using corrected spectral data. 
 I was involved in concept development, experimental design, data acquisition and manuscript 
review. 





15)  Mahdieh Moghiseh, Aamir Raja, Joe Healy, Anthony Butler, Nigel Anderson.  Identification and 
quantification of multiple high-Z materials by spectral CT.   European Congress of Radiology, Vienna 
Austria, 2017. 
 This work describes experiments that demonstrate the continued progression and 
improvement in simultaneous identification of three contrast agents (gadolinium, gold and 
iodine based) and bone (calcium) in a MARS scan.  Phantoms and mice with each material 
concentrated in separate compartments were scanned and the material decomposition results 
examined visually and quantitatively. 
 I produced the phantoms, was primarily responsible for experimental design and performed 
the mouse tail vein injections of gold and iodine contrast agents.   I was involved in scanner 
protocol development and data analysis. 
 This work is covered in Chapter 4 
 
 
16)  Muhammad Shamshad, Marzieh Anjomrouz, Derek J Smithies, Antoine Largeau, Gray Lu, Ali 
Atharifard, Lieza Vanden Broeke, Raja Aamir, Raj Kumar Panta, Michael F Walsh, Brian P Goulter, 
Kishore Rajendran, Srinidhi Bheesette, Joe L Healy, Niels de Ruiter, Alex Chernoglazov, Harish 
Mandalika, Robert Doesburg, Stephen T Bell, Christopher J Bateman, Anthony P Butler, and Philip H 
Butler.  Semi-analytic off-axis  X-ray source model.  2017 JINST 12 P10013 
 This work describes a Monte Carlo-based model for estimating the relative and absolute 
intensity of X-rays of arbitrary energy bins produced by a broad spectrum X-ray source.  The 
model is used in assessing X-ray source and camera function for quality assessment of MARS 
scanners.  In the future, it will be a patented part of the commercial MARS imaging chain. 
 I trained the primary author in use of the machine and was involved in manuscript 
development. 
 This work is not covered in this thesis as I was heavily involved in manuscript development 
but not in the work described. 
 
 
17)  Raj Kumar Panta, Stephen T. Bell, Joe L. Healy, Raja Aamir Younis, Christopher J. Bateman, 
Niels J. A. de Ruiter, Mahdeih Moghiseh, Steven P. Gieseg, Anthony P. H. Butler and Nigel G. 
Anderson.  Element-specific spectral imaging of multiple contrast agents:  a phantom study.  2018 
JINST 13 T02001 
 This work describes a simple procedure for choosing threshold X-ray energy settings to 
optimize simultaneous detection of material k-edges using the MARS spectral scanner.  The 
k-factor is introduced and used in combination with the relative X-ray intensity of each bin 
(which will correspond to the signal to noise ratio) to establish a rank for each protocol for 
each material.  The summed ranks for each protocol are compared and the lowest total is 
deemed optimal.  Results are shown that illustrate the effectiveness of the procedure. 
 I helped develop the ranking system and experimental protocols.  I helped in manuscript 
preparation and editing.  I manufactured the phantoms. 
 This work is covered in Chapter 4 
 
 
18) Hannah Prebble, Sean Cross, Edward Marks, Joe Healy, Emily Searle,
 
Raja Aamir, Nigel 




activation in live excised atherosclerotic plaque.  Immunobiology 
https://doi.org/10.1016/j.imbio.2018.03.002 
 This work describes the use of MARS material reconstruction to measure the quantity of 
calcium in live excised carotid endarterectomy samples.  Plaques were manipulated to 
activate macrophages present in the tissue and then physiological responses and neopterin 
production was measured.  Calcium measurement were assumed to represent material in the 
plaque that could not contribute to physiologic response and so each sections data were 
corrected based on the proportion of that section occupied by calcification. 
 I was involved in protocol development, plaque visualization, the calcium measurements, and 
document editing 
 This work is not presented in this thesis as my role was primarily advisory and in training the 






19)  Identification of lipid and calcium-rich regions in excised carotid atherosclerotic plaque using 
spectral CT—intended for submission to European Radiology. 
 
20)  Material visualization of excised carotid plaque submerged in contrast agent solutions using 




21)  Healy JL, Gieseg SP, Prebble HM, Panta RK, Aamir R, de Ruiter NJA, Bateman CJ, 
Chernoglazov AI, Walsh MF, Bell ST, Anderson NG, Butler APH, Butler PH, White V, Roake J.  
Imaging of Cardiovascular disease by Spectral CT imaging.  Joint Scientific Meetings of the 
Australian Atherosclerosis Society, the High Blood Pressure  Research Council of Australia and the 
Australian Vascular Biology Society, Hobart, Australia 07-10/12/2016. 
 This poster showed the ability to visualize an excised atherosclerotic immersed in a 
gadolinium contrast agent at 6 mg Gd/ml solution.  Material decomposition was compared 
between scans of the same plaque in air and then in the Gd solution.  The lipid and calcium 
component images were maintained in the Gd background.  This is an indicator that intrinsic 
material information of interest will be attainable simultaneously in clinical contrast enhanced 
scans such as CT angiography. 
 I was primarily responsible for all aspects of this study.  I designed and carried out the 
experiments, helped in design of the scanner protocol, produced the phantom, analysed the 
data, performed the custom material decomposition protocol and produced the images used in 
the poster. 
 This work is covered in Chapter 3 
 
22)  Healy JL, Panta RK, Aamir R, Rajendran K, de Ruiter NJA, Bateman CJ, Chernaglozov AI, 
Walsh MF, Bell ST, Anderson NG, Butler APH, Butler PH, Roake, J, Gieseg SP.  Multienergy X-ray-
CT Identification of Lipid Cores and Calcium Mineralisations in Excised Carotid Plaques.  Annual 
Scientific Meetings of the Australian Atherosclerosis Society, Fremantle, Australia, 21-23/10/2015. 





23)  RK. Panta, R. Aamir, JL. Healy, K. Rajendran, NJA. de Ruiter, M. Moghiseh, ST. Bell, MF. 
Walsh, APH. Butler, NG. Anderson, SP. Gieseg and PH. Butler. Element specific spectral imaging 
using a MARS scanner.  ‘MedTech in Christchurch’ workshop, University of Otago, Christchurch, 
New Zealand, 16/12/2014. 
 This poster illustrated the simultaneous discrimination of multiple materials in a MARS scan 
using phantoms of gold, iodine, gadolinium, calcium, water and lipid. 
 I was constructed the phantoms and was involved in protocol design, data collection and 
analysis. 
 This material is covered in Chapter 4 
 
24)  Christopher J. Bateman,  Raj Kumar Panta, Judy Mohr, Niels de Ruiter, R. Aamir,  Anthony 
Butler,  Philip Butler,  Peter Renaud, Alexander Chernoglazov, Joe Healy, Nanette Schleich, Steven 
Gieseg,  Stephen Bell, Karen Alt, Karlheinz Peter, Christoph Hagemeyer.  Material discrimination 
with MARS.  HOPE Meetings, Tokyo, Japan, 11-15/03/2014. 
 This poster was an overview of the MARS system and the material reconstruction results 
available at that time. 
 I provided the atheroma data sets and images used and helped edit the poster 
 This work is contains material covered in Chapters 3 and 4 
 
25)  M.Moghiseh, R.Aamir, J.Healy, Dh.Kumar, K.Chitcholtan, P.Sykes, G.Dachs, R.K.Panta, 
N.J.de.Ruiter, A.I.Chernoglazov, C.J.Bateman, D.Knight, A.M.Henning S.T.Bell, A.Butler, P.Butler , 
N.Anderson.  MARS Spectral Imaging of Nano-Particles As a New Modality For Detecting Cancer.  
Otago Spotlight Series: Cancer Research, University of Otago, Christchurch, New Zealand, 
20/10/2015 
 This work showed the detection and quantification of 2 nm gold nanoparticle in phantoms and 
a Lewis lung carcinoma tumour grown subcutaneously in a mouse.  The abnormally large 
endothelial fenestra in the tumour neovasculature allows the build-up of gold nanoparticles 
specifically in the tumour.  In the future, using MARS to identify gold nanoparticles in 
tumours may be useful in cancer diagnosis, assessment of quality of targeting of treatments 
and monitoring of cancer progression/regression. 
 I was involved in experimental design, data collection, data processing and poster 
development.  I performed the tail vein injections. 





26)  Healy JL.  Breaking down arterial walls: testing the ability of spectral CT to image 
carotid atherosclerotic plaques.  MARS mini-conference.  Centre for Bioengineering, University of 
Otago, Christchurch, New Zealand, 22/05/2013. 
 This talk described my research goals with respect to MARS imaging of intrinsic biomarkers 
of atherosclerosis 
 This work is covered in Chapter 3 
 
27)  Healy JL.  Spectral X-ray Tomography Imaging of Vulnerable Atherosclerotic Plaque.  Annual 




 This talk covered the data presented in publication 3 above. 
 
28)  Healy JL, Atharifard A.  Detector Characterisation for Improving Image Quality.  MARS 
seminar, University of Canterbury, Christchurch, New Zealand, 16/10/2013. 
 This talk presented the first results testing a pixel masking technique for inhibiting pixels on 
the MARS camera and described to MARS users how to use and make use of the masking 
protocol on the scanners. 
 This work is covered in Chapter 5 
 
29) Healy JL.  Spectral X-ray Tomography Imaging of Vulnerable Atherosclerotic Plaque.  Vascular 
Surgery Team meeting, Christchurch Hospital, New Zealand, 20/11/2013. 
 This talk presented our findings to the surgeons who collaborate with us in obtaining carotid 
endarterectomy samples. 
 
30)  Healy JL, Panta RK.  CT 10 and 11 Assessment.  MARS IQ team meeting, University of 
Canterbury, Christchurch, New Zealand, 07/04/2014. 
 This talk described our assessment and work in commissioning two MARS scanners 
 I was involved in all aspects of this work as equal investigator 
 This work is covered in Chapter 5 
 
31)  Healy JL.  Material Characterisation of Atherosclerotic Lesions with Spectroscopic X-ray CT.  
Annual Biology Conference, University of Canterbury, Christchurch, New Zealand, 23/10/2015. 
 This talk describes intrinsic imaging of atherosclerotic plaque 
 I am responsible for all work presented 
 The work is covered in Chapter 3 
 
32)  Healy JL.  Differentiating lipid, water and calcium-rich regions within atherosclerotic plaques 
using multi-energy CT. Scientific Meetings of the Health Research Society of Canterbury, University 
of Otago, Christchurch, New Zealand,  22 & 29/11/2015. 
 See description for previous citation 
 
33)  Healy JL.  Interpreting the Calcium Component of Atheroma MD.  MARS seminar, University of 
Canterbury, Christchurch, New Zealand, 06/07/2016. 
 This work described strategies and problems with interpreting the calcium component of 
MARS MD of atherosclerotic plaque 
 I was involved in all aspects of this work and am entirely responsible for the calcium 
assessment ideas 





34)  Best poster.  MedTech in Christchurch Workshop poster competition.  16/12/2015.  For  Healy 
JL, Panta RK, Aamir R, Rajendran K, de Ruiter NJA, Bateman CJ, Chernoglazov AI, Walsh MF, Bell 
ST, Anderson NG, Butler APH, Butler PH, Roake, J, Gieseg SP.  Multienergy X-ray-CT 








35)  Hayley Schoch.  Radiation survival of cells within excised plaque during spectral-CT imaging.  
University of Canterbury Summer Research Scholarship, 2014. 
 Hayley established that excised plaques scanned in MARS at room temperature and then 
cultured for 48 hours showed no difference in metabolic activity compared to unscanned 
plaques.  This was the first step in establishing the feasibility of using MARS to characterise 
physiological or biochemical processes in live plaques.  Hayley learned how to:  run scans on 
the MARS scanner, create publication quality images using MARS Vision software, design 
replicated experiments, culture human derived cell lines, culture human derived tissues, and 
collect data with UV-vis spectrometers and HPLC machines. 
 This work is covered in Chapter 3 
 
36)  Dylan Paterson.  Small animal monitoring for live spectral imaging for non-invasive 
quantification of multiple biomarkers in different mouse models.  University of Canterbury Summer 
Research Scholarship, 2015. 
 
 Dylan tested small animal monitors for heart rate, breathing rate, blood oxygenation and 
temperature to be used inside the MARS scanner when live animal scanning begins.  He 
learned proper handling technique and anaesthesia procedures for live mice while testing the 
equipment on anaesthetized wild type mice.  He also demonstrated the importance of external 
warming sources to maintain mice body temperature at safe levels while under anaesthesia. 
 This work is covered in Chapter 3 
 
 
Chaired Conference Sessions 
 
37)  Annual Biology Conference, University of Canterbury, Christchurch, New Zealand, 23/10/2015. 
 
38)  Annual Biology Conference, University of Canterbury, Christchurch, New Zealand, 20/10/2016. 
 


















42)  Baker IDI.  Imaged excised carotid atherosclerotic plaques incubated in anti-platelet scfv-
antibody-gold nanoparticle conjugates.  Imaged mice with the same antiplatelet functionalized gold 











This work was undertaken to explore and refine the use of spectral CT to locate,  identify and 
quantify  materials that indicate disease or injury in biological samples, with an emphasis on 
mimicking true human CT scans by filtering low energy photons (< ~30 keV) from the X-ray 
spectrum.  The platform used for spectral CT is the MARS small animal scanner (MARS 
Bioimaging Ltd., Christchurch, New Zealand).  As the MARS scanner is an emerging new 
technology, this work necessarily and intentionally includes developmental work on scanner 
and camera adjustment, calibration and assessment.  The scanner’s material output is termed 
a MARS image and is a quantitative material reconstruction of a scanned volume.  Materials 
of interest were both intrinsic:  lipid and calcium, and foreign:  gold, gadolinium and iodine 
contrast agents. 
Some diseases and their progression can be identified directly by characteristic intrinsic 
material distributions.  Atherosclerosis is characterised by abnormal lipid accumulation and 
calcium hydroxyapatite deposition in the arterial wall.  Excised atherosclerotic plaques were 
scanned to test the differentiation of high lipid and calcium regions from the soft tissue 
background. 
Spectral X-ray CT is especially suited to contrast imaging because the K (or 1s) shell 
photoelectric effect occurs for high atomic number elements (arbitrarily, Z > 50 with a K-
edge at 29.2 keV) in the human CT imaging photon energy range.  X-ray attenuation 
decreases as the cube of increasing photon energy but rises sharply at atomic K-edges.  This 
discontinuity can be detected with spectral CT and means that multiple contrast agents can be 
identified simultaneously.   
Diseases are detectable by the use of introduced contrast agents.  Anatomical, physiological, 
cellular and biochemical traits can be revealed with proper targeting of high atomic number 
contrasts.  To test simultaneous differentiation of contrast agents and intrinsic materials, 
excised atheromas and whole mice were scanned.  Atheromas were scanned in air and 
submerged in gadolinium contrast agent to test the fidelity of the lipid and calcium signals in 
contrast enhanced CT.  To demonstrate cancer detection, mice with implanted subcutaneous 
Lewis Lung carcinoma tumours were scanned after injection of 15 nm gold nanoparticles 
(AuNPs).  The particles do not pass through the fenestrae (pores) of healthy vascular 
endothelium, but will accumulate in tumours due to abnormally large endothelial fenestrae in 
the neovasculature that supplies the tumour.  A feasibility study for simultaneous 
identification of three contrasts (gold, gadolinium and iodine) and three intrinsic materials 





The MARS scanner uses energy discriminating, photon counting technology to 
simultaneously obtain multiple X-ray attenuation datasets in one scan.  The X-ray source 
used in CT imaging produces a broad spectrum with photon energies that range from the 
lowest allowed by filtration, 10 keV or more, to a maximum around 140 keV.  Conventional 
CT measures only total energy attenuation across the spectrum but the MARS scanner can 
measure photon count attenuation within up to eight adjacent energy ranges. 
Every element has a different spectral X-ray attenuation profile.  Adjacent volumes with 
different elemental makeup can have the same total energy attenuation across the spectrum 
and are thus indistinguishable in conventional CT.   However, the pattern of attenuation 
across multiple energy ranges will differ which allows spectral X-ray detection to identify 
materials. 
As with any measurement, the quality of the raw data collected (energy sensitive photon 
count attenuation) determines the quality of the conclusions (material identification and 
quantification).  Any adjustment or technique that improves the accuracy of the photon 
counting or the energy resolution will also improve material identification.  This thesis 
includes work on assessing and masking the MARS camera pixel matrix to eliminate pixels 
that produce faulty data.  Also, standard commissioning tests are described along with a new 
quality assessment technique for the quantitative material images or material decomposition 
(MD).  Finally, two techniques for producing pixel specific energy calibrations are described 
which could replace the chip-wide energy calibration currently in use. 
The ability to identify materials and measure concentrations within a volume using a 
noninvasive measurement has potential value in many fields, including geology, security, 
food processing and medicine.  Both clinical practice and clinical research will benefit from 
material reconstructions which add a new dataset to the diagnostic toolbox. 
 
1.2 Overview 
The thesis chapters are organized into three sections.  Chapters 1 and 2 provide context and 
background on both the machine and the biological models used for scanning.  Chapters 3 
and 4 describe imaging experiments.  Phantoms and biological samples were scanned to test 
material identification under various conditions.  The ultimate goal was to refine protocols to 
optimize material identification using photon energies relevant to human scanning (30 to 120 
keV for this thesis).  This is in anticipation of the first MARS human-sized scanner which is 
undergoing commissioning now.  Chapters 5 and 6 describe technical work on the machine, 
data assessment and pixel specific energy calibration.  The thesis concludes with a chapter 
summarizing the results and describing future work in spectral CT inspired by the outcomes 
of this thesis. 
The background (Chapter 2) is designed to be read unless the reader is very familiar with a 
particular topic.  Each section describes an important field related to the thesis and in some 




introductions that provide the context for much of the research described.  In so doing, it 
prevents repetition in the introductions and discussions of each chapter and chapter section. 
Chapters 3 and 4, intrinsic and contrast enhanced imaging of biological samples with MARS, 
respectively, include a range of studies carried out with several different collaborators, but all 
part of the MARS clinical teams goals to explore the potential of spectral CT and material 
reconstructions to aid disease diagnosis, assessment, progression/regression and treatment.  
The introductions and discussions of some chapter sections are more detailed than others and 
address the MARS scanner’s potential and deficiencies at greater length.  These longer 
chapter sections are the studies that were most interesting to me and/or involved my greatest 
input but the discussions are, largely, applicable to other studies in the same chapter which 
are kept shorter to prevent repetition. 
Each chapter follows the same structure: Introduction, Study 1, Study 2 etc., and 
Conclusion.  Within each Study section, the format is also the same.  An Introduction 
divided into subsections:  Aim, Significance, Publication and Contribution, is followed by 
Methods, Results and Discussion. 
Finally, a note on the terminology used for the material decomposition.  Each voxel of the 
material reconstruction has a concentration for water and one of the other materials used in 
the calibration phantom, e.g. gold or lipid.  While publications from MARS team members 
typically refer to lipid-like or gold-like voxels to make clear the uncertainty in knowing the 
actual content, this thesis will simply say lipid or gold and assume the reader is aware that 
unknown materials have been mapped onto a limited set of calibration materials. 
 
1.3 Chapter topics 
Chapter 1 introduces the thesis goals, reviews the general organization and describes each 
chapter’s content. 
Chapter 2 provides background information to familiarize readers with broad topics of 
importance in the thesis.  Principles and techniques of computed tomography and spectral CT 
are described.  The MARS scanner, camera and software are explained so that readers 
understand the collection and processing of raw photon count data and its transformation into 
attenuation and material reconstructions.  Important biological topics are described, in 
particular, atherosclerosis and cancer. 
Chapter 3 investigates the use of MARS spectral CT to measure lipid and calcium content 
within biological samples, with an ultimate goal of identifying lipid cores and spotty 
calcification in atherosclerotic plaque.  Studies progress from macroscopic views  of a lamb 
chop using low energy photons that maximize soft tissue information to an in depth analysis 
of the lipid and calcium content of atherosclerotic plaque scanned with higher energy photons 




Chapter 4 demonstrates the potential of MARS spectral CT in measuring contrast agent 
distributions and intrinsic material arrangements in biological samples, simultaneously.  
Phantom studies are used to investigate and refine energy threshold placement to optimize K-
edge detection.  Single contrasts are used to show cancer detection by accumulation of 
contrast within a tumour in a mouse model, atheroma detection even when the plaque is 
submerged in contrast solution and macrophage detection resulting from active uptake of 
contrast.  Three contrast agents, bone and lipid are all differentiated simultaneously in a 
mouse. 
Chapter 5 describes efforts to assess the quality of the imaging chain and indicate areas that 
could be improved.  The highlight is preliminary work on determining pixel quality in the 
MARS camera and the subsequent masking software to eliminate bad pixels.  The 
commissioning effort of two MARS small animal scanners is briefly described.  A new data 
graphing technique comparing attenuation values to material concentrations is described that 
provides a strong measure of the impact of the partial volume effect on material 
decomposition. 
Chapter 6 presents two strategies for developing a per pixel energy calibration to replace the 
whole camera calibration currently used.  First, a method for calculating an energy offset for 
each pixel using threshold scans similar to the current global calibration technique is 
described.  Second, a direct per pixel energy calibration is demonstrated using Kα 
fluorescence from molybdenum and lead. 
Chapter 7 concludes the thesis.  An outline of the significant results of each chapter is 
presented.  Future research possibilities are described along with a vision of the potential of 







2.1 MARS scanners 
The MARS small sample scanner (Figure 2.1) is a spectroscopic X-ray CT (see Section 2.4) 
unit.  A lead protected vault houses a micro-focus X-ray source opposite a MARS X-ray 
camera on a rotating gantry with horizontal axis of rotation.  The sample holder moves the 
scan subject horizontally through the X-ray beam near the centre of rotation.  Objects up to 
~100 mm in diameter may be scanned.  The source to object distance (SOD), object to 
detector distance (ODD) and source to detector distance (SDD) are adjustable and the camera 
can be moved tangential to the rotation in order to cover larger diameter objects by repeating 
the scan for multiple vertical camera positions and stitching the overlapping images together. 
 
 
Figure 2.1:  The MARS small animal scanner from outside and in. 
 
The MARS scanner is built around the Medipix chip family of photon counting, energy 
resolving detectors developed at the European Organization for Nuclear Research (CERN) 
(see Section 2.2).  Currently, cameras have between 1 and 5 chips arranged vertically or tiled 
as a four chip square.  A detailed description of the camera is found in the PhD work of 
Robert Doesburg [3]. 
The eight counters per pixel have adjustable lower energy threshold settings.  A threshold 
sets a lower limit for photon energy detection.  In theory, all photons attenuated within a pixel 
that have an energy above the threshold are counted, photons attenuated but below the 
threshold are ignored.  By setting the eight thresholds to different values, simultaneous 
spectroscopic X-ray attenuation data can be acquired.  In reality, sensor and application 




interactions create noise in the data [4].  Correcting for this noise is accomplished through 
Medipix chip adjustment and MARS data processing software. 
MARS vision software consists of reconstruction [5], material decomposition (MD) [6] (see 
Section 2.6) and visualization units [7].  A reconstruction is created for each energy bin using 
a proprietary iterative algebraic reconstruction technique which will be referred to as mART.  
The MD uses the energy bin reconstructions to analyse the spectral behaviour of each voxel 
and determine the material content and concentration.  MARS vision software provides a 
platform for visualizing and making measurements of the attenuation and/or the material 
reconstructions.  Data can be viewed in grayscale or colour, with customisable transfer 
functions based on attenuation or concentration, using 2-D and 3-D projections.  A virtual 3-
D space can be visualized through integration with a zSpace® (zSpace, Inc., Sunnyvale, CA, 
USA) platform. 
The X-ray sources are by source-ray, inc., Ronkonkona, New York, USA.  In this thesis, 
sources have a peak kilovoltage (kVp) of 80 kVp with a ~33 µm focal spot or 120 kVp with a 
~50 µm focal spot.  They are broad spectrum sources with a tungsten target.  The operating 
voltage and current are adjustable, allowing control over the spectrum content and flux. 
 
2.2 Medipix chip and photon counting 
The Medipix chip is an Application-specific Integrated Circuit (ASIC) computer chip 
originally developed for high energy particle detection by an international collaboration 
based at CERN [8–11].  Bonded to a semiconductor sensor it forms a hybrid pixel detector 
for counting single event particle interactions.  It converts electron/hole pair clouds created 
by photon interaction in the sensor into a current that is proportional to the energy of the 
photon.  Thus, it can count individual photon interactions and assess if the energy is above an 
arbitrary threshold.  It has been adapted for use in medical X-ray imaging [12]. 
The chip contains electronics for processing the magnitude of electrical signals (i.e. a current 
or voltage) on a timescale of ~25 ns or less [13].  It is divided into 55 µm pixels each with 
two counters that tally individual electric signals over an arbitrary current magnitude, called 
the energy threshold. 
For the MARS X-ray cameras used in this thesis, a semiconductor sensor layer is bump 
bonded to the Medipix chip on a 110 µm pattern which combines four 55 µm ASIC pixels to 
make one pixel with 8 independent energy sensitive photon counters [11].  At 14.08 mm X 
14.08 mm, the sensor has 128 pixels per row and column for 16,384 pixels total. 
Because the sensor layer is not pixelated the charge clouds created by photon attenuation may 
diffuse across multiple pixels in the ASIC leading to multiple counts for one event, all with 
incorrect energy assessment.  This is called charge sharing.  Medipix has charge summing 
and arbitration electronics for assessing which pixel the photon interaction actually occurred 




While each counter on each pixel processes the event amplitude signal independently, the 
pixels are not truly independent.  The energy threshold value for each counter is set globally 
using a digital-to-analog converter (DAC).  So, counter one has the same threshold DAC 
value for all pixels, counter two has the same DAC value for all pixels and so on for all eight 
counters (see Section 2.3). 
 
2.3 Equalization, energy calibration and material calibration 
The MARS camera requires pixel equalization and energy calibration to maximize its 
spectroscopic function [14, 15].  Equalization minimizes threshold dispersion in the energy 
calibration.  Threshold dispersion means that at a specific global DAC value for a given 
counter, each pixel will actually be set to a slightly different energy threshold.  Equalization 
involves adjusting each pixel so that just above the noise floor (which is presumed to be at 
the same energy for all pixels) corresponds to the same DAC value in the global energy 
threshold settings for each counter.  The adjustment is imperfect and a certain level of 
threshold dispersion remains (see Chapter 6) [4, 11]. 
After equalization, the global energy threshold DAC values must be calibrated to actual 
photon energy values (see Chapter 6).  Currently for MARS cameras, energy calibration is 
done with the X-ray kVp technique [16].  Very simply, the X-ray tube is set to a series of 
voltages and at each the camera is run through a range of DAC thresholds.  The DAC value at 
which half of the pixels are counting and half not is established as the global DAC value 
corresponding to the highest energy photons present in the current beam (which is equal in 
keV to the kVp of the X-ray tube).  A calibration line is then fit for each counter through the 
series of values for each voltage setting. 
Material calibration is required for the MD (see 2.6).  The materials that are identified by the 
MD are arbitrary; therefore, the user establishes the materials of interest and must make a 
phantom for each to use in calibration.  The material phantom with a range of concentrations 
for each material is scanned using the same protocol to be used for sample scanning and the 
attenuation is measured for each material concentration.  This is converted to a mass 
attenuation coefficient for each material at each energy bin.  This series of spectral signatures 
is used as the calibration.  The sample scans are then compared to these signals to determine 
content. 
 
2.4  Charge Summing Mode and Single Pixel Mode 
Charge sharing gives rise to noise due to incorrect counting and energy measurement.  To 
correct for charge sharing, Medipix3RX introduced functional charge summing mode (CSM) 
[11, 17].  The chip can be operated with CSM on or off.  When off, it is operating in single 




In SPM, each pixel operates independently of the surrounding pixels.  The charge collected 
from the sensor layer in each pixel is compared to the thresholds for each counter and tallied 
or not regardless of the source of the signal.  This means that a single photon interaction can 
give rise to a signal in multiple pixels and its energy is divided between them.  The signal 
may be counted as too many photons each with a lower energy or the photon may not be 
counted at all if the energy is dispersed in such a way that no thresholds are exceeded, even 
though the total energy would have been counted by some counters if deposited in a single 
pixel.  In MARS cameras, SPM allows the use of eight energy bins. 
To correct for charge sharing, CSM was introduced.  See 2013 JINST 8 C02016 by 
Ballabriga et al. for a good description of the chip architecture and function [11].  In Charge 
Summing Mode (CSM), the current generated simultaneously in adjacent pixels is summed 
and assigned to the pixel with the largest portion as a single photon where it is counted by 
any counters with thresholds set below the measured total.  In theory, this eliminates the 
counting and energy noise from charge sharing. 
To enable CSM, the eight counters on each pixel are used in different ways, which means that 
eight equivalent energy bins are no longer available.  One counter, the arbitration counter, is 
used for assigning the summed signal to the correct pixel and three are left operating in SPM, 
meaning they do not contain the charge sharing correction.  Thus, four counters remain for 
CSM. 
For all SPM scans in this thesis, eight counters were used for reconstruction and MD.  For all 
CSM scans in this thesis, four counters were used for reconstruction and MD. 
 
2.5 Spectral CT and K-edge imaging 
Spectral CT which was suggested by Hounsfield in his original paper on CT [19] is simply 
the combination of X-ray spectroscopy (measuring the different attenuation of X-rays of 
different energy) with computed tomography reconstruction of the interior appearance of an 
object based on X-ray projections from multiple angles.  By measuring the attenuation of 
each voxel at two or more different energy ranges, conclusions may be made about the 
material composition and concentration of each voxel that are independent of our prior 
knowledge of what materials we expect to see.  It adds another source of information for 
scientists and clinicians, beyond the spatial images of broad-spectrum CT. 
Every element has a unique X-ray attenuation profile across the range of X-ray energies 
(Figure 2.2).  X-ray spectroscopy can identify specific elements or combinations of elements 
in complex samples based on these attenuation differences [20, 21].  Dual energy CT and 
MARS CT bring a rough X-ray spectroscopy to medical imaging and allow material 
identification and quantification [12, 19, 22, 23]. 
Attenuation across energies is not a continuous function for elements.  As X-ray photon 




successive electron shell is reached and electrons from that shell may be ejected from the 
atom by the photoelectric effect [24], a sharp rise in attenuation occurs.  The K-edge is the 
discontinuity in attenuation due to the binding energy of the 1s orbital and is of particular 
interest in clinical X-ray technologies because the K-edge of many elements occurs in the 
range of photon energies used in imaging.  For example, if we assume the typical human CT 
scan has photon energies from ~30 keV to ~120 keV, then every element from antimony (Z = 
51) to  uranium (Z = 92) has a K-edge in the clinical imaging range.  This means that high Z 
elements have particularly strong attenuation in CT imaging and are potentially valuable as 
X-ray contrast agents (see Section 2.7). 
The combination of spectral CT and high Z contrasts with K-edges in the imaging spectrum 
opens up the possibility of identifying multiple materials in the same scan.  Figure 2.2 shows 
how materials with exactly the same concentration could be distinguished based on their 
differing spectral attenuation.  Carbon (as a surrogate for soft tissue), calcium (surrogate for 
bone) and iodine would have to be distinguished based on the curvature of the graph, but 
gadolinium, hafnium and gold would all show distinct rises in attenuation from one lower 
energy bin to the next higher energy bin.  This K-edge effect simplifies the detection of more 
materials in a simple four energy bin spectrometer like the MARS scanner [6]. 
 
 
Figure 2.2:  Linear attenuation for equal densities of six elements.  The colour regions show how 
thresholds might be set in a spectral CT system to detect the K-edges of three different contrasts made 
with gadolinium, hafnium and gold.  In MARS, each colour represents a subtracted energy bin, 
meaning that, for two adjacent threshold settings, like 32 and 48 in the graph, the counts from the 48 






2.6 Material Decomposition 
For spectral CT, material decomposition is using attenuation patterns across energies to 
estimate the material make-up of each voxel, giving a material reconstruction [6, 25–28].  
With proper calibration, the concentration of each material may also be estimated.  
The material image produced in MARS is a quantitative reconstruction of the concentration 
of materials in each voxel.  In the MD, each voxel’s spectroscopic linear attenuation pattern 
is compared to the calibration materials using a constrained linear least squares algorithm [6].  
Each voxel is assumed to consist of two materials, water and one other calibration material 
that contributes most strongly to the spectral response.  Any voxel consisting of only lipid 
and water is termed a soft tissue (ST) voxel; while voxels with other calibration materials are 
deemed high Z (for atomic number).  All ST voxels are reported in concentrations of lipid 
and water (pure lipid and pure water must be included in all material calibration phantoms).  
All high Z voxels are reported in concentrations of water and one of the high Z materials 
from the calibration phantom (can be an element, compound or complex mixture). 
For the intrinsic material scans in this thesis, the only high Z material is calcium.  For the 
contrast based scans, high Z materials may be calcium, iodine, gadolinium or gold.  The 
material data are reported as concentrations in mg/ml. 
For intrinsic materials with appreciable concentrations, there are no K-edges within the range 
of photon energies used in MARS scanners.  The arbitration counter, which always has the 
lowest threshold, is usually set around 10 keV.  Figure 2.3 shows the difficulty of this 
problem, especially for scans using energies relevant in human clinical scanning (considered 
30 to 120 keV for this thesis).  In this case, the useful energies for lipid/water differentiation 






Figure 2.3:  The problem of MD for intrinsic materials.  Panel (a) shows the mass attenuation of 
CaCl2, water and lipid across all energies.  (b) shows how the area with the greatest differences in 
magnitude and slope are eliminated by the filtration of the spectrum, shown in (c) with and without 12 
mm of added aluminium.  The coloured regions in (b) represent the energy bins used for plaque 108 








2.7 Contrast Agents 
Contrast agents are materials added to the sample to increase the difference in signal between 
a region of interest and the surrounding area.  They can act by creating hypo- or hyper 
intensity in the region of interest (ROI) or the surrounding area.  In CT, an increase in 
attenuation using high Z materials is the norm. 
Iodine and barium are the most common elements used in X-ray contrast agents.  Many other 
elements are being investigated for future use, especially gold nanoparticles because of gold’s  
high attenuation and the ease of manipulating its chemical surface to make biologically 
compatible contrasts [29–32]. 
All contrasts are targeted to some degree.  For example, we inject iodine contrast agents 
intravascularly to see the vasculature, looking for stenosis, haemorrhage, tumours etc. or we 
drink barium sulphate to show abnormalities in the digestive tract.  As chemistry and 
biochemistry advance, the ability to target specific structures, cells, proteins, diseases and so 
on with contrast agents and/or treatments is growing.  The degree of specificity ranges from 
targeting by size for  tumours with abnormally large endothelial fenestrae (see 2.9) [33] to 
targeting a specific conformation of a single glycoprotein using iron oxide or gold conjugated 
to anti-body fragments [34, 35] (see Table 2.1 for a small sample).  See some recent reviews 
for a more thorough examination of targeting contrasts for medical imaging and research 
[29–32, 36–38]. 
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Cardiovascular disease (CVD) causes one fourth of all deaths worldwide [43] and includes 
coronary heart disease, carotid artery disease, peripheral artery disease and chronic kidney 
disease.  One of the primary causes of CVD is atherosclerosis, which is the formation of 
lesions in the artery walls called plaques.  The thromboses that cause heart attack and stroke 
often result from the rupture of atherosclerotic plaques.  Abnormal physiology and 
biochemistry leads to abnormal structure and composition of the artery wall [44–50].  In 
particular, the retention of lipid-rich particles such as low density lipoprotein (LDL) in the 
intimal layer of artery walls is associated with the initiation and progression of plaques [51].  
The vulnerable plaque most often associated with rupture is characterised by a lipid-rich 
necrotic core, spotty calcifications, a thin fibrous cap, positive remodelling of the artery wall, 
intra-plaque haemorrhage, neovascularisation, and inflammation associated with immune 
cells such as macrophages [52–58].  Detecting these abnormalities noninvasively before they 
cause severe clinical events is a focus of atherosclerosis research [59–68]. 
In this thesis, the focus will be on MD of the spatial arrangement of high lipid regions 
(corresponding to the necrotic lipid core) and calcifications.  The earliest stages of lesion 
development involve the accumulation of lipids in the form of low density lipoprotein (LDL).  
As plaques progress, a necrotic lipid core forms within the intima and its size correlates with 
the risk for rupture.  Calcifications are hypothesized to stabilize plaques or promote rupture 
depending on their size and location.  Large, continuous calcifications that wrap around most 
of the circular arc of a vessel are thought to promote plaque stability while spotty 
calcifications are often proposed to promote rupture [69–78] 
 
2.9 Cancer 
Cancer caused 15.2% of all deaths worldwide in 2010 [43].  Cancer is the uncontrolled 
proliferation of native cells that can spread to neighbouring tissues, sometimes metastasising 
to varied locations throughout the body [79, 80].  It can form solid tumours or exist as 
circulating cells. 
Cancers are frequently imaged with CT.  In unenhanced CT imaging, cancers may be viewed 
by abnormal hypodensity [81],  hyperdensity [82] or isodensity [83].  Calcifications are 
common in certain cancers and can be imaged [82, 84].  Solid tumours frequently have traits 
that can be exploited for contrast enhanced imaging,  both in the research and clinical 
environment, including neovascularization with abnormally large endothelial fenestrae [85, 
86] and protein expression that is not normally found in healthy, mature tissues [41, 42, 87–
90]. 
In this thesis, the leaky nature of cancerous neovascular endothelium is exploited to 




Calcifications are not specifically investigated in a cancer model, but the microcalcification 
work on atheromas is applicable. 
 
2.10 Phantoms 
Phantoms are artificial objects designed to test or calibrate some aspect of the scanner set-up 
or performance.  For material calibration, phantoms are tubes of known concentration of the 
materials of choice for the MD.  At least two concentrations for each material are necessary, 
but since the MD assumes that all voxels contain water and one other material, one of the 
concentrations is always zero (i.e. 100% water) for all materials.  The MD requires that water 
and lipid are present in all material calibration phantoms.  For all scans in this work, lipid is 
canola oil and water is Milli-Q® ultrapure water (Merck KGaA, Darmstadt, Germany).  
Other materials are water solutions or resin suspensions. 
All phantoms in this thesis were produced by me except the commercial hydroxyapatite 
phantoms (QRM GmbH, Moehrendorf, Germany). 
 
2.11 Foil fluorescence 
When a 1s electron is ejected from an atom by photoelectric attenuation (see Section 2.4), an 
electron from a higher energy shell may release energy as an X-ray fluorescence (XRF) 
photon and fill that lower energy state.  The electron can come from any shell but the most 
common transition is from the second, or L, shell to first, or K, shell [91].  This transition is 
termed Kα fluorescence.  It typically has two photon energies present, representing the 
transition from the 2s and 2p orbitals.  The most likely transition is 2p to 1s, or Kα1, which 
has a slightly higher energy than the 2s to 1s, or Kα2, transition.  The Kα fluorescence signal 
from various monoatomic foils can be used for energy calibration of the MARS camera (see 
Chapter 6), and for this purpose, the two Kα energies are considered to be a single, nearly 
mono-energetic signal at the Kα1energy. 
Not every K-edge photon attenuation results in a photoelectric X-ray emission.  The 
proportion of K-edge attenuation events that result in photoelectric X-ray emission is the 
fluorescence yield, ω [92].  The fluorescence yield of just Kα photons is labelled, ωKα.  Only 




3 Intrinsic Material Differentiation with MARS  
 
3.1 Introduction 
Medical imaging is basically the search for anomalous views that reveal injury or disease.  
When viewing intrinsic tissues using unenhanced CT (i.e. no contrast agents), anomaly 
consists of abnormal spatial arrangements or abnormal X-ray density in relation to known 
anatomy.  The latter includes hyperdense abnormalities like calcifications in breast cancers  
and atherosclerosis (see 2.8 and 2.9) or uric acid crystals in gout [93] and hypodense 
abnormalities like lipid cores in atherosclerosis, fatty liver diseases [94] or glioblastomas of 
the brain [95].  The MARS team is investigating unenhanced imaging in all of these diseases 
and I have contributed to each, but my focus has been atherosclerosis. 
Atherosclerosis provides an excellent model for testing intrinsic MD.  Plaques take many 
forms, but the most common structures associated with plaque rupture and subsequent 
adverse ischaemic events are a plaque with a lipid-rich necrotic core, spotty calcifications, a 
thin fibrous cap, positive remodelling of the artery wall, intra-plaque haemorrhage, 
neovascularisation, and inflammation associated with immune cells such as macrophages.  
While all of these may be identifiable with MARS images, this preliminary work 
concentrates on the basic separation of lipid-rich and calcium-rich regions from background 
tissue, termed water-rich.  The lipid core and the range of sizes of calcification from sub-
voxel to many cubic millimetres offer a good test of the material separation and 
quantification capabilities of MARS. 
Each of the energy bins in MARS systems is a separate view with different information based 
on the varying interactions of materials and X-rays of different energies.  While these 
multiple views of the same region can be analysed by eye, analytic software like MARS MD 
assess the attenuation profile of each voxel across the energy bins and convert it to material 
concentrations (see Chapter 2).  This provides researchers and clinicians with an analysis of 
spatial arrangements of materials in a sample independent of their own interpretations of a set 
of attenuation reconstructions. 
The three scans described in this chapter were designed to test the limits of the MARS system 
in identifying lipid-rich and calcium-rich regions under gradually more difficult conditions.  
First a scan of lamb meat is described that tests intrinsic MD at low kVp where soft tissue 
contrast is superior.  Second, an eight energy bin SPM scan of an excised, partially 
dehydrated carotid atherosclerotic plaque was done in the hope of maximizing the lipid 
contrast at the human energy range (~30 to 120 keV).  The third scan uses fully hydrated 
tissue and demonstrates lipid core and spotty calcium identification in the MD using CSM 





Table 3.1:  Scan parameters for the samples in this chapter 
Sample Lamb meat Plaque 72 Plaque 108 Plaque 90 
Detector Medipix3RX Medipix 3.1 Medipix3RX Medipix 3.1 
Sensor 2 mm CdTe 600 µm GaAs 2 mm CdTe 600 µm GaAs 
Camera mode CSM SPM CSM SPM 
Bias voltage (V) -440 -300 -700 -300 
Pixel matrix 128 x 128 128 x 128 128 x 128 128 x 128 
Pixel pitch (µm) 110 110 110 110 
SDD (mm) 131.8 190 185 219 
SOD (mm) 83.8 120 130 155 
Magnification 1.57 1.58 1.42 1.41 
Projections/rotation 720 720 980 720 
Flatfields 500 720 720 720 
Tube Voltage (kV) 50 120 118 120 
Tube Current (µA) 120 300 30 300 
Exposure (ms) 40 350 200 350 
Filtration 
(mm) Al or brass 
1.8 Al intrinsic 
11.8 Al (1.8 
intrinsic + 10 
added) 
13.8 Al (1.8 
intrinsic + 12 
added) 
11.8 Al (1.8 
intrinsic + 10 
added) 
Thresholds (keV) 15, 20, 25, 30 
30, 35, 40, 45, 
50, 60, 70, 80 
30, 42, 49, 81 
30, 35, 40, 45, 
50, 60, 70, 80 
Focal spot size 
(µm) 







mART mART mART 
Voxel size (µm) 100 41 90 41 
 
The chapter ends with a brief review of two summer student projects I supervised to begin 
preparing for live cell, tissue and animal scanning.  The scan of plaque 90 was part of Hayley 





3.2 Lamb tissue:  demonstrating CSM and MD at low kVp 
Introduction 
Aim 
Charge summing mode was usable in the MARS system for the first time in 2014. We 
scanned a sample of lamb meat at a low kVp with three goals.  First, demonstrate the 
functionality of CSM in producing a quality reconstruction and MD of biological material.  
Second, using optimal parameters for ST imaging, test MD separation of lipid, water and 
calcium components on a macroscopic scale relevant to current expectations of CT spatial 
resolution.  Third, provide open access to a full MARS dataset from raw projections through 
the processing chain and finally the attenuation and material reconstructions. 
Significance 
Charge sharing is a significant source of noise and blurring in small pixel hybrid detectors 
[18].  This work demonstrates the functionality of CSM as a correction for charge sharing and 
is one of the first datasets made available utilizing CSM. 
Soft tissue contrast is one of the weaknesses of CT imaging because the attenuation 
differences are so small between different tissue types [96].  As MARS scanners develop on a 
technological and algorithmic progression, it is important to demonstrate the accompanying 
progression in the quality of attenuation and MD reconstructions. 
Publication 
This work appears in the Journal of Instrumentation [97]. 
Contribution 
As a member of the MARS clinical team, I was part of all discussions concerning scan 
protocols and priorities for demonstrating MARS functionality on a clinical level.  I 
contributed to manuscript development and editing. 
Methods 
A fresh lamb chop with conspicuous meat, fat and bone (Figure 3.1) was scanned at 50 kVp 
(see Table 3.1 for full protocol).  The material calibration phantom consisted of 0.2 µl PCR 
tubes (inside diameter of ~5 mm) filled with lipid, water and 320 mg CaCl2/ml solution in 
water. 
As with all MARS datasets, the raw data are flatfield corrected by dividing each projection by 
an open beam projection that is averaged over a large number of frames.  This partially 
corrects for fixed pattern noise due to pixel variability.  Ring filtration is then applied to the 
projections.  The unstitched frames are input to mART for reconstruction followed by MD.  
The energy bins were not subtracted for the reconstruction, meaning the first energy bin is 






Figure 3.1: Lamb meat sample.  a) White lines show the region scanned.  b) Tissue in the sample 
holder for scanning.  Used with permission [97] 
Results 
Figure 3.2 illustrates the MD results.  All raw, processed and reconstructed data for the lamb 
meat scan and the calibration phantom scan are available at http://hdl.handle.net/10092/8531. 
 
Figure 3.2: Transverse slice 100 which includes bone, fat and meat.  Panel a) Attenuation based 
reconstruction of the 15 keV energy bin, b) fat component, c) water component, d) calcium 
component and e) a composite material image.  The MD components in b, c and d are displayed as 
binary data, no concentration scaling is done. The colourscale for (e) is normalized relative to the 
calibration concentrations.  Used with permission [97]  
a b 






The results clearly show the quality of the MD on a macroscopic scale.  Lipid-rich and 
calcium-rich regions can be discerned at a voxel resolution of 100 µm.  The attenuation 
reconstruction in Figure. 3.2 (a) and the composite MD in (e) are nearly identical to the eye.  
The large fat strips on the left and near the centre show very high lipid concentration while 
the meaty portions have some small marbling of fat, as might be expected.  The spatial clarity 
and MD quality demonstrate the functionality of CSM. 
This study demonstrates the potential for MARS material images in distinguishing intrinsic 
material arrangements with implications for medical imaging.  Dual-energy CT can also 
provide material reconstruction [98] but requires two data acquisitions as opposed to the 
simultaneous four bin acquisition in this study.  This is important in a range of clinical work 
done by the MARS team in atherosclerosis, fatty liver disease, breast imaging, and contrast 
enhanced imaging with functional nanoparticles.  Beyond medical uses, quality ST imaging is 
also of interest to the meat industry for machine assisted butchering. 
No effort was made to confirm the results with histology or material quantification as the 
macroscopic results match expectations of the familiar appearance of lamb chops. 
 




The scan was part of efforts to demonstrate successful MD at energies relevant to human 
scanning using eight SPM energy bins and gallium arsenide (GaAs) as the sensor layer for 
the detector [99].  Zainon et al. [100] have previously shown successful MD of lipid, water 
and calcium components of excised carotid plaque at low kVp with a silicon sensor layer.  
This study sought to mimic a true human scan by operating at 120 kVp and adding 10 mm of 
aluminium filtration to produce an x-ray spectrum simulating the filtration and attenuation of 
a human head and neck scan.  Using the atherosclerotic plaque model for lipid rich and 
calcium rich regions on more microscopic scales than the meat sample in Section 3.2, we 
scanned a series of excised carotid plaques looking for a clear lipid core and 
microcalcifications.  We then sought to confirm the MD with histological level examination 
of regions of interest that contained lipid and calcification. 
Significance 
By operating at 120 kVp and filtering the source this work demonstrated the feasibility of 
producing material reconstructions of vulnerable plaque that allow identification of a lipid 




eight simultaneously acquired energy bins to produce high spatial resolution material images 
of vulnerable atherosclerotic plaque.  It also demonstrates the value of GaAs as a sensor layer 
for medical imaging systems. 
Publication 
This work is featured in the New Zealand Medical Journal [101] 
Contribution 
I was involved in all aspects of this work as a co-investigator with Raj Panta.  I am solely 
responsible for all sectioning, staining, photography and microscopy. 
Methods 
Human carotid endarterectomy samples are used for scanning and obtained under human 
ethics approval reference CTY/01/04/036/AM05.  Carotid endarterectomy samples are 
obtained from surgical theatre and placed in a -80C freezer for future use.  The samples are 
then thawed at room temperature in a moist environment and scanned in air inside a 
polypropylene tube. 
Scanning was carried out using eight energy bins in SPM with a 600 µm GaAs sensor layer 
bump bonded to the Medipix3.1 chip.  See Table 3.1 for protocol details.  The phantom 
contained lipid, water, and CaCl2 (100, 140 and 200 mg CaCl2/ml solution). 
At this time, the MARS scanners were fairly unstable in operation both mechanically and 
with respect to camera stability.  Furthermore, developers were making frequent changes to 
software at many points in the imaging chain, from machine control to camera adjustment to 
reconstruction and MD algorithms, so it was difficult to know what changes lead to 
improvements in results.  In order to maximize chances of a quality scan, we simply decided 
to repeat the same scan over and over in a single day, examining the results of one scan while 
the next was running.  Also, in order to maximize the chances of successful material 
separation of high lipid regions, the plaque was scanned repeatedly at room temperature in a 
ventilated tube to allow the tissue to dry slowly.  After a series of previous scans proved 
unsuccessful in producing a quality MD of high lipid regions (typically, noise was simply too 
prevalent or little to no lipid was reported despite the near certainty that lipid is present), it 
was hoped that allowing the tissue to dry might enhance the contrast between lipid and other 
regions that might contract as water was lost (becoming more dense). This approach was, 
admittedly, highly unscientific and we made no attempt to monitor changes in wet weight. 
After the MD results showed a potential lipid core and spotty calcification we sectioned the 
plaque by hand using a scalpel blade at positions of interest.  The sections were photographed 
and then stained for neutral lipids using oil-red O.  Sections were submerged in a saturated 
solution of oil-red O in 60% isopropanol and water for 15 minutes with agitation on a rocker 
table.  Sections were then rinsed three times in 60% isopropanol for five minutes each rinse.  
Sections were photographed again in white light; then photographed in an epifluorescence 




at 546 nm and emission was a 590 nm long pass filter.  Calcifications autofluoresce 
(hydroxyapatite does not, but associated compounds, including cholesterol result in intense 
fluorescence) and oil-red O fluoresces weakly red under green excitation [102, 103] so 
fluorescence microscopy highlights the two MD materials of interest (lipids and 
calcifications). 
Results  
The fifth scan of plaque 72 was chosen for use in this study because of the quality of the MD.  
Scans 1-4 were deemed too noisy, with many high lipid voxels in the air regions surrounding 
the plaque and within the lumen (note the clean air regions in the MD in Figure 3.3 (d) 
despite the noise in the air in the reconstruction, Figure 3.3 (c)).  Review of the MD showed a 
likely lipid core in the ICA and spotty, variably shaped calcifications around the bifurcation.  
Figure 3.3 shows the correlation between histology and reconstructions. 
 
 
Figure 3.3: Lipid and calcium comparison of MD and histology.   Yellow arrows point to a triangular 
lipid region that is apparent in the red fluorescence image (a) the oil-red O stained photo (b) and the 
MD (d), but is not obvious in the reconstruction of the first energy bin (c).  White arrowheads point to 
a teardrop shaped calcification that is clear in all four images.  The scale bar in (b) applies roughly to 
(a) as well and the same for the scale bar in (c) applying for (d). 
 









Figure 3.4: Spotty calcification at high resolution.  Panels a and b show the high spatial resolution of 
calcifications in both the MD (a) and attenuation based reconstruction (b).  Panel c is a MARS 3D 
image showing the spotty calcifications (white) in and around the bifurcation.  The ECA is pointing 
down and in the back of the image.  For the MD in (a):  green = lipid-like, blue = water-like and red = 
calcium-like.  The scale bar in (a) also applies to (b) but not (c).  Used with permission [104] 
 
Discussion 
This study shows the feasibility of identifying lipid cores and spotty calcifications in carotid 
plaques using photon energies that are relevant to human CT scanning.  MD of intrinsic 
biological materials using SPM with eight energy bins is possible.  GaAs is a reasonable 
sensor material for higher energy CT scans though its low absorption efficiency at higher 
energies (~40% at 80 keV for 1mm GaAs) indicates patient doses could be higher than if 
more efficient materials were used such as CdTe[105–107]. 
The quality of the calcium component of the MD (Figure 3.4) indicated that more detailed 
analyses of microcalcifications were worthwhile in future carotid scanning.  Figure 3.4 (a) 







considered an indicator of vulnerable plaque and microcalcifications are a possible source of 
weakness in the thin fibrous cap that may be the site of cap failure [70, 75, 76, 108]. 
The excellent contrast of calcifications in the epifluorescence images and the ease of 
identifying oil-red O staining compared to white light illumination are apparent comparing 
Figure 3.3 (a) and (b).  Thus, the technique was refined for use in future plaque imaging (see 
Section 3.4). 
 
3.4 Plaque 108: MD using CSM and the human energy range 
Introduction 
Aim 
The goal of this work was to demonstrate the potential of MARS spectral CT in CSM with a 
CdTe sensor to identify lipid and calcium components of plaques using a spectrum relevant to 
live human imaging.  The plaque was scanned fully hydrated (unlike plaque 72 in Section 
3.3) to better represent a true scan and better test the improved scanner which featured greater 
machine stability, improved pixel/camera stability, functional pixel masking on the camera 
and in raw data pre-processing (see Chapter 5), superior reconstruction and MD software and, 
importantly, functional CSM.  Using the MARS spectral CT scanner, with 4 energy bins in 
CSM, we scanned excised carotid atherosclerotic plaques using the X-ray tube at ~120kVp.  
To mimic a true human head and neck scan, we added filtration, eliminating almost all 
photons below 30keV. 
The work also presents a more detailed analysis of the quantitative aspects of the MD.  The 
concentrations that might be expected inside a plaque were researched and thresholds for 
viewing the MD data were established based on this search. 
This work also used histological examination to corroborate the presence of a lipid core and 
microcalcifications shown in the MD. 
Significance 
This work demonstrates the potential to find two hallmarks of vulnerable plaque, the lipid-
rich necrotic core and spotty calcifications, in true human scans using future MARS human 
scanners.  The value of CdTe as a sensor layer is also confirmed. 
Publication 
Parts of this work are published in the New Zealand Medical Journal [109].  A manuscript is 
in preparation for submission to European Radiology.  Parts of this work have been shown in 
posters and talks at national and international conferences. 
Contribution 





Human carotid endarterectomy samples are used for scanning and obtained under human 
ethics approval reference CTY/01/04/036/AM05.  Plaque 108 was received from a carotid 
endarterectomy and frozen in a -80C freezer.  It was then thawed to room temperature and 
scanned in a tube with moist cotton to maintain 100 % humidity and prevent water loss.  
Scanning was done in CSM with a Medipix3RX camera with 2 mm CdTe sensor.  The 
calibration phantom contained water, lipid and 50, 150 and 250 mg CaCl2/ml solutions in 
polypropylene tubes with an inside diameter of ~3 mm.  Filtration of 12 mm Al was added to 
produce a spectrum with essentially no photons below 30 keV (0.5%) according to a 
SpekCalc produced data set [110–112].  The mean photon energy was 65.5 keV.  See Table 
3.1 for the full protocol. 
The phantom was included with the sample (see Fig 3.5) to provide a simultaneous material 
calibration under exactly the same scan conditions.  This was done as a precaution due to 
some evidence of drift between scans from other MARS developers.  
For the first time, thresholds were set specifically to maximize water/lipid differentiation.  As 
stated in Section 2.6, most of the spectral information valuable in soft tissue MD is below 50 
keV.  Thresholds used for the CSM counters were 30, 42, 49 and 81 keV.  For simplicity, 
energy bins will be referred to by the lowest photon energy of the subtracted bins.  For 
graphing, however, the mean bin energy calculated from SpekCalc will be used, 37.5 keV (30 
to 42 keV bin), 45.6 keV(42 to 49 keV bin), 63.0 keV (49 to 81 keV bin) and 94.1 keV(81 to 
118 keV bin).  Thresholds were set to maximize information below 50 keV;  however, due to 
the threshold dispersion of the energy calibration (about 8 keV at 59.5 keV,  which limits the 
narrowness of adjacent threshold settings) [16] and our interest in maintaining continuity with 
future studies using gold nanoparticles, the highest threshold was set to 81 keV (the k-edge of 
gold).  The remaining thresholds were chosen to give roughly equal, open beam photon 
counts in the first two bins. 
For assessing the traits of vulnerable plaque using the MD, the following criteria were 
established for lipid and calcium concentration assessments.  No attempt was made to 
quantify the components by other techniques.  The MD output values for both lipid and 
calcium concentrations vary from zero and up, but the practical significance of, for example, 
a CaCl2 concentration of 5 mg/ml or a lipid content of 50 mg/ml is not clear.  For perspective, 
an isotonic solution of pure CaCl2 would have a concentration of about 11.4 mg CaCl2/ml.  
With respect to lipid, the mass percent of lipid in human cells has been measured at about 12 
%, so roughly 120 mg/ml.  In this light, calcium and lipid data were examined both with all 
values included and excluding voxels valued lower than thresholds of 12 mg CaCl2/ml and 
120 mg lipid/ml.  In composite material images, the calcium component is usually displayed 
as a replacement volume.  This means that the Ca colour scheme is not mixed with the 
accompanying water value in red.  This allows visualisation of voxels with low Ca 
concentrations which would otherwise be washed out by the associated high water 
concentration.  For all colour MD images in this section, lipid is represented by yellow, water 




MD results were compared to histology by visual analysis of selected cross sections of the 
plaque.  Sections were cut with a scalpel roughly perpendicular to the axis of scan rotation at 
five points of interest and then examined with and without staining for neutral lipids.  After 
sectioning, all cut surfaces were photographed unstained, then stained for neutral lipids with 
oil-red O and photographed again under white light.  The staining procedure was the same as 
that in Section 3.3 except the rinse procedure was expanded.  The plaque was rinsed for two 
hours total in 60% isopropanol with changes in the rinse solution at 5 minutes, 10 minutes, 15 
minutes and 1 hour. 
Stained sections were also photographed using an epifluorescence stereomicroscope (Leica 
M205 FA stereomicroscope) with a GFP plus filter (460 to 500 nm excitation, 510 nm long 
pass emission).  The fluorescence images highlight calcifications and neutral lipids.  
Calcifications fluoresce intensely yellow due to incorporated or associated lipids such as 
unesterified cholesterol [103, 113] or ceroid [114].  Neutral lipids fluoresce red due to oil-red 
O staining (yellow/green autofluorescence of lipids such as cholesterol are quenched by the 
stain)[102, 115].  Other materials such as elastin and collagen also autofluoresce 
yellow/green, but the larger calcifications are obvious by shape and intensity. Photographs of 
the unstained sections were examined and labelled by a pathologist with experience in 
atherosclerosis but without access to the scan results.  The plaque sections were correlated by 
eye with sections of the CT reconstruction and MD based on plaque outline and visible 
calcifications. 
The MD was also compared to the 30 keV energy bin to assess agreement of the MD with 
traditional radiologic analyses of CT data.  The attenuation data for the four energy bins were 
converted to bin specific CT numbers using spectral Hounsfield units within each bin 
according to the procedure proposed by Hurrell et al. [116].  A customized transfer function 
for the spectral Hounsfield unit (HU) data of the 30 keV bin, which should have the best 
tissue contrast, was used to examine the spatial agreement between attenuation and the 
material reconstruction.  It should be noted that the values of spectral HU for spectral energy 
bins cannot be directly compared to those expected for integrating CT datasets. 
Results 
Spectral calibration data for material discrimination are shown in Figure 3.5 along with a 
transverse slice reconstruction from each energy bin displayed in HU with a constant window 
level.  Attenuation is proportional to CaCl2 concentration in each energy bin (Figure 3.5 b) 
and, relative to water, as energy increases, the attenuation of CaCl2 decreases while the 
attenuation of lipid increases (Figure 3.5 c).  This trend can be seen in the grey scale images 
(Figure 3.5 a) of the phantom tubes.  The combination of the linear relationship of attenuation 
to density within a material in Figure 3.5 (b) and the different shapes for different materials 
of the trend lines in Figure 3.5 (c) allow the discrimination and quantification of materials in 
MARS images.   
The MD algorithm is conservative in favour of soft tissue over calcium.  To illustrate, 




50 voxels are misidentified as soft tissue, while 0.1% of water phantom voxels are 
misidentified as calcified.   
 
 
Figure 3.5:  Calibration results:  (a) CT attenuation grey scale images of each energy bin for a single 
transverse slice displayed in Hounsfield Units.  Window level is -700 to 3300 HU.  Voxel size is (90 
µm)
3
.  (b) Attenuation in HU vs concentration of CaCl2 for each energy bin.  (c) Attenuation in HU vs 
energy for the calibration phantoms.  Ca 50, Ca 150 and Ca 250 are 50, 150 and 250 mg CaCl2/ml 
solution, respectively.  Points are plotted on the energy axis at the estimated mean photon energy of 
the bin. 
 
A longitudinal section of the reconstruction and MD through the carotid bifurcation is 
displayed in Figure 3.6.  The MD displays two distinct regions of plaque surrounding the 
bifurcation of the common carotid artery (CCA): a heavily calcified region in the internal 
carotid artery (ICA) which extends down into the ICA side of the CCA and a proposed lipid 
core with spotty calcifications on the external carotid artery (ECA) side of the CCA.  The 






Figure 3.6:  Various views showing the lipid core (blue ⁎) and spotty calcification of the same 
longitudinal slice through the bifurcation of the plaque pictured in (a).  MARS images consist of 
material volumes.  The lipid component in yellow (b) and calcium component in grey (c) are 
combined with the water component in red (not pictured) to form a composite (d and f). In d, the lipid 
and water opacity are reduced and the large calcification that dominates the right side of the image has 
been removed to highlight spotty calcium in the proposed lipid core.  The MARS material composite 
in (f), based on spectral data, corresponds well with the raw attenuation data from the 30 keV energy 
bin shown in (e).  In (f), calcium is shown as a replacement volume (see Methods). 
 
Figure 3.7 visually compares a hand cut transverse slice (about 3 mm upstream from the 
internal beginning of the bifurcation) through the proposed lipid core to the corresponding 
slices of the reconstruction (30 keV bin) and the composite MD.  Due to repeated rinsing, 
some material has been washed away between the unstained photo and the oil-red O stained 
fluorescence image (Figure 3 b and a, respectively) which is especially apparent in the region 




The intense green region of fluorescence in the proposed lipid core is magnified in Figure 
3.8.  Among other possibilities, the small granules visible within the tissue may be 
cholesterol crystals, ceroid deposits or HA crystals associated with cholesterol or ceroid (see 
Discussion).  The lack of oil-red O staining may be due to a combination of material washing 
away during rinses, high concentrations of non-neutral lipids such as free cholesterol and 
cholesterol crystals or a lack of lipids altogether.  
 
 
Figure 3.7:  Lipid and calcium correspondence between histology and reconstruction.  Histology(a 
and b) and attenuation (c) or material (d) reconstructions of a transverse slice located about 3 mm 
upstream from the internal beginning of the bifurcation.  Panel (a) is an epifluorescence microscope 
image after oil-red O staining. Excitation 460 to 500 nm, emission 510 nm long pass filter.  Panel (b) 
is a photo of the unstained section.  Panel (c) is an attenuation based reconstruction of the 30 keV 
energy bin.  Panel (d) is a MARS material image. The distinctly shaped lipid core without large 
calcifications on the left side of the plaque is clear in both the unstained photo (the yellow to brown 
region in (a) and the MARS material image (d), while it is present but less distinct in the attenuation 
image (c). In the MARS material image (d), materials are presented as follows:  the calcium 
component has a lower threshold of 12 mg CaCl2 /ml, and it is shown as a replacement volume (see 






Figure 3.8:  Granular appearance of autofluorescence in the non-staining region of the lipid core.  A 
close-up of the region in the white box on the left from Figure 3.7 (a).  It is possible that the brighter, 
granule-like shapes may be sub-voxel sized microcalcifications, ceroid-like deposits, cholesterol 
crystals or pockets of un-crystallized cholesterol, but their make-up has not been determined. 
 
The composite MARS material images and a single energy bin’s attenuation data (30 keV) 
show clear spatial agreement (Figure 3.6 e, f).   
Quantitative comparison of the MD concentrations with HU values in the 30 keV energy bin 
are summarized in Table 3.2 for the lipid core ROI and, for reference, the calibration 
phantoms.  For all ROI voxels with a positive lipid value, the mean concentration of 260 mg 
lipid / ml corresponds to ~27% lipid by weight, assuming approximately water density for the 
remaining material in the voxel.  The lipid-containing voxels measure ~23 mm
3
 while the 
entire ROI measures ~68 mm
3
. 
Of the 93810 voxels in the ROI, 3444 were calcified, with 1950 measuring above the 12 




the 3444 calcified voxels, 83 are isolated single voxels surrounded by soft tissue.  The 12 
mg/ml threshold was chosen for a conservative approach to the data, but it should be noted 
that many of the voxels below that value probably represent true calcium detection and future 
testing and refining of the scanner may allow assessment of such low concentrations. 
 
Table 3.2:  Comparison of MD quantification to attenuation values for lipid and calcium 
 
 
A pathologist reviewed the photo in Figure 3.7 (b) and identified the yellow to brown region 
on the left as a lipid core without obvious calcification, Figure 3.9.  Areas of major 
calcification on the right and top of the MD were also noted. 
 
 
Figure 3.9:  A pathologist’s view of the plaque section in Figure 3.7 (b).  The words are 






The MARS spectral CT system, using a CdTe sensor, can identify and quantify lipid rich and 
calcium rich regions in human atherosclerotic plaque tissue using x-ray energies (~30 to 118 
keV) relevant to human scanning necessities.  This feasibility study shows that a lipid core 
and spotty calcifications can be identified in material reconstructions.  As these features are 
frequently present in both developing and vulnerable plaques, the information may be useful 
for assessing imminent and long term risks in cardiovascular disease.  MARS material images 
are produced with automated software using the spectral data and so, offer an independent 
evaluation of plaque structure and composition that adds to the radiologist’s toolbox.  The 
voxel size of (90 µm)
3
 is smaller than current clinical CT and MRI [78] which may also allow 
detection of atherosclerotic burden at less advanced stages and smaller lesion sizes. 
MARS material images match with traditional CT and histology analyses.  In Figure 3.6 (e) 
(a customized transfer function using attenuation data from the 30 keV bin) and (f) (the 
composite material reconstruction) the lipid and calcium distributions follow closely with 
attenuation data, as would be expected in the lowest energy bin where tissue contrast is 
greatest.  In Table 3.2, the average lipid and calcium concentrations in the lipid core ROI 
follow the same trends as the HU(30 keV) values.  Review of tissue appearances by a 
pathologist also outlines macroscopic lipid rich and calcified regions in agreement with the 
MARS images (Figure 3.9).  Fluorescence microscopy of oil-red-O stained transverse cuts of 
the plaque reveal extensive neutral lipid staining throughout much of the plaque (Figure 3.7 
(a)).  This highlights the agreement of lipid distributions in the MD for regions with little to 
no calcification (left hand side of Figure 3.7 (a) and (d)) but also demonstrates the limitations 
of the current MD, which does not allow a lipid measurement in voxels that are determined to 
be calcified (right hand side of the same figure panels). 
Lipid measurements 
The external carotid artery side of the common carotid artery contains a clear lipid core based 
on pathologist review of tissue photos and the fluorescence microscopy, Figure 3.9 and 
Figure 3.7 (a), respectively.  The MARS material images have a clear lipid signal with similar 
shape in the same region, Figure 3.7 (d).  In the voxels with lipid values greater than zero, the 
lipid measurement corresponds to a tissue lipid content of about 27% by wet weight (Table 
3.2).  By comparison, healthy aorta is only 1.8% lipid wet weight [117] and only fatty tissues 
such as adipose, adrenal gland and bone marrow have similar or higher lipid content.  This 
extreme fatty content, based on the MD, and the similar shape seen in MD and photography 
are strong indicators that the MD can provide an image of atherosclerotic lipid core. 
The large unstained region of the lipid core highlighted in Figure 3.8 may be made up of non-
neutral lipids such as free cholesterol which do not stain with oil-red O, but this was not 
confirmed.  Staining future plaques with Nile red or filipin, which both stain non-neutral 
lipids,  might provide a more complete assessment of the lipid core [115, 118].  Another 
possibility is that stained material was washed away in the rinse process.  However, the 




some voxels that are most likely calcified as soft tissue (see Section 5.4) and these voxels 
usually have relatively high HU values.  These voxels would likely receive lipid values of 
near zero and be excluded from the images shown. 
Calcium measurements 
Distributions of larger calcifications showed strong agreement between attenuation, MD and 
histology (Figure 3.7).  Smaller and microcalcifications in the MD are not obvious in the 
attenuation and histology images; however, the correspondence between the HU based image 
in Figure 3.6 (e) and the MD in Figure 3.6 (f) is strong evidence that the smaller and 
microcalcifications are real.  Sub-voxel sized HA deposits should be detectable to the MARS 
MD.  Figure 3.10 is a plot of the expected attenuation in the 30 keV bin of hydroxyapatite in 
three different arrangements and compared to CaCl2 which was the calibration material for 
calcifications in this study.  The HA attenuation is graphed for, one, HA evenly distributed in 
water (circles), two, HA exists as a cubic particle in water (triangle pointing up) and three, 
HA exists as a cubic particle in adipose tissue (triangle pointing down).  The values are based 
on attenuation data derived from the National Institute of Standards and Technology (NIST) 
database [119].  Three traits of this plot are important for MARS material imaging. 
 
Figure 3.10:  Comparison of attenuation of hydroxyapatite in three different arrangements in a 100 
µm voxel.  The attenuation values correspond to expected values in the 30 keV bin.  Circle is HA 
homogeneously distributed in water, triangle pointing up is an HA particle in water and triangle 
pointing down is an HA particle in adipose tissue.  Square is a CaCl2 solution in water for comparison 
to the phantom standards used in this scan.  The horizontal line passes through CaCl2 at 50 mg/ml and 
highlights the broad range of actual HA concentrations that could be associated with a single CaCl2 




First, sub-voxel sized HA particles should be detectable.  In a (100 µm)
3
 voxel, a 50 mg/ml 
HA cube in water has a HU (30 keV) value of 211 and is just 25.1 µm on a side. 
Second, the attenuation of the same concentration of HA is highly dependent on how it is 
distributed.  For example, 50 mg HA/ml as a single, cubic particle in adipose would have HU 
= 9, as a particle in water the attenuation would be HU = 211, while the same quantity of HA 
in water but evenly distributed throughout the voxel would have HU = 632.  On the other 
hand, at the same attenuation, the potential HA concentration can vary widely (see horizontal 
line at HU = 281 for 50 mg CaCl2/ml).  It might be hoped that the spectral data could correct 
for some of this dispersion, but that issue has not been investigated yet. 
Third, the MD does not account for the presence of lipid near calcifications, but there is 
clearly an impact on the attenuation.  HA is commonly associated with lipid in atherosclerotic 
plaques [103].  The presence of lipid changes the attenuation and the spectral pattern.  This 
may result in MD concentrations of calcium that are too low or, even more important with 
respect to detecting microcalcifications, the voxel may be classified at ST when, in fact, HA 
is present. 
The definition of spotty calcification varies.  Kataoka et al. (2012) and Ehara et al. (2004) 
make the key distinction that the calcification not occupy more than 90⁰ of the vessel 
circumference [72, 74].  Ferencik et al. (2012) define it as isolated nodules less than 3 mm in 
diameter [120].  By these standards, spotty calcification is clearly detectable with the MARS 
MD.  Some researchers would include much smaller calcifications as a sign of vulnerability 
to rupture.  Microcalcifications are now understood to form in and around the necrotic lipid 
core and even in the fibrous cap, where they may form regions of stress in the cap that could 
lead to rupture [70, 75, 76, 108].  The MARS MD contains many calcified regions that are 
smaller than 1 mm
3
, including isolated voxels that are surrounded by soft tissue (83 in the 
lipid core ROI of plaque 108).  An important goal for future research with MARS will be to 
establish a confidence level in the reality of such small calcifications.  If MARS can indeed 
reliably detect sub-voxel sized calcifications it could play an important role in assessing risk 
of plaque rupture due to microcalcifications near the fibrous cap. 
When MARS scanners are more prevalent in pre-clinical and clinical research, it will be 
important to establish guidelines for how to interpret the concentrations of material 
reconstructions.  As discussed in the methods, the meaning of low concentrations of lipid or 
calcium is difficult to assess and lower thresholds with more relevant meaning than the ones 
used in this study (12 mg Ca/ml and 120 mg lipid /ml, see Section 3.4 Methods) should be 
established. 
Other limitations of this study 
The material decomposition algorithm does not allow lipid assessment in voxels deemed to 
have calcification.  This means that calcified plaque regions cannot be classified as fatty or 
fibrous, which could have an impact on risk assessment [53].  The next generation of MARS 
reconstruction which will include simultaneous reconstruction and MD, may allow three 




The histology technique is rough.  We are pursuing traditional thin section histology for 
future plaques but it was unavailable for this study.  The presence of calcifications causes the 
tissues to tear during sectioning and is a major problem.  The fluorescence microscopy offers 
excellent visualization of larger calcifications, but smaller yellow/green granules such as 
those seen in Figure 3.8 cannot be positively identified.  Staining of our thick sections or 
traditional thin sections with stains for calcium (Alizarin red) or phosphate (von Kossa) might 
confirm the presence of microcalcifications appearing in the MD [70, 121]. 
Several traits of vulnerable plaque that might be identified by MARS images were not 
assessed.  Iron differentiation from calcium was not deemed important at this time, but 
MARS team members are beginning work in that area of plaque imaging.  Zainon et al. 
showed that calcifications and iron deposits could be visualized with MARS but the MD for 
iron separation was not reliable [100].  Wang et al. were able to quantify iron in the presence 
of calcium using dual energy CT [121].  Fibrous cap thickness has a strong correlation with 
rupture [57, 122].  Detection of the fibrous cap thickness might be assessed with MARS if 
appropriate thresholds for lipid content were established and effective blood pool contrast 
agents that do not diffuse into the cap were used, but this is speculation.  Positive remodelling 
might also be assessed with MARS images, again, probably with the use of contrast agents.  
Inflammation and macrophage content could also be imaged with properly targeted contrasts 
(see Section 2.7 and Chapter 4). 
 
3.5 Scanning and monitoring live samples 
 
3.5.1 Live excised plaque 
Introduction 
Aim 
As a developmental technology, the MARS scanners capabilities are modified and upgraded 
on a regular basis.  Hardware and software changes were expected (and have since) to bring 
scan times from hours to minutes.  In anticipation of this we began some simple tests to 
confirm that living tissues could be scanned without severe impacts to viability.  This project 
was designed as a simple introduction to MARS scanners for an undergraduate summer 
student, Hayley Schoch. 
Our lab cultures freshly excised carotid plaques for up to four days [123].  We wanted to test 
if plaque sections could be cultured after scanning with minimal impact on the plaque 
responses.  As with any summer student project we wanted to expose an undergraduate to 






Showing that live carotid plaque samples could be scanned with minimal impact on plaque 
physiology is a first step in developing a whole new line of research where plaque traits such 
as lipid and calcification content can be measured and correlated with biochemical research 
done in a tissue culture model [124] 
Contribution 
I worked closely with Hayley on all aspects of her work, from tissue culture, to lactate 
measurements, to scanning and visualization. 
Methods 
Scan parameters appear in Table 3.1 for plaque 90. 
Human carotid endarterectomy samples are used for scanning and obtained under human 
ethics approval reference CTY/01/04/036/AM05.  A freshly excised carotid endarterectomy 
sample was acquired from surgical theatre.  It was transported on ice to a PC2 lab where it 
was rinsed for five minutes in PBS, then cut into six transverse sections of about 4 mm thick 
with a scalpel.  Three sections were randomly assigned to be scanned, while three were 
placed in an adjacent scanner but without scanning.  The scanned sections were exposed to x-
rays for 20 minutes in a pseudo-scan, as this was expected to be longer than any upcoming 
scans with new faster hardware. 
After treatment, the six sections were returned to a PC2 lab, weighed and cultured in Gibco
TM
 
RPMI 1640 media with 10% human serum. At 24 and 48 hours the culture media was 
pipetted off and placed in a sterile, polypropylene centrifuge tube.  Fresh media was then 
added.  Used media was analysed for lactate production using a colourimetric lactate assay 
kit.  The lactate assay is used as a measure of overall metabolic activity.  Lower lactate 
production indicates less activity.  After two days of culture the sections were returned to the 
MARS scanner for a true scan and then stored in a -80C freezer. 
Results 
Lactate production over 24 and 48 hours is shown in Figure 3.11 (a).  Data are reported as mg 
Lactate/ g wet tissue weight.  There was no significant difference in lactate production 
between the X-ray exposed sections and the controls at either 24 or 48 hours. 
Discussion 
X-ray treated plaque tissue was unaffected metabolically compared to controls according to 
lactate production on a per gram wet weight basis.  This result was a strong initial indicator 
for the MARS team that tissue culture experiments could be performed on plaque samples 






Figure 3.11:  (a) Lactate production over 48 hours with and without 20 minutes of X-ray exposure.  
Bars are standard error of the mean.  (b) Reconstructed slice of the three plaque sections exposed to 
X-rays.  The actual scan was performed after completion of the experiment since scan times were still 
in the 2 hour range. 
 
3.5.2 Monitoring Mice 
Introduction 
Aim 
The MARS small animal scanner is designed to be used on living laboratory animals such as 
mice and rats.  In preparation for faster scan times that would allow live animal scanning, we 
began testing animal monitoring equipment for ease of use and to strategize techniques inside 
the scanner.  Monitoring provides data concerning the animal’s status, as well as 
physiological measurements that can be correlated with MARS scan data. 
We sponsored a summer undergraduate student project to set up the equipment and test it on 
live animals outside the machine.  UC undergraduate Dylan Paterson carried out this work. 
Significance 
This work helped move the MARS team closer to live animal scanning.  It also revealed 
some of the difficulties associated with using the animal monitoring equipment.  It also 
provided experience to Dylan in using scientific equipment and dealing with live animals. 
Contribution 
I worked with Dylan in all aspects of this work except the retrospective gating program and 






Live mice were anaesthetized with inhalation of isoflurane.  After mice were unresponsive to 
a toe pinch, the monitoring equipment was applied.  Respiration was monitored with a 
pressure sensitive pillow placed under the rib cage.  Temperature was monitored by rectal 
fibre optic probe.  Transmissive pulse oximetry was attempted on the tail and the ankle with a 
general purpose clip and special purpose ankle/tail holder. 
Six mice were monitored with all equipment simultaneously.  Six more mice were monitored 
for temperature only over a ten minute period to assess temperature changes in the mice 
during anaesthesia with and without a heating pad set to 37C. 
Results 
Mice were successfully monitored for respiration rate, temperature and pulse oximetry.  
However, the pulse oximeter was problematic.  The general pulse-ox clip could not be made 
to acquire data.  The specialized clip was very difficult to use.  It could not be made to 
acquire data on the tail.  It was very difficult to apply to the ankle, requiring a customized 
technique in which the ankle was pulled though the clips ring with a thread taped to the 
mouse’s foot.  Only 1 mouse of the six was successfully monitored with pulse-ox. 
Breathing rate data was used to develop a retrospective gating program that could choose 
time correlated CT images with the same point in the breath cycle and reject projections 
taken during breath movements.  The program was tested on an old CT and respiration 
dataset from a live mouse scan (source unknown) and found 55% to 60% of projections were 
retained. 
Mice placed on a heating pad had better temperature stability.  Heated mice dropped in rectal 
temperature by an average of 0.63C in 10 minutes while unheated mice cooled by an average 
of 2.8C in ten minutes 
Discussion 
The work revealed some of the difficulties that will be encountered in live animal scanning.  
The Pulse oximeter is difficult enough to use that we recommended looking for other designs.  
The layout of the measuring devices will require a mouse bed in the scanner that holds the 
animal in place because mice had a tendency to slip off the respiration pillow.  The 
temperature probe on the other hand was easy to use and could be taped in place. 
 
3.6 Conclusion 
Material reconstruction of the spatial arrangement of lipid and calcium-rich regions in 
atherosclerotic plaque was successful using photon energies relevant to human imaging (30 to 
120 keV). 
A series of studies demonstrated the potential to identify lipid-rich and calcium-rich 




volumes.  Lipid and calcium components were identified on a macroscopic scale in a lamb 
tissue sample and on a smaller, microscopic scale in excised carotid plaque samples that 
demonstrates the superior spatial resolution of MARS scanners compared to current clinical 
CT. 
GaAs and CdTe are suitable sensor materials for obtaining accurate MD of lipid and calcium 
components of atherosclerotic plaque.  Both SPM and CSM generate quality spectral data 
sets that allow MARS MD software to discriminate intrinsic material arrangements. 
Lipid and calcium MD separation from surrounding tissues mean that two intrinsic markers 
of atherosclerotic plaques that are at risk for rupture can be identified in material 
reconstructions:  the necrotic lipid core and spotty calcifications.  Histologic examination 
confirmed the macroscopic arrangement of a lipid core and spotty calcifications with good 
spatial agreement between photography, attenuation data and MD results. 
In future, human versions of the MARS scanner, atherosclerotic burden may be assessable 
with detection of lipid cores and spotty calcifications in plaques of various stages of 
development, not just vulnerable advanced plaques. 
Live tissue scanning was shown to be feasible in a twenty minute scan. 







4 Contrast Enhanced Imaging with MARS 
 
4.1 Introduction 
MARS scanners use spectral patterns to identify materials of interest to the researcher or 
clinician.  In combination with contrast agents, a powerful new tool will be developed in 
diagnosing, treating and assessing treatment of disease and injury.  With four to eight energy 
bins, MARS scanners can be used for K-edge imaging to identify multiple contrast agents 
simultaneously while maintaining the ability to discern intrinsic material arrangements of 
lipid and calcium that are also important in disease and injury assessment (see Chapter 2).  
Current clinical CT can only discern contrast agents from body structures because of known 
spatial arrangements in the body and very high attenuations from high contrast concentration.  
Dual energy CT can identify materials by a spectral signature, but is limited to two materials 
[22, 125]. 
Material identification in contrast enhanced CT has many potential benefits.  The ability to 
reliably differentiate contrast agents from calcifications is one area where MD with spectral 
CT will aid clinicians.  Atherosclerosis is characterized by calcifications, usually 
hydroxyapatite, varying in size from nanometres to millimetres.  With neovascularization and 
diffusion, contrast agents move into the plaque from the adventitia and the lumen, requiring 
rapid CT acquisition to avoid contrast blurring of the lumen and intraplaque features [68].  
Accurate MD separation of contrast and intrinsic materials may relax the need for rapid 
acquisition and enable positive identification of small, spotty calcifications (especially ones 
in the fibrous cap) even in a background of contrast agent. 
Another example of a possible benefit of MD over attenuation based CT is in repeat scans of 
patients with subdural effusions.  An initial iodine enhanced scan reveals a hyperdense 
subdural effusion due to extravasation of contrast.  On subsequent noncontrast scans, residual 
iodine can lead to misidentification of the effusion as a subdural hematoma (which is 
hyperdense in noncontrast scans) [126].  Accurate MD would identify the residual iodine in 
the second scan, preventing misidentification. 
Energy threshold settings establish the spectral pattern used in MD so it is important to 
consider the best values for identifying the high-Z materials of interest.  K-edges of high-Z 
contrasts largely dictate the placement of thresholds and this chapter includes two phantom 
studies that address threshold placement and the resulting MD of three contrasts, calcium, 
lipid and water components.  Iodine, gadolinium and gold are used for these studies because 
of their prevalence in approved human medical imaging (iodine [127–129]and gadolinium 
[130, 131]) and current pre-clinical research (gold [132–134]). 
Four scans of biological tissue are presented which highlight different aspects of contrast 
enhanced imaging.  Plaque 82 tests the ability to discern tissue and maintain lipid and 




potential for MD measurement of passive accumulation of gold nanoparticles in a tumour via 
the enhanced permeability and retention (EPR) effect [135].  The multi-contrast mouse 
demonstrates MD of six materials simultaneously in a biologic system.  Finally, the 
macrophage scan tests the uptake of untargeted gold nanoparticles by cultured human 
monocyte derived macrophages (HMDMs) as a feasibility study for research using 
macrophage targeted gold nanoparticles.  The scan parameters for all six studies are listed in 
Table 4.1. 
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Bias voltage 
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This work developed and tested a scheme for calculating the optimal energy threshold 
settings to be used in multiple K-edge imaging with spectral CT.  It accounts for the trade-off 
between maximizing the difference in signal between adjacent energy bins and maintaining a 
strong signal to noise ratio for all bins. 
Within the limits of the noise floor at the low energy end and the maximum photon energy in 
a scan protocol, the energy threshold choices for the MARS camera energy bins are entirely 
arbitrary. He et al. developed the signal difference to noise ratio (SDNR) to determine the 
optimal energy bins for discrimination of a single K-edge but provided no procedure for 
imaging with multiple K-edges simultaneously [136, 137].  The SDNR combines differences 
in attenuation above and below the K-edge with values for the noise in each bin to obtain a 
single value that is maximized to optimize bin selection. Our study separates the attenuation 
and noise components and develops a simple ranking system for choosing the optimal 
thresholds for the four CSM counters given a particular scan protocol and set of K-edge 
contrast agents.  The technique is based on two simple measures of information quality.  
First, the K-factor is introduced to quantify the spectral difference between adjacent energy 
bins on either side of the K-edge of each contrast agent.  Second, the percentage of the total 
spectrum contained in the energy bin that lies just above the K-edge for each material is used 
as a theoretical measure of the signal to noise ratio (SNR). 
The results of the ranking system are tested with real data sets using two threshold schemes 
and comparing the measured values of the K-factor and the signal to noise ratio (SNR). 
Significance 
The technique provides a simple way of assessing threshold schemes for identification of 





This work is featured in the Journal of Instrumentation [138] 
Contribution 
I produced the phantoms used and was involved in concept and manuscript development. 
Methods 
In K-edge imaging, there is a trade-off between spectral information, which is maximized by 
the difference between attenuation of adjacent energy bins, and SNR within an energy range.  
Narrow energy bins maximize energy information by maximizing the difference between the 
effective energy of adjacent energy bins.  Wide bins maximize SNR, which is approximately 
equal to the square root of the X-ray intensity, simply by containing more counts. 
The K-factor is introduced to provide a quantitative measure of the quality of the energy 
information between two energy bins on either side of a material’s K-edge. 
𝐾 − 𝑓𝑎𝑐𝑡𝑜𝑟 =  
(𝑋−𝑟𝑎𝑦 𝑎𝑡𝑡𝑒𝑛𝑢𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑒𝑛𝑒𝑟𝑔𝑦 𝑏𝑖𝑛 𝑎𝑏𝑜𝑣𝑒 𝑡ℎ𝑒 𝐾−𝑒𝑑𝑔𝑒)100%
(𝑋−𝑟𝑎𝑦 𝑎𝑡𝑡𝑒𝑛𝑢𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑒𝑛𝑒𝑟𝑔𝑦 𝑏𝑖𝑛 𝑏𝑒𝑙𝑜𝑤 𝑡ℎ𝑒 𝐾−𝑒𝑑𝑔𝑒)
  (4.1) 
It is simply the ratio of the theoretical mass attenuation of a material for two adjacent energy 
bins on either side of its K-edge multiplied by 100 to create a convenient number.  A higher 
K-factor implies better energy information.  A particular threshold protocol gives a K-factor 
for each material.  To compare different protocols the K-factors are ranked within each 
material and the ranks for each protocol are summed.  The lower the sum, the better the 
protocol with respect to overall energy information 
For the theoretical assessment of SNR, the technique simply uses the percentage of the X-ray 
spectrum contained within the above K-edge energy bin for each element.  Protocols are 
again ranked within each material based on the percentage, with a larger percentage ranking 
higher.  The X-ray intensity ranks are summed within each protocol and the lower the sum 
the better the overall noise ranking. 
Finally, the two summed values for each protocol, K-factor and intensity, are added together 
and the protocols ranked from lowest total to highest.  Ties are broken by opting for the 
protocol with a better theoretical K-factor sum. 
Theoretical protocol ranking was performed for five possible threshold schemes for 
distinguishing iodine, gadolinium and gold.  The top two protocols were used to scan a multi-
contrast phantom with identical settings other than thresholds.  Then, the reconstructed data 
were used to calculate measured K-factor and SNR values and assess the results of the 
theoretical technique.  Measured K-factor is based on mass attenuation coefficients calculated 
for the highest concentration of each contrast.  SNR is calculated from the mean of 720 
flatfields for each energy bin of interest divided by its standard deviation. 





The threshold schemes and resulting theoretical K-factor and X-ray intensity ranks are shown 
in Table 4.2.  Scheme D scores the lowest with a total of 9, followed by schemes A and B 
with 15.  Scheme B is chosen for measured comparison to scheme D based on a lower K-
factor sum (8 for B, 9 for A).  The final rankings are shown in Table 4.3. 
Table 4.2:  Comparison of five different threshold schemes for K-factor and estimated 
percentage of spectrum photons in the over K-edge energy bin (i.e. the bin which will show 









The measured K-factor and signal to noise ratio (SNR) data for the two schemes are 




Figure 4.1:  Comparison of measured K-factors and SNRs between schemes B and D.  (a) measured 
K-factor for the highest concentration of iodine, gadolinium and gold phantoms and (b) measured 
SNR for the above K-edge energy bin for each material and protocol.  Used with permission [138] 
 
Scheme D proves to be more informative overall than scheme B.  All following analyses are 
for scheme D only. 
Figure 4.2 illustrates the quality of the scheme D data.  The K-edge is clearly visible for even 
the lowest concentrations of each high-Z contrast.  The MD image in Figure 4.2 (d) shows 
excellent separation of materials, with little to no visible crosstalk. 
Discussion 
The theoretical calculations of K-factor and X-ray intensity showed scheme D was clearly 
superior to the other four threshold schemes.  In testing vs scheme B, scheme D proved 
superior in K-factor for all three elements and in SNR for gadolinium and gold.  Only the 
iodine SNR was inferior for scheme D and that is in keeping with its poor theoretical score 
for iodine’s above K-edge X-ray intensity percentage (Table 4.2).  The measured K-factors 
for scheme D (all below 140% or lower) are below the theoretical values (all above 204%).  
This is an indicator of the noise in the system and probably represents the strong effect of 
threshold dispersion in the energy calibration (see Chapter 6), which blurs the spectral 







Figure 4.2:  K-edge detection and resulting MD for scheme D.  The increase in attenuation 
(Hounsfield units) relative to water is apparent from the below to above K-edge energy bins at all 
concentrations for (a) iodine, K-edge = 33.2 keV, (b) gadolinium, K-edge = 50.2 keV, and (c) gold, 
K-edge = 80.7 keV.  The MD  of the phantom (d) with purple for iodine, green for gadolinium, yellow 
for gold and white for calcium.  Concentrations are in mg element/ml solution except for calcium 
which is mg CaCl2/ml solution.  Used with permission [138] 
The two part ranking technique using the K-factor to evaluate energy information and X-ray 
intensity to evaluate SNR provides a simple, objective format for choosing optimal energy 
threshold schemes.  The five component MD of a multi-contrast phantom shows the quality 
of the scheme “chosen” by the technique.  The technique is easily applied to any contrast 
agents with K-edges in the X-ray spectrum used.  Libraries of K-factor and SNR values could 
be developed for a range of contrasts and scan protocols (i.e. different X-ray spectrum and 
threshold combinations). 
This study did not examine a technique for optimizing thresholds by calculating K-
factor/SNR scores across the continuum of possible combinations.  While this would require 








4.3 Six material MD of a multi-contrast phantom 
Introduction 
Aim 
This phantom study was formulated with the idea of demonstrating the MARS scanner’s 
ability to distinguish six materials, four of which are high-Z, using photon energies relevant 
to human imaging.  Only intrinsic source filtration is used, so low energy photons (below 30 
keV) are still present in significant quantity.  Lipid and water components are distinguished 
as well as calcium, iodine, gadolinium and gold.  Like the lamb tissue data set (Section 3.2), 
the raw, partially processed and fully processed data is made available to the public for 
examination. 
Significance 
This phantom study demonstrates six material MD using CSM and four energy bins with an 
X-ray spectrum spanning 18 keV to 118 keV.  It also introduces the identification chart which 
provides a simple display of the sensitivity and crosstalk in the MD.  As the MARS scanner 
and software packages mature and stabilize, the team is moving into more stringent analysis 
of correct MD identification and quantification. 
Publication 
This work is published in JSM Biomedical Imaging Data Papers, [139] 
Contribution 
I produced all the phantoms used in this study.  I was part of the protocol development team 
and participated in manuscript editing. 
Methods 
The phantom layout is shown in the left side of Figure 4.3.  Gold is gold chloride (Salt Lake 
Metal, Salt Lake City, UT, USA).  Gadolinium is MultiHance (Bracco Diagnostics Inc., 
Milan, Italy).  Iodine is Omnipaque 300 (GE Healthcare, Chicago, IL, USA) and calcium is 
calcium chloride (BDH Laboratory Supplies, Poole, UK).  The phantom holder is Polymethyl 
methacrylate (PMMA). 
The scan protocol is listed in Table 4.1.  The energy bins are set so that each of the three 
highest bins encompasses one K-edge ( iodine (30 to 45 keV, K-edge = 33.2 keV), 
gadolinium (45 to 78 keV, K-edge = 50.2 keV) and gold (78 to 118 keV, K-edge = 80.7 
keV)). 
A 900 voxel ROI in each phantom was used to generate the identification chart.  Voxels are 
assessed for which materials are present (water is ignored unless the voxel concentration of 





The attenuation reconstruction of a transverse slice is shown in Figure 4.3.  The K-edge effect 
is visible for the highest concentration of iodine, gadolinium and gold.  In the lower 
concentrations it is more difficult to discern, except for iodine where it is still obvious at 18 
mg I/ml.  However, the data for the lower concentrations still shows the K-edge effect for Gd 
and Au (data not shown). 
 
 
Figure 4.3:  Attenuation of the six material phantom in four energy bins.  In the schematic, for gold, 
gadolinium and iodine the numbers represent mg of element/ml of solution while for calcium the 
concentration is 140 mg CaCl2/ml solution.  The grayscale is in HU with a window of -1000 to 1500.  
Used with permission [139] 
 
 
Figure 4.4:  MD of the six material phantom.  Materials are in the same arrangement as the schematic 
in Figure 4.3.  The PMMA spectral signal was added to the MD as a seventh material to separate it in 
the images for a clean look but the technique would not be applicable in MD of unknown samples.  
Used with permission [139] 
 
The MD distinguished all materials but significant crosstalk occurs for 2 mg Gd/ml (Figure 





Figure 4.5:  Identification chart.  Each bar represents the calibration vial listed at the bottom of the 
chart.  The colour bands represent the percentage of each vial identified as containing the 
corresponding material, i.e. yellow is the percentage of voxels identified as gold, red as gadolinium 
etc. as shown in the legend on the right.  Since all voxels have a water value, the water percentage is 
only voxels that have a concentration of zero for the other materials.  Alternatively, a lipid voxel is 
any voxel with a lipid concentration above zero.  Used with permission [139] 
Discussion 
A six material phantom was successfully decomposed.  The identification chart (Figure 4.5) 
shows the high quality of the sensitivity at higher concentrations for all materials.  The 
gradual decay in sensitivity as concentrations decrease is seen in the 2 mg Au/ml and 
especially the 2 mg Gd/ml phantoms.  The MD might be improved by using alternative 
thresholds, perhaps by using the K-factor technique described in Section 4.2, but this was not 
attempted.  Making the data set available to the public marks the first full MARS dataset that 
includes high-Z contrasts that can be analysed by independent parties. 
 
4.4 Plaque 82:  MD of submersion in gadolinium contrast 
Introduction 
Aim 
This study tested the ability to visualize an excised carotid plaque when submerged in a water 
based gadolinium contrast solution and to distinguish lipid, calcium and gadolinium 
components.  Visualization in air provides excellent contrast for the tissue outline, but does 




a middle ground between air and unenhanced CT imaging in water or in vivo while roughly 
simulating a contrast enhanced CT scan.  The study sought to observe the diffusion of 
contrast into the plaque.  Would a hydrophilic contrast agent diffuse throughout the plaque, or 
would it be excluded from the more hydrophobic lipid core?  Would the lipid and calcium 
signals be maintained in a background of high-Z material?  Both the air and gadolinium scans 
were performed at 118 peak kilovoltage (kVp) with filtration to eliminate photons below ~30 
keV.  Like plaque 108 (Section 3.4), this simulates a true human scan. 
Significance 
Again, all results are accomplished while scanning in the human diagnostic energy range 
above ~30 keV.  This study shows that the MARS MD quantitative data allows concentration 
gradients in high-Z materials to be used in conjunction with a customized transfer function to 
visualize tissue details.  It also demonstrates that the lipid and calcium MD are relatively 
stable between scans in air and submerged in contrast solution.  Scan results indicate that 
hydrophilic contrast agents may not significantly diffuse into high lipid regions which may 
translate to more reliable identification of lipid core atheromas in clinical enhanced CT. 
Publication 
A manuscript is in development for submission to European Radiology 
Contribution 
I carried out all aspects of this work. 
Methods 
A calibration phantom was assembled as shown in the left side of Figure 4.6.  Hydroxyapatite 
nanoparticle in resin phantoms were used in place of the CaCl2 solutions of the past.  For 
material calibration, the phantom was scanned in air prior to plaque scanning. 
Human carotid endarterectomy samples are used for scanning and obtained under human 
ethics approval reference CTY/01/04/036/AM05.  A carotid endarterectomy sample was 
acquired from surgical theatre and frozen in a -80C freezer.  The calibration phantom and 
both plaque scans were performed in the same day following the protocol listed in Table 4.1 
for plaque 82.  The plaque was removed from the freezer and allowed to thaw at room 
temperature in a sealed tube with moist cotton to maintain 100% humidity.  The plaque was 
scanned in the tube.  Immediately following the air scan, the plaque was transferred to 
another polypropylene tube filled with Gadovist® 1.0 Contrast (Bayer, Inc., Leverkusen, 
Germany) diluted to 6 mg Gd/ml solution.  Air bubbles were gently separated from the 
plaque and then the tube was sealed and allowed to stand at room temperature for two hours 
to allow the gadolinium contrast time to diffuse into the tissue.  The plaque was then scanned 
again. 
The MD follows the criteria for plaque 108.  The lipid component is displayed only above 




have a different meaning with the change from a CaCl2 water solution phantom to an HA 
nanoparticle in resin phantom (see Figure 3.10).  Calcium is shown as a replacement volume 
in both plaque scans but not in the phantom images. 
Results 
The MD of the phantom is shown in Figure 4.6.  The gadolinium signal is strong at 2 mg 
Gd/ml and present even at 1 mg Gd/ ml.  The HA MD is still strong at 50mg HA/ml. 
The identification chart in Figure 4.7 shows the percentage of voxels in each calibration vial 
that are identified as one of the four MD materials.  Gadolinium is misidentified as calcium at 
lower concentrations, especially at 1 mg Gd/ml where just over 21% of voxels were 
mistakenly assigned to the HA component.  On the other hand, HA is rarely misidentified as 
gadolinium, even at 50 mg HA/ml. 
Figure 4.8 displays, roughly, the same transverse slice through the plaque for both the air and 
gadolinium scans.  The plaque outline and lumen are visible at a transition between a strong 
gadolinium signal and a signal dominated by intrinsic plaque materials.  The calcium and 
lipid components are present in similar distributions in both scans. 
 
 
Figure 4.6:  The phantom layout on the left and MD on the right.  Gd # = mg of gadolinium/ml 
solution using Gadovist® 1.0 Contrast (Bayer, Inc., Auckland, New Zealand).  Ca # = mg 
Ca5(PO4)3(OH)/ml using calcium hydroxyapatite nanoparticles in resin ‘water’ (QRM GmbH, 
Moehrendorf, Germany).  The MD colourmap is Gd = green, Ca = grey, Lipid = yellow, Water = red. 
 
The three dimensional appearance of the plaque is obvious in air (Figure 4.9 (a)) and the 
same basic outline is present in the gadolinium scan (Figure 4.9 (b)).  Without the obvious 
contrast of the air/tissue interface, the plaque shape in panel 4.9 (b) is revealed by the 
combined appearance of the microcalcifications near the plaque’s outer surface and 






Figure 4.7:  Identification chart for the four material phantom in Figure 4.6.  Each column represents 
a vial from the phantom.  Each colour represents the percentage of voxels in that vial that were 
identified as containing the corresponding material from the legend on the right.  Since all voxels have 
a water value, the water percentage is only voxels that have a concentration of zero for the other 




Figure 4.8:  MD of a transverse slice.  (a) photo of the whole plaque.  The blue line shows the 
approximate position of the slice.  The MD of roughly the same slice from scans in air (b) and in 6 mg 
Gd/ml (c).  The lipid and calcium signals are similar in both.  The colourmap follows that of Figure 
4.6 but Ca is shown as a replacement volume (the water signal is ignored). 





Figure 4.9:  Comparison of the whole plaque in air and in 6mg Gd/ml gadolinium solution.  The 
general shape of the plaque is seen in air (a) and the same outline is revealed by diluted gadolinium 
contrast that has diffused into the plaque (b).    In (b) Gd is shown only between 0 and 3 mg Gd/ml 
solution which has eliminated the Gd from the surrounding solution but shows the diluted Gd contrast 
in the outer layers of the plaque.  The calcium signal is virtually unchanged between the air scan (c) 
and the Gd scan (d).  Most of the microcalcifications forming the “mesh” near the bifurcation in (c) 
were still detected in the Gd scan but are not shown because crosstalk from the Gd resulted in many 
low calcium concentration voxels in the surrounding solution and plaque periphery (see Figure 4.7).  
Thus, the Ca windows are > 12 mg/ml in (c) and > 25 mg/ml in (d). 
Discussion 
Scanning in the human CT energy range from ~30 keV to ~118 keV, lipid, calcium and 
gadolinium components have been differentiated in an excised carotid plaque submerged in 
gadolinium contrast.  The key results of this study are the fidelity of the lipid and calcium 
signals between the air and Gd scans, the apparent exclusion of the hydrophilic Gd contrast 
from the lipid core and the ability to use concentration gradients in the MD to enhance the 
view of spatial features. 
The air scan of this plaque revealed a prominent lipid core upstream from the bifurcation of 






around the outer surface of the plaque sample, as seen in Figure 4.8 (b) and Figure 4.9 (c).  
Both the lipid core and the spotty calcium are also prominent in the Gd scans (Figure 4.8 (c) 
and Figure 4.9 (d)).  This important result indicates that intrinsic material spatial 
arrangements that are important in assessing disease may be identified in contrast enhanced 
spectral scans.  In particular, the mesh of calcifications near the outer surface of the plaque is 
present in the Gd scan.  To highlight this, the thinner soft tissue of the CCA at the bottom of 
the plaque is not prominent in the Gd scan (compare the bottom of the plaque in Figure 4.9 
(a) and (b)) but the calcium component of the Gd scan shows the plaque outline even in this 
area where the submersion in water-based Gd solution prevented detailed soft tissue imaging.  
Possibly, Gd contrast has diffused throughout this thinner region of tissue (the walls are ~0.5 
mm thick), but the calcium signal is maintained.  Identifying microcalcifications like these in 
thin fibrous caps even in the presence of diffused contrast agent could have significant 
benefits in clinical identification of vulnerable plaque.  Furthermore, it may reduce the need 
for multiple scans with and without contrast, reducing patient costs, inconvenience and dose. 
There is little Gd signal in the lipid core regions of the plaque (Figure 4.8 (c)), even after two 
hours of diffusion.  This may indicate that the more hydrophobic lipid core will exclude water 
soluble contrast agents and lead to enhanced contrast in attenuation data of lipid cores 
adjacent to other soft tissue that does not exclude contrast.  Previous studies have shown 
enhanced contrast of lipid cores in contrast enhanced carotid scans using iodine with CT [68] 
and gadolinium with MRI [140].  However, the differentiation of lipid-rich regions from 
other soft tissue components is still problematic, especially with smaller sized lipid cores or 
smaller vessels such as coronary arteries [68, 141].  Furthermore, attenuation increases are 
seen in lipid cores in MRI between noncontrast and Gd enhanced scans [142], so contrast 
most likely does enter the lipid core.  With the MARS scanner, the smaller voxel size and the 
MD resulting from multiple energy bins should allow more reliable identification of lipid 
cores even if the attenuation is altered by the penetration of contrast.  However, this will 
require the development of new reconstruction and MD procedures that can provide a high Z 
component and a lipid component in the same voxel (currently only water is allowed as a 
second material), which the MARS team are currently working on. 
In Figure 4.9 (b), the plaque is submerged in 6 mg Gd/ml, but the plaque outline is made 
visible in the MD by windowing the Gd component so that only concentrations below 3 mg 
Gd/ml are shown.  This demonstrates the diverse benefits that quantitative material 
identification may have.  By using concentration-based windowing in the material 
reconstructions, different aspects of anatomy can be highlighted at different concentration 
zones. 
The potential for quantitative contrast measurements in improving spatial contrast have been 
demonstrated in human abdominal scans by Pourmorteza et al. [143].  They compared iodine 
enhanced scans with a traditional energy integrating detector and with a two energy bin 
photon counting detector.  Using the summed count data for both energy bins in the photon 
counting detector to make a single reconstruction, they compared the attenuation data and 
found no differences in image quality, noise, artefacts, Hounsfield units (except in the spinal 




values),  noise power spectrum or spatial resolution.  However, when they used the two 
energy bins to make an iodine concentration map, they found the contrast to noise ratio 
between the kidney and paraspinal muscle was 32% greater for the concentration map over 
the energy integrating reconstruction. 
Concentration gradients in iodine or gadolinium staining of animal organs or whole bodies is 
well established in CT based morphology studies and Silva et al. [144] have demonstrated the 
use of dual-energy micro-CT to add quantitative contrast measurements to the detailed 
reconstructions.  MARS scanners have demonstrated the same potential and add the 
possibility of using multiple contrasts simultaneously. 
Concentration gradients may also improve injury or disease assessment if contrast agents 
have different diffusion or adhesion properties in healthy versus damaged or altered tissues.  
Abraham et al. showed that iodine contrast enhancement of damaged myocardium over 
normal myocardium was due to loss of membrane integrity in damaged cells, allowing 
diffusion of contrast agent into the damaged cells [127].  Possibly, gradients in iodine 
concentration measured by spectral CT could be used to assess the extent of damage to 
myocardium after heart attacks.  Recent reviews by Sun [145] and Michel et al. [146] discuss 
the possible role of vasa vasorum in the development and progression of atherosclerotic 
p1aques.  Contrast enhancement of both ultrasound and MRI have been useful in assessing 
neovascularization and intraplaque haemorrhage  of plaque tissue, largely due to the more 
leaky, less mature nature of these vessels that grow into the thickening plaque wall.  Again, 
contrast enhanced spectral imaging with MARS scanners may allow CT assessment of 
neovascularization through concentration gradients of contrast. 
The misidentification of gadolinium as calcification is 21% at 1 mg Gd/ml and 9% at 2 mg 
Gd/ml (Figure 4.7).  This error necessitated the raising of the calcium window lower 
threshold in Figure 4.9 (d) to 25 mg HA/ml to exclude (presumably) erroneous Ca voxels in 
the surrounding solution.  This indicates that measures of intrinsic Ca may be less reliable in 
Gd enhanced scans.  Similar misidentification in the opposite direction is not seen in the HA 
50 phantom, but lower concentrations of HA should be included in future phantoms to assess 
the MD at lower Ca concentrations that may represent microcalcifications (see Section 3.4). 
Several factors limit the scope of interpretations from this work.  The excised plaque has been 
frozen and thawed which may change the potential diffusion of contrast into the tissue.  
Furthermore, the plaque segment is not under normal hydraulic stresses associated with an 
artery in vivo and does not include the entire artery wall which also may affect contrast 
diffusion.  As with the intrinsic material scans of Chapter 3, iron is not included in the MD.  
Lastly, results were not checked against alternative methods such as histology, although 
Chapter 3 provides evidence that the lipid core and spotty calcifications are reliable 
measurements in the air scan. 
The results presented provide strong initial evidence that spectral CT with MARS can 
produce high resolution quantitative material reconstructions of lipid, calcium and 




markers of atherosclerotic plaque including the lipid core, spotty calcifications and any 
plaque traits such as leaky neovascularization that could be revealed by concentration 
gradients of contrast. 
 




Cancers are frequently characterized by abnormal neovascular growth into the tumour [80, 
147, 148].  The resulting larger vessels and capillaries are termed ‘leaky’ due to fenestrae and 
gaps in the endothelium that are much larger, on the order of micrometers [149], than in 
normal capillaries where particles over about 8 nm cannot easily exit [150].  This trait can be 
exploited through the passive accumulation of particles, which can be contrast agents or 
treatments or both, over 8 nm from the bloodstream into tumours via the enhanced 
permeability and retention effect (EPR) [33, 135, 151, 152].  Nanoparticles utilizing the EPR 
effect to concentrate in cancerous tumours have already been approved for clinical  use and 
many are in testing phases [153].   
This study sought to image and quantify the passive accumulation of intravenously injected 
15 nm gold nanoparticles in subcutaneous Lewis Lung carcinoma tumours in live mice.  
Aluminium filtration of 3.8 mm reduced low energy photons to demonstrate gold 
identification using photons energies similar to human scanning.  While utilizing the EPR 
effect can involve active manipulations of tumour and animal physiology [152], this 
preliminary study is completely passive and relies only on the interaction of the 15 nm gold 
nanoparticles with the tumour vasculature. 
Significance 
Several MARS team members and collaborators are attempting to produce gold nanoparticles 
that target cancers for the purposes of tumour identification, drug delivery and monitoring of 
tumour progression or regression after treatment.  This study demonstrates that gold 
nanoparticles accumulated in a tumour can be viewed in detail and that MARS MD allows 
the quantification of gold in the tumour and other organs.  This will enable researchers to 
estimate efficiency in contrast uptake by the targeted region as well as delivery of any drugs 
loaded onto the nanoparticles.  It will also allow measurements of tumour dimensions and 
changes over time.  Furthermore, the temporal fate of nanoparticles in tumours and various 
organs could be monitored for short- and long-term toxicity studies [134, 154–156]. 
Publication 





I was primarily responsible for the experimental design.  I prepared the purchased 
nanoparticles for injection and performed all mouse manipulations.  I participated in data 
collection and assessment.  I am involved in document editing for journal submission. 
Methods 
Work was conducted under AEC protocol C04/14.  Two C57BL mice were implanted 
subcutaneously with Lewis Lung carcinoma (LL/2) cells while under anaesthesia at 8-10 
weeks of age.  13 days later, tumours were ~75 mm3 for mouse #1 and ~87.5 mm3 for mouse 
#2.  On that day, they were injected using a 31 gauge needle via tail vein, under isoflurane 
anaesthesia, with 20 mg Au as 200 µl of 100 mg Au/ml solution.  Gold nanoparticles were 
Aurovist
TM
 – 15 nm Gold Nanoparticle X-ray Contrast Agent (Nanoprobes, Inc., Yaphank, 
NY, USA) suspended in buffered saline solution.  Mice were euthanized at 24 hours after 
injection to allow accumulation in the tumour and a decrease in vascular concentration (~15 
hour blood half-life) [157].   
Euthanized mice were X-rayed to assess gold accumulation in the tumour, placed in 
polypropylene tubes for scanning and refrigerated for twelve hours to allow rigor mortis to 
set in.  Mice were scanned at room temperature according to the tumour mouse protocol in 
Table 4.1.  A phantom for material calibration was scanned first, on the same day.  The 
phantom consisted of Aurovist
TM
 15 nm gold nanoparticles in saline at 20, 10, 8, 6, 4, 2 and 1 
mg Au/ml, hydroxyapatite in resin rods (QRM GmbH, Moehrendorf, Germany) at 1200, 800 
and 200 mg HA/ml, lipid and water. 
The MARS Vision software was used to quantify the gold present in the tumour as well as 
the renal blood pool of the kidneys.  Because of poor results for the 4, 2 and 1 mg Au/ml 
phantoms a lower threshold of 4 mg Au/ml was used for all imaging and measurements.  This 
means that all gold quantification is most-likely underestimated due to exclusion of regions 
of lower concentration. 
Results 
Gold concentrated in the tumour and is apparent in the MD (Figure 4.10).  Gold, lipid and 
calcium components were separated allowing for measurements of gold quantities in various 
regions of interest, including the tumour and kidneys.  All images and measurements include 
only gold over 4 mg Au/ml as explained in the methods. 
The measured concentration of gold in the phantoms in mg Au/ml were 8 ± 2, 10 ± 1 and 20 
± 1 for the 8, 10 and 20 mg Au/ml phantoms respectively.  This indicates the reliability of 
measurements of higher concentrations of gold in the mouse scans.  Furthermore, ~100% of 
voxels in the 6, 8, 10 and 20 mg Au/ml phantoms were correctly identified as gold.  For 4, 2 





Measurements of gold in the mice were as follows.  Mouse #1 had 0.497 mg Au in the 
tumour, 0.481 mg Au in the right kidney and 0.374 mg Au in the left kidney.  Mouse #2 had 





Figure 4.10:  Gold nanoparticle accumulation in a tumour for mouse #1.  15 nm gold nanoparticles 
are clearly visible in the periphery of a Lewis Lung carcinoma (LL/2) tumour implanted in a C57BL 
mouse (white arrowhead in a, c and d) and in larger blood vessels (red arrow in b and d).  Panels a and 
b are an MD overlay onto transverse slices of the attenuation reconstruction.  Panel c is a 3D image of 
the calcium and gold components of the MD.  Panel d is a coronal slice reconstruction through the 
tumour.  For the MD, gold = yellow, grey = calcium, blue = lipid.  The liver, kidneys and spleen are 








At concentrations over 4 mg Au/ml, gold was successfully differentiated from bone (calcium) 
and lipid in the MD (Figure 4.10) and identified within the tumour.  Furthermore, the 
concentrations in the phantom MD were very accurate.  These two results indicate that 
quantification of gold contrast used in medical and research procedures may be possible 
using spectral CT with the MARS scanner. 
The differentiation of bone and gold means that gold could be used in detection of disease or 
injury in bony regions.  Tumours in bones may be identifiable and their shape elucidated with 
a noninvasive technique.  Furthermore, the calcifications associated with some cancerous 
tumours (see Section 2.9) may be discernible even in a gold targeted tumour scan.  Zhang et 
al. developed a targeted gold nanoparticle for damaged bone tissue and MARS scanners 
might be able to measure this nanoparticle in vivo [159]. 
The results were not confirmed with other techniques but the samples are preserved and that 
measurement may be possible in the future or in future experiments.  Confirmation of MD 
measurements with other techniques will be an important step for the integration of spectral 
CT material reconstructions into research and clinical practice. 
Gold concentrations can be determined with CT, as shown by Hainfeld et al. [160] using 
micro-CT for a breast cancer mouse model, but this technique is not suitable for live imaging.  
Furthermore, the measurement depends on subtracting the signal of a known background 
tissue and therefore the measurement would be affected by other anomalies common in some 
cancers, such as calcifications.  The ability of MARS material imaging to distinguish intrinsic 
materials from high-Z contrasts and to, in the future, image live animals could make contrast 
quantification with spectral x-ray CT a reality [138, 139, 161]. 
A 15 nm particle should not be filtered by the kidneys and the bladder was not highlighted by 
gold accumulation.  Therefore, the measured gold in the kidneys is most likely in the blood 
pool.  The injected quantity of 20 mg of  gold is quite large, meaning at injection the 
concentration of gold in the blood would be approximately 10 mg Au/ml, assuming a ~2 ml 
blood volume which is conservatively large [162]. 
Gold was identified in the vasculature and various organs.  Thus, whole body scans would 
allow quantitative assessment of the distribution of gold in test subjects.  This measurement 
would be important in trials of any clinical or research contrast agent.  As stated in the 
significance section for this study, viewing and quantifying the whole body distribution of 
any contrast agent has value in assessing targeting efficiency and the temporal fate of contrast 
agents for toxicity analysis.  For example, while some studies indicate that gold formulations 
have low toxicity in the short term [154, 163], long term studies show that gold can persist in 
some organs, especially the liver.  Sadauskas et al. [134] found that 40 nm gold nanoparticles 
injected intravenously into mice accumulated in the Kupffer cells of the liver and persisted 
for the six months of the study while slowly aggregating into fewer and fewer total cells.  
MARS spectral CT might prove useful in studying the long-term distribution of gold in 




The poor results at gold concentrations of 4 mg Au/ml and below indicate that quantification 
of total gold content would be underestimated.  Gold identification was much better in the 
phantom experiment described in Section 4.3, but that study had less aluminium filtration and 
different energy thresholds for the charge summing counters which could partially explain the 
better result.  MARS developers continue to improve machine and software performance to 
address poor detection at lower concentrations. 
This study demonstrates the ability to quantify 15 nm gold nanoparticle accumulation in a 
tumour via the EPR effect.  When live animal scanning is feasible in MARS scanners in the 
future, longitudinal studies may be possible that include assessment of gold distributions, 
from single or repeated applications, and thus measurements of and correlations with 
treatment and disease progression or regression. 
 
4.6 Multi-contrast mouse: simultaneous MD of three high-Z 
contrast agents in a sample 
Introduction 
Aim 
This study sought to extend multi-contrast identification from the phantom studies of 
Sections 4.2 and 4.3 into a biological sample.  Iodine, gadolinium and gold were administered 
internally to a mouse so that each would dominate a different region in the body.  MD of the 
scans included all three contrasts plus lipid, water and calcium components.  The scan was 
performed using 0.375 mm of brass to again eliminate photons below ~30 keV and simulate a 
scan relevant to human imaging. 
By imaging three contrasts in a biologic system, this feasibility study also sought to highlight 
the kinds of images and analyses attainable with the MARS vision software.  Thus, the results 
presented largely show various capabilities of the visualization system. 
Significance 
The rapid development of nanotechnologies and their potential uses in medical imaging and 
treatments represent a natural fit for the development of spectral CT and material 
reconstruction described in this thesis (see Chapter 2).  The ability to target contrasts 
(possibly with treatment capabilities) to very specific sites in the body with attached 
antibodies [34, 42, 88, 160, 164] or ligands [41, 165]  lends itself to the idea of using multiple 
targets in one scan.  By demonstrating the simultaneous separation of three high-Z contrast 
agents along with intrinsic high lipid and high calcium regions in a biologic sample while 
using only photons above 27 keV, this study helps illustrate the parallel progression in 





The scan was performed using cadmium/zinc/tellurium (CZT) as the sensor layer in the 
camera.  This study demonstrates the feasibility of CZT as a sensor layer for high energy 
spectral CT scanning. 
Publication 
A manuscript is in preparation for submission to Radiology in 2018 
Contribution 
I was primarily responsible for the experimental design.  I prepared all contrast agent 
dilutions and performed the tail vein injections.  I participated in protocol development for 
the scanner.  I was involved in data analysis.  I am involved in document preparation for 
journal submission. 
Methods 
The administration strategy to attain high contrast concentrations in separate regions of the 
mouse was as follows.  Intravascularly injected commercial iodine contrast agent would 
concentrate in the kidneys and then the bladder for about 20 minutes while simultaneously 
depleting in the blood vessels [166].  Gold nanoparticles of 15 nm would remain in the 
vasculature since the kidneys do not filter particles of this size and the mouse would be 
euthanized before significant filtration by the liver and spleen.  Gadolinium would be isolated 
to the digestive tract by gavage. 
Work was conducted under AEC protocol C19/13.  Three C57BL mice were prepared for 
scanning.  The mice were brought to a nonresponsive state assessed via toe pinch using 
isoflurane anaesthesia.  Mice were then injected with 16 mg of iodine in the form of 100 µL 
of iodixanol (Visipaque 270 (Ge Healthcare, Princeton, USA)) diluted to 160 mg I/ml.  
Iodine was allowed to concentrate in the bladder and kidneys while simultaneously reducing 
in the blood stream for 15 minutes.  At this point, 16 mg of 15 nm Aurovist
TM
 (Nanoprobes, 
Inc., Yaphank, NY, USA) was injected as 150 µL of 107 mg Au/ml.  The mice then received 
0.4 ml of gadobutrol (Gadovist, (Bayer AG, Leverkusen, Germany)) diluted to 8 mg Gd/ml 
by oral gavage.  Immediately after oral gavage, mice were euthanized by CO2 at roughly 21 
minutes post iodine injection.  An additional 0.4 ml of the same Gd solution was then 
administered by rectal gavage.  Quantities of contrast agents were chosen to achieve expected 
concentrations in the intended regions of the mouse that would give high identification 
accuracy, based on previous phantom studies. 
Mice were placed in a polypropylene tube (Figure 4.11) and allowed to sit in a refrigerator 
for ~12 hours to allow rigor mortis to set.  Mice were then scanned at room temperature 
following the protocol in Table 4.1 for multi-contrast mouse.  A 0.375 mm brass filter was 
used to eliminate low energy photons ( < ~ 30 keV) and simulate a human scan. 
The phantom scan was performed just prior to mouse scanning using the same protocol.  The 
phantom consisted of a 38 mm polymethyl methacrylate cylinder drilled to hold 12 phantom 




mg Gd/ml, iodine at 18, 9 and 4.5 mg I/ml, hydroxyapatite nanoparticles in resin at 800 and 
200 mg HA/ml, lipid and water. 
 
 
Figure 4.11:  The euthanized mouse with three contrast agents was placed in a polypropylene tube for 
scanning.  Used with permission [158] 
MARS reconstruction software was used to generate attenuation based reconstructions for 
each energy bin which were then used to generate the MD with six components:  lipid, water, 
calcium, iodine, gadolinium and gold.  MARS vision software was used to generate all 
images. 
Results 
The material calibration phantom results are shown in Figure 4.12 as attenuation of each 
material versus energy bin.  The k-edges for each high-Z contrast are clearly visible as a rise 
in attenuation from the below k-edge bin to the above k-edge bin.  However, gold and 
hydroxyapatite show a rise in attenuation with increasing energy between the 27-36 keV bin 
and the 36-52 keV bin which does not match physical expectations. 
The identification chart for the phantom is displayed in Figure 4.13.  For the highest 
concentrations of each contrast agent identification was 90% for iodine, 100% for 
gadolinium, and 82% for gold.  Hydroxyapatite is correctly identified in 98% and 93% of 
voxels for 800 and 200 mg HA/ml, respectively.  For 2 mg Gd/ml, identification is still better 
than 80%, but at lower concentrations of iodine and gold considerable cross talk occurs.  
These results illustrate our reasoning to achieve concentrations in the mouse of near 8 mg 
Gd/ml and near 8 mg Au/ml (after dilution in the blood assuming ~2 ml or less of blood 
volume).  The commercial iodine concentrates in the kidneys and bladder so its initial 
concentration was less critical. 
Various instructive images of the mouse material decomposition are shown in Figures 4.14, 
4.15 and 4.16.  The three contrast materials are visible in three separate regions of the mouse 
while also being separated from the bones in the material images.  Figure 4.14 demonstrates 
the anatomical visualization of various structures.  The digestive tract is seen with gadolinium 
(green), especially the descending colon, the kidneys and bladder are clear in the iodine 







Figure 4.12:  Attenuation (HU) versus energy bin for the calibration phantom.  The K-edges of  (a) 
iodine (33.2 keV), (b) gadolinium (50.2 keV) and (c) gold (80.7 keV) are all detected even at the 
lowest concentration.  Panel (d) shows the spectral pattern for HA.  The inappropriate rise in 
attenuation between the 27-36 keV bin and the 36-52 keV bin for gold and HA may contribute to the 
MD crosstalk seen in Figure 4.12.  Used with permission [158] 
Figure 4.15 demonstrates the potential for different windowing levels in the material 
reconstructions.  The large intestine is seen in differing detail depending on where the lower 
threshold is set for gadolinium visualization. 
Each component is a separate data set so bits of one material can be removed from images 
without affecting the visualization of other materials.  In Figure 4.16, some of the bone has 
been removed to allow an unobstructed view of the gold component in the lungs and jugular 








Figure 4.13:  Identification chart for the six material calibration phantom.  The bar labels name which 
calibration vial is analysed while the colours represent what percentage of the vial was identified as 
the material listed in the colour legend.  Since all voxels have a water value, the water percentage is 
only voxels that have a concentration of zero for the other materials.  Alternatively, a lipid voxel is 
any voxel with a lipid concentration above zero.  Used with permission [158] 
 
 
Figure 4.14:  MD showing bone and three contrast materials in a mouse.  Bones (gray) are 
distinguished from:  iodine (red) in the bladder and kidneys, gadolinium (green) in the digestive tract, 
including the descending colon (white arrow in a) and gold (yellow) in the collapsed lungs and the 






Figure 4.15:  Windowing MD components allows differing examinations of the same region.  The Gd 




Figure 4.16:  Partial bone removal allows examination of the gold MD while maintaining the overall 
anatomic view.  Used with permission [158] 
 
Discussion 
Iodine, gadolinium, gold, bone (calcium), lipid and water components were discriminated 
simultaneously in a single scan using the MARS spectral CT scanner.  By creating easily 
identified regions of known high concentration for each material, the qualitative results could 
be confidently interpreted without the need for chemical or histological procedures.  This 
feasibility study confirms the potential for quantifying multiple contrasts in a single scan at 
higher photon energies (> 27 keV), while maintaining material identification of intrinsic 
materials of interest.  The results presented highlight the contrast agents in relation to bone, 
so lipid and water components are not presented or discussed. 
While the K-edges of each high-Z contrast is apparent at all concentrations in Figure 4.12, the 





keV and 36-52 keV bins.  This may contribute to the crosstalk with the iodine component 
seen in the identification chart (Figure 4.13).  The crosstalk between iodine and HA at lower 
concentrations is not problematic in this feasibility study due to the high concentrations 
attained in the kidneys and bladder for iodine and the high concentration of HA in bone; 
however, in studies requiring sensitivity to lower concentrations of either material, such as 
the imaging of calcified plaques described in Chapter 3 and Section 4.4, this misidentification 
could prevent confident interpretation of results.  Thus, the appropriate uses of spectral CT 
will depend on an understanding of the sensitivity and specificity of material identification at 
different concentrations and in different scenarios.  Continuing refinement of hardware, 
software and techniques should continue to expand what is possible. 
Any study with multiple but varied targets or physiologic processes that could create different 
arrangements of contrasts might benefit from simultaneous measurement of multiple 
contrasts.  Symons et al. [167] have shown the potential  for using spectral CT in split-bolus 
dual-contrast multiphase kidney imaging in a canine model.  By injecting commercial based 
gadolinium contrast followed three minutes later by iodine contrast they generated 
quantitative images that showed high renal cortex concentrations of iodine compared to high 
renal medulla concentrations of gadolinium.  This study also included a bismuth contrast in 
the digestive tract to demonstrate three contrast separation.  Cormode et al. [168] used a 
rabbit to show vascular and renal enhancement by gold and iodine, respectively, using a 
strategy similar to this study.  Both of these spectral CT studies were performed on modified 
human scanners. 
This study also sought to demonstrate some of what is possible, visually, with the MARS 
vision software.  Figure 4.14 presents the whole mouse body from two angles and clearly 
visualizes the lungs and jugular veins in yellow for gold, the digestive tract in green for 
gadolinium and the kidneys and bladder in red for iodine all within the bone framework in 
grey.  MARS software allows 3D imaging and rotation of the subject to view from any angle.  
In Figure 4.15, the potential for changing the view by altering material concentration 
threshold is demonstrated. By simply altering the lower threshold for gadolinium, the large 
intestine view is altered.  This might allow details to be examined based on concentration 
gradients as discussed in Section 4.4.  The components of the MD are separate datasets so 
they can be imaged alone (see Figure 4.9 (c) and (d)) or in composite.  Figure 4.16 shows 
how a composite image can be altered by removing part of one component (in this case, the 
calcium) to view other components more clearly, while maintaining the overall anatomic 
reference. 
The successful material decomposition of three contrast agents from bone in a single scan of 
a mouse demonstrates the potential of spectral CT for multicontrast imaging in clinical 
research.  Upscaling to human imaging with MARS cameras is expected to be simple from a 
detector and data point of view because the camera and source will be the same.  The first 
MARS human scanner prototype is constructed and will undergo testing in 2018 using 





4.7 Macrophage uptake of gold nanoparticles 
Introduction 
Aim 
Cultured human monocyte derived macrophages were incubated with two different 
concentrations of non-targeted gold nanoparticles both of which were below the measured 
sensitivity of the MARS scanner.  The study sought to test if macrophages would concentrate 
the gold to levels detectable by MARS material reconstruction.  This was a feasibility 
experiment to justify further exploration with macrophage targeted nanoparticles for 
atherosclerosis detection (though, of course, the macrophages could be associated with other 
disease or injury states). 
Significance 
With respect to atherosclerosis, concentrated macrophages associated with inflammation in 
plaques are considered a biomarker of advanced and vulnerable plaque [169].  This study was 
undertaken as an initial test of gold nanoparticle uptake by the macrophage cultures created in 
the Free Radical Biochemistry lab at the University of Canterbury.  These cultured 
macrophages will be used in initial experiments aimed at creating gold nanoparticles 
specifically targeted to macrophages that could be used in detection of atherosclerotic plaque 
using spectral CT.  It is important to establish if macrophages will concentrate contrast above 
the surrounding concentration to levels detectable by MARS scanners at this time. 
Contribution 
I am the primary experimental designer.  I performed all the scans and image processing. 
Methods 
Gold nanoparticles with a proprietary coating for solubility and biocompatibility were 
prepared at 18 nm mean diameter and concentrated to 1000 µg Au/ml. 
Human monocyte derived macrophage culture is performed under human ethics approval 
reference number CTY/98/07/069/AM05.  Macrophages were cultured and classically 
activated to a pro-inflammatory phenotype following the labs standard procedure [170].  
Macrophages were cultured at roughly 2 million cells per well in a 48 well cell culture plate 
where they are adherent to the well walls.  The culture media was removed and replaced by 1 
ml of fresh media plus gold nanoparticles in three treatments.  Three wells were a control 
with no gold and received an extra 125 µl of media.  Six wells received 125 µl of the 1000 µg 
Au/ml stock for a total addition of 125 µg of Au.  Three wells received 42 µg of Au total by 
diluting the stock to 333 µg Au/ml with culture media and adding 125 µl.  The accepted 
detection limit for gold in the MARS scanners at this time was 1 mg Au/ml or higher. 
Two wells with 125 µg of Au added were harvested at 15, 44 and 77 hours after addition.  




cultures were photographed just prior to harvesting.  Cells were suspended, removed by 
pipette, and rinsed twice with PBS by centrifuging and resuspending.  Cells were then 
centrifuged at 1000 g for 5 minutes to a pellet.  The PBS was removed by pipette and liquid 
agar was pipetted over the pellet to cause minimal disturbance and allowed to solidify. 
Pelleted cells were then scanned according to the protocol in Table 4.1.  The material 
calibration phantoms were included with the scan.  The phantom included lipid, water, gold 
nanoparticles at 8, 4, and 2 mg Au/ml and gold chloride (AuCl3) at 8 mg Au/ml.  The 30 hour 
pellet for 42 µg Au added was destroyed during agar addition and so was unscannable.  The 
supernatant from the 77 hour well was scanned to confirm that its concentration was below 
detectable limits. 
Results 
Macrophages did take up the gold nanoparticles as seen in Figure 4.17.   Most cells were still 
alive by visual inspection at the 77 hour endpoint for the control and 125 µg Au treatment 
and the 62 hour endpoint for the 42 µg treatment.  Gold accumulation is seen as a dark purple 
to black colour in the cells.  Some macrophages did not take up any gold (by visual 
inspection).  The reddish colour of the nanoparticle solutions changed to a dark purple after a 
few hours of incubation with the macrophages, probably due to clumping as a result of an 
interaction with proteins in the culture media, though this was not confirmed.  Other 
researchers have solved this problem at this time but those results were achieved without my 
input and are not shown here other than to mention their success. 
 
 
Figure 4.17:  Photographs of macrophages incubated with gold nanoparticles.  Macrophages and the 
corresponding cell pellet after centrifugation after incubation with (a) no AuNPs for 77 hours, (b) 125 
µg AuNPs / ~2 million cells for 77 hours and (c) 42 µg AuNPs / ~2million cells for 62 hours.  AuNP 
accumulation in cells appears as an obvious black/dark purple colour. 
 




Gold was concentrated in the macrophages to levels detectable by MARS material 
reconstruction for all vials scanned (excluding the 15 hour time point for 125 µg Au which 
was missed in the scan).  Figure 4.18 shows the MD with gold, gadolinium, iodine, calcium 
and water components.  There was nearly perfect identification of gold in all cases with very 
few gadolinium, iodine or calcium voxels in the entire volume. 
 
 
Figure 4.18:  Volumetric image of the MD of the macrophage cell pellets after incubation with gold.  
The labels on the right are the interior four vials in the MD image.  Gold is yellow and water-like is 
red.  The water opacity is set low to maximize gold imaging.  The pellet for 125 µg AuNPs for 15 
hours was missed in the scan, but because of the preliminary nature of this study, rescanning was not 
deemed necessary.  Gadolinium, iodine and calcium components are include but there was very little 
cross talk to these components that were not present in the sample. 
 
Discussion 
This preliminary feasibility study showed that macrophages will concentrate gold 
nanoparticles from levels below those detectable by MARS scanning to levels that can be 
distinguished as gold in MARS material reconstructions.  At the time of this study, the 
accepted minimum detection concentration for gold in a brass filtered scan on a MARS 
system equipped with CZT was > 1 mg Au/ml.  The detection of gold in macrophages 
incubated with 42 µg of gold in just over 1 ml of media means that macrophages 
concentrated gold by over 20 times (from < 0.042 mg Au/ml to at least 1 mg Au/ml).  The 
control vial with 0 µg Au added showed no gold signal.  The supernatant removed from the 
77 hour well with 125 µg Au added did not show detected gold indicating that its 
concentration was below our detection limit and that the probable clumping did not create 





The change of colour in the culture media, if it does represent clumping, throws doubt on the 
uptake of the actual 18 nm gold nanoparticles.  However, the results of this study were 
encouraging and other researchers were able to change the culture media and show uptake of 
nanoparticles without the change in colour of the media (unpublished data). 
Macrophages are present in almost all inflammation events and are considered a hallmark of 
the inflammation associated with vulnerable atherosclerotic plaque.  Possibly, the degree and 
location of macrophage infiltration in plaque could be monitored noninvasively using 
targeted contrast agents and spectral CT.  Cormode et al. [171] used spectral CT to visualize 
high density lipoprotein-like particles with a gold core in a mouse atherosclerosis model.  
Gold appeared near the aorta of the mice in the CT reconstruction and was confirmed to be 
present in plaque macrophages by microscopy.  Imaging plaque macrophage burden might 
improve assessment of at risk patients or it might be used in time course research to gain 
better understanding of how macrophage populations change in plaques over time. 
This study showed the possibility of using gold nanoparticles to image macrophages in our 
lab.  The results have provided enough evidence for the continuation of targeting experiments 




Techniques for using MARS spectral CT and K-edge values to identify and quantify high-Z 
contrast agents in biologic systems were developed and demonstrated.  The work 
concentrated on using photon energies up to ~120 keV to show relevance to scan 
requirements for larger objects and the K-edge of gold (80.7 keV).   All studies utilized 
charge summing mode to correct for charge sharing in the hybrid detector. 
A simple technique for choosing energy thresholds that optimize the outcome of material 
decomposition was developed. The simple, two-part ranking system was used to compare 
five possible threshold combinations for a three contrast scan including iodine, gadolinium 
and gold.  The top two protocols were compared experimentally by scanning a multicontrast 
phantom.  The protocol with the best rank proved to have the better overall performance in 
the scans. 
A series of phantom and biologic sample scans demonstrated some of the possible uses for 
quantitative material reconstruction of contrast enhanced spectral CT scans.  A second three 
contrast phantom study introduced the identification chart as a simple visual assessment of 
the quality of the MD across a range of material concentrations.  The phantom results 
demonstrated the MD of six materials, including lipid, water, calcium and, again, three K-
edge material, iodine, gadolinium and gold.  For this protocol, gold was identified correctly in 
over 80% of voxels at 2 mg Au/ml while gadolinium identification was very good at 8 mg 




An excised carotid atherosclerotic plaque was scanned in air and then submerged in 
gadolinium contrast.  The air scan indicated a lipid core and extensive spotty calcium around 
the perimeter, both of which were identifiable in the gadolinium scan as well.  Gadolinium 
did not appear to extensively enter the high lipid regions of the plaque.  The concentration 
gradient of Gd in the plaque’s outer surfaces that resulted from two hours of diffusion 
allowed the plaque shape to be distinguished by windowing the Gd component to 
concentration below 3 mg Gd/ml.  These results offer evidence that contrast enhanced human 
scans with MARS spectral CT might allow simultaneous assessment of carotid stenosis and 
important plaque traits such as the presence of a lipid core and spotty calcifications. 
As part of a collaboration with cancer researchers, a mouse cancer model was used to 
demonstrate the passive accumulation over 24 hours of gold nanoparticles in a subcutaneous 
tumour via the EPR effect.  The MD separated gold, calcium (bone), lipid and water 
components and allowed quantitative measures of the gold distribution in the body and 
tumour.  MARS quantitative material images might be useful in cancer diagnosis, assessment 
of tumour characteristics such as size and neovascularization patterns, following the fate of 
nanoparticles throughout the body over time, noninvasively, and monitoring tumour 
progression/regression in response to treatments. 
Three high-Z contrast agents were simultaneously differentiated from each other and bone in 
a mouse scan performed at 118 kVp and with filtration to eliminate photons below ~30 keV.  
This feasibility study shows the potential for identification and quantification of three 
contrasts in a biologic sample using the photon energies needed for human scanning.  The 
study highlights the vast potential of the combination of spectral CT and the rapidly 
expanding field of targeted contrast agents. 
Cultured human monocyte derived macrophages were shown to concentrate gold 
nanoparticles to detectable levels from a surrounding culture media that is below levels 
currently detectable with MARS spectral CT.  In one vial, the concentrating effect was most 
likely, over 20 times.  This feasibility study was performed in cooperation with researchers 
seeking various targeted contrast agent strategies including targeting macrophages resident in 




5 Machine and Data Assessment 
 
5.1 Introduction 
In any scientific endeavour, part of the researcher’s responsibilities includes continual 
assessment of equipment and software performance.  Machines must be properly set-up, 
calibrated, integrated, maintained and monitored.  The MARS scanner and the imaging 
software that processes the raw data were both under constant developmental work during the 
timeframe of this thesis and so machine set-up and data assessment were a constant part of 
every student’s role.  All students working with MARS are expected to use the standardized 
quality assurance tests as part of their training.  As these tests identify new issues with data 
quality, projects are outlined by the developers and students participate in finding solutions.  
The typical project involves several iterations by evolving groups of students as the problem 
is more clearly understood and the potential solutions are refined. 
This chapter describes the more significant results of my work within the machine and data 
assessment role.  A first generation pixel inhibition mask is described that is the predecessor 
of  the more complex pixel masking software now installed on the commercial release of the 
MARS scanner.  Important results of the commissioning regiment for two new scanners are 
described along with the resulting improvements in machine set-up and scanning protocols.  
Finally, a new graphing technique is described that identifies noise in the MD related to the 
partial volume effect. 
 
5.2 Pixel masking 
Introduction 
Aim 
Significant noise is introduced in the raw data due to faults or lack of homogeneity in the 
sensor crystals, the bonding of sensor to the Medipix chip and the electronics of the chip 
itself (see Chapter 2).  Because of this, many pixels produce very poor data and it was 
determined that pixels should be inhibited (turned off) on the camera so that they would not 
produce data.  This work defines the criteria by which faulty pixels should be identified, 
produces software to implement these criteria to form a pixel inhibition mask on the camera, 
produces a graphical user interface (GUI) to allow users to produce and assess the mask, and 
shows the impact of the mask on scan reconstructions of a biological sample. 
Significance 
This work established the four major criteria for defining faulty pixels that are used in the 




work only masked the camera by turning off pixels.  The scans produced showed that pixel 
inhibition removed too much useful data and lead to the two step masking now in use that 
was developed by Muhammad Shamshad and Marzieh Anjomrouz. 
Publication 
Some of this work is presented in the Journal of Instrumentation [172].  The commercial 
release of the pixel masking software is described in the doctoral theses of Muhammad 
Shamshad and Marzieh Anjomrouz [1, 2]. 
Contribution 
Ali Atharifard and I were co-investigators and contributed to all of the aspects of this work.  
The only portions where the contribution differ from 50/50 are in programming where Ali 
was primarily responsible for the coding of the data analysis and graphing program, while I 
was primarily responsible for the coding of the pixel mask algorithms into the MARS scanner 
control software and for the appearance of the pixel masking GUI (GUI coding was 
performed by Dr. Stephen Bell) 
Methods 
The logic for differentiating useful from faulty pixels is based on four simple concepts. 
1. Pixels that count when there is no  X-ray input are faulty 
2. Pixels that do not count when there is an X-ray signal are faulty 
3. Photon counting is expected to follow a Poisson distribution (the variance is equal 
to the mean of counts) over multiple measurements.  Pixels that have a variance 
much greater than or less than the mean of counts are faulty. 
4. Under the same signal, pixels should have the same mean after repeated measures.  
Pixels with a mean drastically different from the mean of the whole chip (after 
removal of the previous three groups of bad pixels) are faulty. 
Software was written to apply tests related to each of the four types of faulty pixel to frames 
taken with the camera.  The initial recommended criteria were arbitrary and refined by 
Shamshad and Anjomrouz.  For the scans presented the masking criteria were: 
Darkfield Mode:  take 20 frames with the X-ray off.  Any pixel with counts > 2 in any frame 
is inhibited. 
Flatfield Mode:  Take 1000 frames with the X-ray on. 
 Any pixel with mean counts < 3 is non-functional and is inhibited 
 Any pixel with a variance in counts > 3 times its mean is inhibited 
 The fourth criteria was not applied at this time. 
A graphical user interface was developed that allowed users to choose which of the three 
available criteria to use, then review the created mask and choose to apply it to the camera or 




pixel colour-coded, red for pixels that counted in darkfield, blue for pixels that did not count 
in flatfield and green for pixels that failed the variance test. 
 




To test the masking results, an atherosclerotic plaque was scanned with only the flatfield 
counts < 3 criteria applied (to eliminate non-functional pixels) and then with the full mask 
criteria applied.  The protocol used was 2mm CdTe bonded to Medipix3RX chip, tube 
voltage of 80 kVp, tube current 10 µA, exposure of 50 ms, SDD 201 mm, and ThL set to 15 
keV. 
Results 
The mask removed ~20% of all pixels on the chip used.  Figure 5.2 shows the distribution of 
all pixels before and after masking around the expected Poisson distribution shown as a red 
line for variance equal to the mean.  Figure 5.3 (located in the discussion) shows the mask.  
The black shows the pixels left on and used for scanning.  The faulty pixels can be seen to be 
distributed widely over the entire pixel array. 
 
 
Figure 5.2:  Variance in counts versus mean of counts for all pixels before and after masking.  Mean 
counts are calculated over 1000 frames.  Masking criteria were darkfield:  counts > 2; flatfield:  
counts < 3; variance:  var > 3 * mean.  Used with permission [172] 
 
Figure 5.4 (located in the discussion) shows approximately the same slice from a plaque 
scanned without masking on the left and with masking on the right. 
Discussion 
The pixel mask succeeded in removing a great deal of noise, especially ring artefacts as seen 
in Figure 5.4.  However, in the case of this camera, so many pixels were inhibited that the 
data had to be filled in during post-processing using a median filter resulting in loss of 
resolution and contrast.  This simple result indicated that inhibiting too many pixels 
prevented the collection of adequate data (unless an excessive amount of oversampling was 
used).  Other researchers found that leaving most pixels on and then masking the raw data 





allowed pixels that worked properly much of the time to be used when their data was good 
and eliminated only when their data was faulty.  Again, see the theses of Muhammad 
Shamshad and Marzieh Anjomrouz [1, 2]. 
 
 
Figure 5.3:  The completed mask.  Red voxels are removed by the darkfield mask.  Blue voxels are 




Figure 5.4:  Scans of the same atherosclerotic plaque before inhibition masking and after.  Both 
reconstructions are poor quality.  The scan on the left has obvious noise produced by bad pixels.  The 
scan on the right looks better, but so many pixels were inhibited that the reconstruction algorithm had 
to fill in large portions of missing data with a median filter of large radius.  Both images are 




5.3 CT10 and CT11 commissioning 
Introduction 
Aim 
Two new scanners were commissioned.  Much of the testing was performed by me and Raj 
Panta.  We set up the configuration software for the machine controllers, found the geometric 
alignment corrections for the reconstruction software, tested the source stability, tested the 
camera stability, measured the spatial resolution, and performed energy and material 
calibrations. 
Significance 
We brought two machines to full functionality for use at the University of Canterbury and the 
University of Otago, Christchurch.  We identified issues with camera stability, source 
stability and CSM count rate capabilities that improved machine function and protocols.  
Only some key results are shown from this work. 
Publication 
This work was presented at MARS seminars. 
Contribution 
All of the work was performed in equal effort by me and Raj Panta. 
Methods 
The source and camera stability scans were performed with the following protocol.  3000 
open beam frames were acquired.  Data from a 210 pixel ROI of ‘good’ pixels was used.  The 
tube voltage was set to 117 kV, the tube current was 30 µA.  The first charge summing 
counter was set to 20 keV.  The bias voltage was set to -600 V.  For CT 10 the source to 
detector distance was 317.2 mm and for CT11 it was 282.2 mm.  Filtration was 5.5 mm 
aluminium equivalent in CT 10 and 5.6 mm in CT 11.  For source stability the camera 
exposure time was 5ms.  For camera stability, the exposure time was 150 ms and 200 ms in 
two trials. 
The counts should increase linearly with increases in tube current.  We examined linearity in 
counts vs tube current in both single pixel mode and charge summing mode.  The acquisition 
criteria were the same as for the source stability tests except that tube current was varied from 
15 to 340 µA. 
Results 
The camera with fingerboard 3 (which holds the Medipix3RX chip) was found to behave 
erratically over time as seen in Figure 5.5.  The mean counts over the ROI would drop to zero 




camera was moved to other scanners.  Further investigation showed that the energy threshold 
setting was jumping from 20 keV to 200 keV which is above the highest photon energy for a 
tube kVp of 117 kV. 
Figure 5.6 shows the behaviour of the measured counts, measured tube voltage and measured 
tube current over time for CT 10 with fingerboard 3.  All three measures have a decreasing 
trend over time after an initial spike.  The mean counts drops by ~2% over the acquisition 
time while the tube voltage changes by ~0.03% and the tube current changes by ~1%. 
The count rate is not linear with respect to tube current in either SPM or CSM as seen in 
Figure 5.7.  The departure from linearity is more pronounced and happens earlier for CSM. 
 
 
Figure 5.5:  Camera instability over time for fingerboard 3 in CT 11:  2mm CdTe bonded to 
Medipix3RX.  The mean counts per frame across a region of interest over 3000 frames.  Used with 
permission [104] 
Discussion 
The commissioning of CT 10 and CT 11 prepared to machines for delivery and use.  The tests 
highlighted here revealed several issues that needed to be resolved by developers or helped to 






Figure 5.6:  Temporal monitoring of the X-ray source in CT10.  The mean counts per exposure (a), 
the X-ray tube voltage (b) and the x-ray tube current (c) plotted versus time in seconds.  Measurement 
settings were 117 kVp tube voltage, 30 µA tube current, 5 ms exposure time per frame for 3000 
frames.  Used with permission [104] 
 







The camera instability over time revealed in the plot in Figure 5.6 was found to be a result of 
a sudden change in the energy threshold settings for the camera.  Fingerboard 3 had recently 
been move to a new camera body and the high voltage supply had been changed.  Developers 
found problems with the wiring and were able to fix the instability.   
The spike in voltage and current during the first 500 or so seconds of acquisition time seen in 
Figure 5.7 indicated that the X-ray tube needed a warm-up period before the output would 
stabilize.  After this finding and work by other MARS developers, a 15 minute tube warm-up 
was applied to the machine scan software. 
The count rate versus applied tube current deviates from linearity as seen in Figure 5.8.  
Further work by Raj Panta [104] established the departure from linearity to be at about 80 µA 
for SPM and about 40 µA for CSM when the tube was operated at the maximum of 120 kVp.  
For CSM this equated to a count rate of about 12 counts per pixel per ms and so a 
recommended maximum count rate for all protocols was established at 10 counts per pixel 
per ms. 
 
5.4 Material decomposition analysis 
Introduction 
Aim 
While analysing data from the plaque 108 scan (Section 3.4), I observed that many soft tissue 
voxels had very high Hounsfield unit values that would be expected to fall into the calcium 
component of the MD or very low values that would be expected to be part of the air or 
background.  To further investigate this, I plotted the Hounsfield unit values from the 30 keV 
energy bin for all the soft tissue voxels in the plaque from slices 120 to 205 versus the 
concentration in water from the MD. 
Significance 
This plotting technique reveals three distinct populations of voxels in the soft tissue portion 
of the MD that would appear to be classified incorrectly.  The voxels all appear at the border 
of calcifications and probably represent the MD’s inability to account for the partial volume 
effect at the edge of dense materials.  It revealed this error in the MD for the first time and 
lead to discussion about how to correct it in future iterations of the MD software. 
Contribution 







The x,  y and z coordinates of all voxels in the plaque over 86 slices (from 120 to 205) were 
recorded with their associated attenuation measurement in Hounsfield units from the 30 keV 
energy bin and water concentration in mg water/ml from the water component of the MD.  
Each voxel’s data was then plotted on a graph of Hounsfield units versus water concentration. 
Four populations of voxels were chosen from the data and each was colour coded following 
the colour pattern in Figure 5.8 and plotted on the attenuation reconstruction of the 30 keV 
energy bin.  One population represented ‘non-extreme’ voxels (grey), while the other three 
had extremely low HU values (red), extremely high HU values (green) or extremely high 
water concentration (blue). 
Results 
The graph in Figure 5.8 shows the results.  Three distinct populations of voxels are apparent 
that do not follow the expected values that should centre in a narrow range of Hounsfield 
units around zero and vary in water concentration from zero (for 100% lipid) to near 1000 mg 
water/ml for pure water (values above this are  not excluded by the MD software).  The 
legend shows the arbitrary values chosen to distinguish the extreme populations. 
Colour coding the extreme voxels and plotting them on the reconstruction of the 30 keV 
energy bin revealed what type of voxels made up each extreme category (Figure 5.9).  The 
low HU voxels border the air/plaque boundary, usually but not always, near calcifications as 
seen in the red voxels in the left hand slice.  The high HU voxels are found at the 
plaque/plastic boundary near calcifications as seen in the green voxels in the middle slice.  
Finally, the high water concentration voxels were usually found within the plaque at the 
calcification/soft tissue boundary as seen in the blue voxels in all three slices.  These voxels 
often formed a ring completely surrounding small calcifications. 
Discussion 
All three populations of extreme voxels from the plot in Figure 5.8 were found to occur at the 
border between two materials of very different density.  This is a strong indicator that the 
partial volume effect is causing voxels with a spectral pattern that fits most closely to the soft 
tissue portion of the MD but whose HU values suggest that one material dominates the 
voxel’s total attenuation in any given energy bin.  For example, a calcified voxel near the 
air/plaque boundary that falls into the extremely low HU value category (red) might have a 
HU value of -800 that clearly indicates it is mostly air, but its spectral pattern was altered by 






Figure 5.8:  Plot of attenuation in Hounsfield units versus the concentration of water from the MD for 




Figure 5.9:  Slices of plaque 108 highlighting the three groups of aberrant soft tissue voxels from 
Figure 5.8.  The colour scheme is the same:  red for HU < -350, green for HU > 1000 and blue for 
water concentration over 1260 mg water/ml.  The left slice highlights the red groups typical location 
at the air/plaque boundary near calcifications.  The middle image shows the typical location of the 
green group at the plaque/plastic tube boundary near calcifications.  The right slice highlights the blue 
group which occurred predominantly in the interior of the plaque within or surrounding calcifications. 
Most of the voxels in all three categories were near calcifications.  This may indicate that 
beam hardening artefacts are also affecting the data near these dense features, so the partial 




The partial volume effect blurs the border of dense objects and prevents distinguishing small 
objects from surrounding soft tissue in conventional CT if the voxels size is large relative to 
the objects [174].  The MARS development team is aware of these issues and may attempt to 
account for this probable influence of the partial volume effect in future iterations of the MD. 
 
5.5 Conclusions 
I participated in various machine and data assessment projects over the course of my thesis 
work.  This chapter highlights some of the more important results. 
A first generation pixel masking algorithm was applied to the MARS camera for pixel 
inhibition.  Results of scans with this mask revealed that most pixels should be left on and the 
majority of faulty pixel measurements should be masked in post-scan processing.  
Nevertheless, the four basic criteria for identifying faulty pixels that were defined form the 
core of the current pixel masking software on the commercial MARS scanner. 
Two CT machines were commissioned and results from the standardized tests found several 
sources of error in the MARS imaging chain.  The X-ray source was found to require several 
minutes of warm-up before its output stabilized.  One camera was found to have hardware 
issues that caused sudden changes in the energy threshold settings.  Optimal guidelines for X-
ray tube operating current and camera count rate maximums were established. 
A graphing technique was developed that compared HU values for a voxel to its water 
concentration in the soft tissue voxels of the MD.  This revealed three populations of voxels 
with extreme HU or concentration values that usually lie on the boundary of two materials of 
very different density.  This was a strong indicator that the partial volume effect influences 





6 Per Pixel Energy Calibration 
 
6.1 Introduction  
The spectroscopic ability of MARS cameras is achieved with the adjustable lower thresholds 
for each of the eight counters on each pixel (see 2.2 and 2.4 ).  Each pixel has independent 
signal processing electronics; however, the threshold settings are controlled by a 9-bit global 
digital to analog converter (DAC).  Energy calibration is a map of photon energy in keV onto 
the range of available DAC values (0 to 511).  Thus, every CSM1 counter operates at the 
same DAC value corresponding to the user chosen energy threshold.  All CSM2 operate at 
another global DAC value and so on for all counters.  MARS scanners are calibrated using 
the X-ray kVp technique (see section 2.3) applied globally, meaning a single calibration line, 
     Eγ = mg IDAC + cg    (6.1) 
 is generated for all corresponding counters across the pixel matrix [16], giving eight lines 
total.  Eγ is the energy in keV corresponding to IDAC, the value of the global low threshold 
DAC for a particular counter.  mg and cg are the slope and offset for the DAC to energy 
conversion, respectively. 
Due to variations in sensor layer crystals, solder bonding and pixel electronics the true energy 
responses of the individual counters do not match, exactly, the global energy calibration 
(Figure 6.1)[175].  Also, limitations in pixel equalisation precision contribute to threshold 
dispersion [14]. This threshold dispersion distorts spatial and material information [11].  
MARS images depend on the quality of spectral data, so finding the energy calibration for 
each pixel would improve spectral resolution and material decomposition.  Several 
techniques exist to calibrate photon counting detector pixels individually.  Most techniques 
use monochromatic or near-monochromatic X-ray sources like synchrotrons, radio-isotopes, 
and X-ray fluorescence [16, 106, 176, 177], while Panta et al. suggested but did not pursue a 
modification of the broad spectrum X-ray kVp technique. 
I participated in two projects designed to find pixel-specific energy calibrations of the form, 
     Eγ,px = mpx IDAC + cpx    (6.2) 
where Eγ,px, mpx, and cpx are the energy, slope and offset for a specific pixel.  First, I will 
describe a technique that uses the broad spectrum to find the energy offset of each counter 
from the global calibration, and thus, requires no special, monochromatic source[172].  






6.2 Broad spectrum energy offset technique 
Introduction 
Aim 
The X-ray kVp technique for calibrating MARS scanners is convenient because it uses the 
broad spectrum source and requires no special source or technique to create a monochromatic 
calibration signal.  We sought to achieve a per pixel energy calibration in the same way. 
The idea for this work came from the observation that if all the pixels are identical except in 
the threshold dispersion, then a simple threshold scan will measure the relative energy offsets 
of each pixel from the mean by simply finding the DAC value for each pixel that gives counts 
closest to the mean counts for the chip at the global DAC.  Figure 6.1 shows this situation.  
The upper graph shows that there are 400 counts expected at ThL of 40 keV.  Threshold 
scans for 3 pixels are shown below and the DAC value counting 400 is aligned to 40 keV, 
giving a per pixel calibration.  If the global threshold DAC is set to 100, only pixel 1 will 
measure 40 keV; pixel 2 will measure 42 keV and pixel 3 will measure 38 keV. 
In reality, pixels’ counts differ for many reasons other than threshold dispersion.  We 
developed a technique that would account for differences in pixel behaviour and effective 
pixel area, thereby isolating the inter-pixel threshold dispersion effect and producing a per 
pixel energy calibration. 
Significance 
Threshold dispersion is a known source of noise in the Medipix3RX chip [4, 16].  The global 
energy calibration cannot correct for this.  Using the proposed technique, a calibration line is 
calculated for each pixel and this correction could be applied within the current 
reconstruction and MD process, though that work has yet to be completed.  MARS is 
attempting to move to a simultaneous reconstruction and MD using projection data and some 
form of per pixel energy calibration correction will be applied.  This technique offers one 
simple solution that requires no new equipment or materials. 
Publication 
The work described is published in the Journal of Instrumentation [172]. 
Contribution 
For this work, I contributed to the concept development, experimental design, data collection 
and manuscript editing.  My primary contribution was in the conceptual ideas and the 






Figure 6.1:  A portion of a hypothetical spectrum with integrated counts versus energy and the 
response of three pixels that are identical except in threshold offset.  If the global threshold DAC 
value is 100, Pixel 1 measures 40 keV, Pixel 2 measures 42 keV and Pixel 3 measures 38 keV. 
 
Methods 
Overview and Definition of Terms 
To achieve a per pixel calibration, we must isolate and quantify the threshold dispersion 
while accounting for counting variations between pixels due to other factors.  After applying 
a count correction to pixel data at the global DAC value, the difference in counts between a 
pixel’s expected counts and its actual counts is converted to an energy difference.  The 
energy offset is measured at several energies and a line is fit to the data to give the per pixel 
energy calibration (Equation 6.2).   





Figure 6.2:  Flow chart for the broad spectrum per-pixel energy offset technique.  Used with 
permission [172] 
Data acquisition 
The data presented were collected using MARS camera CdTe-3 equipped with a 
Medipix3RX ASIC bonded to 2mm of CdTe at a pixel pitch of (110 µm)
2
.  Scan parameters 
were 120 kVp, tube current of 30 µA, and 2.8 mm aluminium equivalent filtration.  Results 
are shown for a 100 pixel region of interest using counter CSM1, but the technique can be 
applied to all pixels and all counters. 
The camera inhibition mask was applied (see Section 5.2) to remove un-useful pixels.  At ten 
energies, 20 to 110 keV in steps of ten, an open-beam threshold scan of five consecutive 
DAC values centred on the global DAC value for the chosen energy was performed (Figure 
6.4).  200 frames were collected at each value and the mean counts for each pixel calculated. 
200 frames are sufficient to eliminate quantum noise effects. 
Effective Count Difference 
We must account for inter-pixel count variations not resulting from threshold dispersion.  The 
threshold for Carb (see Chapter 2) is set during equalisation just above the noise floor[14].  
With added filtration, Carb’s threshold is well below the lowest energy photons in the 
spectrum (Figure 6.3).  This means that Carb data should be independent of threshold 
dispersion.  Where Carb is the mean counts for a specific pixel’s arbitration counter and  𝐶arb 
is the global mean for the detector, the ratio Carb / 𝐶arb is a generalized correction, termed the 




was no threshold dispersion, then for 𝐶, the mean counts for a particular counter across the 
detector, we define the expected counts, Ce, for a pixel as, 
     Ce = 𝐶   ( 
𝐶arb
𝐶arb 
 )    (6.3). 
The effective count difference, Cdiff, for a pixel that has mean counts Cpx is defined as, 
     Cdiff = Ce − Cpx    (6.4). 
Cdiff measures the threshold dispersion-related difference in counts of a pixel from the global 
mean at a particular global energy setting under a particular flux. 
 
Figure 6.3:  The estimated spectrum for this study.  ThL for the arbitration counter is well below the 
low end of the spectrum.   Data represents all the events counted above the ThL setting for each 
counter (blue region).  Used with permission [172] 
Per-pixel energy mapping 
To progress to a per pixel energy calibration, Cdiff, must be converted to an energy offset at 
each of the measured energy settings.  Figure 6.4 shows the mean counts data for a single 
pixel at the global DAC value plotted against the global energy setting.  The inset displays 
the pixel’s behaviour for the 5-step threshold scan centred on the global DAC value (80), 
corresponding to 30 keV.  For each pixel, a slope of counts versus ThL is calculated at each 
energy ( ∆𝐶 ∆𝑇ℎ⁄  ).  Assuming that the slope of the global energy calibration (mg = 𝐸𝛾 ∆𝑇ℎ⁄  ) 





     
∆𝐸𝛾
∆𝐶
 =  
∆𝐸𝛾
∆𝑇ℎ
 ×  
∆𝑇ℎ
∆𝐶
     (6.5) 
The energy offset for a given pixel ( ∆𝐸𝛾,px ) at a particular energy is then, 
    ∆𝐸𝛾,px =  𝐶diff  ×  
∆𝐸𝛾
∆𝐶
     (6.6) 
So, at a global energy setting, ( 𝐸𝛾,global ) the actual energy measured by a pixel at that DAC 
value is 
    𝐸𝛾,px =  𝐸𝛾,global  − ∆𝐸𝛾,px    (6.7) 
 For each pixel, a line is fit to the ten values of  𝐸𝛾,px versus 𝐼DAC to give the per pixel energy 
calibration, Equation 6.2. 
 
Figure 6.4:  The mean counts for a single pixel at the global DAC for the experimental energies.  The 




The slopes of the per-pixel energy calibration for the upper left 25 pixels of  the 100 pixel 
ROI are shown in Figure 6.5 (a).  The minimum R
2
 value was 0.998.  The magnitude of the 
greatest difference in slope from the global calibration is 0.0276 keV/DAC.  This corresponds 
to a divergence of that pixel from the global calibration of 5.75 keV over 208 DAC steps 





        Global Slope = 0.4805 keV/DAC      Global Threshold = 60 
keV 
                                 (a)                                                                                         (b) 
Figure 6.5:  Results of the broad spectrum energy offset technique for the upper left 25 pixels of the 
100 pixel ROI.  (a)  Slopes of the per-pixel energy calibration lines.  (b)  Actual energy measured by 
each pixel when thresholds are set to the global DAC for 60 keV.  Used with permission [172] 
Figure 6.5 (b) maps the per-pixel energy response at a global setting of 60 keV for the same 
25 pixels.  The largest difference from the global value is 3.5 keV and the largest difference 
between pixels is 5.96 keV.  For the 100 pixels of the ROI, the root-mean-square error of the 
energy offsets varies from 1.38 keV (at 30 keV setting) to 1.87 keV (at 100 keV). 
Evaluation using molybdenum fluorescence measurements 
The per-pixel energy calibrations acquired with the broad spectrum technique were compared 
to the global energy calibration using threshold scans of oblique X-ray fluorescence from a 
molybdenum foil placed between the source and camera (see Section 6.3 for the procedure) 
[178].  The Kα1 and Kα2 fluorescence energies for molybdenum are 17.48 and 17.37 keV, 
respectively.  The difference of 0.11 keV is insignificant in relation to the sensor sensitivity 
of around 0.48 keV/DAC. 
Figure 6.6 plots the difference in counts between DAC settings three steps apart (e.g. counts 
at DAC 50 minus counts at DAC 53) versus energy for the global energy calibration (6.6 (a)) 
and the per-pixel calibration.  To reduce quantum noise, 100 frames per DAC were averaged.  
Points are averaged over the100 pixel ROI.  The global energy calibration has a broader, 
noisier peak with full width at half maximum (FWHM) of 5.69 keV.  The per-pixel energy 
calibration has a single peak with FWHM of 4.08 keV, a reduction of 28.3%.  The maxima 
are at 17.89 keV (error of +0.41 keV from Kα1) for the global calibration and 17.37 keV 





Figure 6.6:  Differential counts versus energy for a threshold scan across the molybdenum Kα 
fluorescence energy of ~ 17.5 keV.  DAC values are converted to energy using (a) global energy 
calibration by the kVp technique [16] and (b) broad spectrum per-pixel technique [172].  Used with 
permission [172] 
Discussion 
The broad spectrum per-pixel energy offset technique produces per-pixel energy calibration 
lines that improve the energy resolution of the Medipix3RX based MARS camera.  This 
should improve attenuation and material reconstructions.  The accuracy and precision are 
both improved as shown by the molybdenum fluorescence data.  The true energy response for 
each pixel can be calculated for any global setting and the range of energies measured by the 
entire chip assessed.   
Like the kVp global calibration method, the technique does not require any special materials, 
equipment or set-up, so it can be easily implemented and automated on MARS scanners.  
Only two additional measures are required to achieve pixel specific calibration.  The effective 
count difference provides a simple correction for inter-pixel count variations not due to 
threshold dispersion.  This enables the counts per DAC step, ∆𝐶 ∆𝑇ℎ⁄ , to be used to find the 
energy offset for each pixel due to threshold dispersion.  Parameters must be constant for the 
entire procedure (except DAC steps of course) to ensure that the value of counts per DAC 
step is correlated with the effective count difference.  Despite this, once the pixel specific 
calibration lines are established, they should apply to any scan parameters. 
Because of the global DAC settings for ThL, the per-pixel calibration cannot be applied to 
data acquisition, but can be used to improve data processing.  The algebraic reconstruction 
technique used could be modified to use the true energy response of each pixel and the raw 
count data.   This process is not simple because the attenuation value for each voxel of the 
reconstructed volume is calculated from the input of many pixels, which would each have 




different energy bin ranges.  Alternatively, a library of counts per keV could be assembled for 
different flux rates and a rough correction to the counting data of each pixel could be 
performed on the raw data and flatfields before reconstructing based on the global energy 
thresholds.  This technique could be easily applied but assembling the counts per keV library 
would require a large array of data points.  Neither of the suggested data processing 
corrections has been attempted, so the actual impact of per-pixel energy calibration on 
reconstruction has yet to be determined. 
This procedure assumes that the chip averages represent the most accurate value (i.e. pixels 
that count at the chip average are correctly measuring energy) and adjusts other pixels from 
there.  Thus, while the magnitude of the energy offsets calculated may be correct, the entire 
calibration may have an additional, unidentified offset.  This fact makes good pixel masking 
(Chapter 5) especially important since inclusion of malfunctioning low or high counting 
pixels could affect the mean count values used in the calculations.  The data presented used 
only a 100 pixel region of interest that closely followed poisson counting statistics and had 
offsets of less than 4 keV.  In future work with the entire chip, it will be important to monitor 
the effect of more extreme pixels.  The uncertainty in using chip means as a standard is one 
argument for direct per-pixel calibration using foil fluorescence or monochromatic X-rays 
[16, 178]. 
Threshold dispersion was smallest at the lowest energies measured and largest at the highest 
energies.  This trend is expected because pixel equalisation is performed at the noise floor 
(i.e. at the lowest energy)[14, 16].  The R2 value of 0.998 or higher for all per-pixel 
calibration lines indicates that fewer data points could be used to streamline the procedure. 
As seen in Figure 6.6 (b), the energy response function still has dispersion and distortion.  
This is partially explained by the fact that X-ray fluorescence is not a true monochromatic 
input.  The Kβ fluorescence of molybdenum is only 2 keV above the Kα.  Other sources of 
error include flux variations, Fano noise, leakage current, charge trapping, incomplete charge 
collection, resistance and capacitance variations, charge sharing, pulse pile-up and 
imperfections in the per-pixel calibration [11, 17, 175, 176].  Any of these errors that are 
systematic in nature might be correctable if they can be quantified.  The reconstruction uses 
flatfield correction which accounts for some of these error sources[179].  Using the Medipix 
charge injection electronics might allow a separation of sensor and electronic noise, but the 
injection pathway contains its own noise[175].  Spatial and temporal flux variations are not 
expected to be significant based on work done for the MARS X-ray source model[180].  
Pulse pile-up is also not significant since the global, per-pixel and fluorescence calibration 
data are collected at count rates (less than 10 counts/pixel/ms) within the linear behaviour 
region of the camera used (see Section 5.3 ).   Charge sharing is largely corrected for by using 
charge summing mode in the Medipix3RX but may still contribute imprecision[11].  
Incomplete charge collection is more significant in thicker sensor materials such as the 2mm 





6.3 Oblique fluorescence per-pixel energy calibration 
Introduction 
Aim 
The MARS team is attempting to use fluorescence from up to six different monoatomic foils 
mounted on a single aluminium filter plate to obtain a quality per-pixel energy calibration.  
Calibration with monochromatic X-rays of known energy provides a direct map of energy to 
DAC value on a per-pixel basis.  However, monochromatic X-ray sources like synchrotrons 
and radioisotopes are not practical for periodic calibration of MARS cameras mounted in 
scanners due to size, cost, convenience, time and safety issues.  Characteristic X-ray 
fluorescence from monoatomic foils mounted on the filter bar of the MARS scanner’s X-ray 
tube provides a nearly monochromatic X-ray source (see Section 2.11) and an easily 
automated calibration procedure.  Since the foils are closer to the detector than the source and 
fluorescence is emitted isotropically, a pure fluorescence signal can be detected by 
positioning the detector out of the main beam.  Using the automated collimators between the 
foils and the detector, an isolated beam of fluorescence can be used to illuminate the properly 
positioned detector with minimal scatter contamination. 
Significance 
Easily automated, foil fluorescence energy calibration will allow on demand calibration and 
quality assurance for end users, reducing the need for factory support. 
Publication 
This work is featured in the Journal of Instrumentation [178].  Lieza Vanden Broeke’s 
Master’s thesis expanded on the foil thickness and fluorescence output calculations while 
featuring the initial fluorescence measurements that appear in this thesis [181]. 
Contribution 
I was the team leader for the foil fluorescence project.  The team consisted of me and four 
other MARS students or employees:  Brian Goulter, Ali Atharifard, Lieza Vanden Broeke 
and Mohsen Ramyar.  I lead the foil fluorescence team through the initial experimental 
design phase and the first molybdenum and lead fluorescence measurements featured in this 
chapter.  I played a significant role in experimental design and mathematical derivations for 
determining optimal foil thickness [181].  I also contributed to data collection, data analysis 
and document editing.   
Methods 




We successfully measured oblique fluorescence from two of the six foils mounted in the filter 
bar of the MARS scanner, lead and molybdenum.  The physical arrangement of the foils and 
scanner are illustrated in Figure 6.7.  Indium was also attempted, but quality data was not 
obtained and is not presented here. 
 
Figure 6.7:  The scanner setup used to measure oblique fluorescence of lead.  The detector is 
positioned in a region (yellow) of pure Pb fluorescence between the collimated main beam and a 
region of overlap between Mo and Pb fluorescence (green).  By repositioning the horizontal 
collimator gap in front of the Mo foil, an isolated Mo fluorescence signal is created in a similar 
location.  The source to detector plane distance is 150 mm.  Used with permission [178] 
Data collection consisted of a threshold DAC scan across a range of DAC values that 
surrounded the Kα photon energy for the foil of interest.  At each DAC step, 50 (for Mo) or 
100 (for Pb) frames were recorded and then averaged.  A differential spectrum was calculated 
by subtracting every third DAC step (i.e. the averaged frame from DAC 100 is subtracted 
from the averaged frame from DAC 97) 
Table 6.1:  Scanner settings for the molybdenum and lead XRF measurements. 
Foil Molybdenum Lead 
Detector Medipix3RX Medipix3RX 
Sensor 2 mm CdTe 2 mm CdTe 
Camera mode CSM CSM 
Bias voltage (V) -600 -600 
SDD (mm) 150 150 
Frames per DAC step 50 100 




Tube Current (µA) 350 300 
Exposure (ms) 10,000 10,000 
Filtration 
(mm) Al or brass 
2.8 Al (1.8 intrinsic + 1 
added) 
2.8 Al (1.8 intrinsic + 1 
added) 
Focal spot size (µm) ~50 ~50 
DAC step range 40 to 100 165 to 220 
Foil thickness (µm) 300 300 
 
Optimal foil thickness 
Difficulties, especially very low photon counts, encountered while attempting our first 
oblique fluorescence measurements, lead us to investigate the effect of foil thickness on 
fluorescence flux.  At the time of the research presented here, we were still using the 
available foils and had not experimented with optimizing foil thickness.  This work is 
theoretical and will guide our future efforts in foil XRF calibration. 
As a broad spectrum X-ray beam passes through a monoatomic foil, Kα photons are produced 
and absorbed until the far side of the foil is reached, at which point a flux of fluorescence 
photons may travel to the detector for energy calibration.  At some optimal thickness, the 
number of new Kα photons produced equals the number of previously produced Kα photons 
absorbed and a maximum number of Kα photons is emitted toward the detector.  Any thicker 
and the number of new photons is less than the number of previous photons absorbed and the 
Kα flux declines. 
For a monochromatic input, I0 of photon energy, E, over the K-edge and a foil of thickness, 
L, combining the generation of new Kα photons at a point x in the width of a foil with the 
attenuation of previously generated Kα fluorescence at the same point gives: 
 
 𝑁𝐾𝛼 is the number of fluorescence photons emitted, 𝜔𝐾𝛼 is the fluorescence yield for Kα 
photons, 𝜏𝐾 is the K-shell photoelectric linear attenuation coefficient (µ) at E, µ(E) is the 
linear attenuation coefficient at E, x is the distance from the input side of the foil, and µKα is 
the linear attenuation coefficient of the material for Kα photons. 
Integrating equation 6.8 over all energies from the K-edge to the maximum photon energy (or 
to infinity) in a broad X-ray spectrum will give the total number of fluorescence photons 




formulas for I0, τK , and µ are all complex.  Thus, a numerical integration is performed by 
calculating a model spectrum with SpekCalc, then finding and summing N for each discreet 
energy bin from the K-edge to the maximum photon energy.  For this work, the spectrum was 
calculated based on a 120 kVp source and 2.9 mm Al filtration.  An energy bin size of 0.1 
keV was used.  Values of τK were obtained from Scofield (1973) [182] and then interpolated 
for each energy bin.  Values of µ(E) were obtained from the NIST XCOM database [183]. 
NKα was then calculated for a range of foil thicknesses from 0 to 1 cm.  The optimal foil 
thickness is then simply the value of L with the largest NKα.  Calculations were performed for 
molybdenum,  indium and lead foils. 
Results 
The XRF measurements obtained from a single pixel are displayed as a differential spectrum 
in Figure 6.8.  The peak for Mo occurs at DAC = 54 and corresponds to the Kα fluorescence 
at ~17.5 keV.  The peak for Pb is at DAC = 177 and corresponds to the Kα of ~75.0 keV.  
Calculating the energy calibration line from this data gives a slope of 0.467 keV/DAC. 
 
Figure 6.8:  Differential XRF measurements from (a) molybdenum and (b) lead.  Each graph 
represents data from a single pixel.  Used with permission [178] 
The graphs in Figure 6.8 are for a single pixel.  Most well behaved pixels produced a good 
signal for lead; but, molybdenum was much more inconsistent, with many well behaved 
pixels failing to produce a clear XRF peak.  These inconsistencies were even more 
pronounced for the indium foil (data not shown) and lead us to pursue the optimal foil 
thickness calculations that follow. 
The theoretical calculations for optimal foil thickness are shown in Figure 6.9.  The optimal 






Figure 6.9:  Number of Kα1 photons versus foil thickness for molybdenum, indium and lead.  For 
simplicity, the calculations were performed leaving out constants, so the counts are not representative 
of a true expectation.  Used with permission [181]. 
Discussion 
Oblique fluorescence is a viable per-pixel energy calibration technique for the MARS 
scanner.  A clear XRF peak was obtained for molybdenum on some pixels and for lead on 
most pixels.  The calculations of optimal foil thickness indicate that the 300 µm Mo and In 
foils are not optimal (Figure 6.9) and thinner foils should be acquired for future work. 
The calibration slope of 0.467 keV/DAC step for one pixel was obtained from just two 
points, lead and molybdenum. It is similar to the global calibration slope of 0.4805 keV/DAC 
and falls in the range of slopes, 0.4529 to 0.5008 keV/DAC, found for 25 pixels using the 
broad spectrum energy offset technique in Section 6.2.  This further indicates the potential for 
foil fluorescence as an energy calibration technique. 
The trouble in obtaining a clear fluorescence signal for all well-behaved pixels using the 
molybdenum and indium foils indicates that the procedure must be refined.  First, the foil 
thicknesses should be changed to match the optimal values calculated in this work.  Because 
Compton scattering is more prevalent in the forward direction [96], it may introduce more 
noise in our geometry than is found in reflection arrangements that position the detector at a 
greater angle from the input beam axis.  MARS developers have measured significant scatter 
in the detector plane (internal communication) and the narrow collimation may introduce 
greater scatter [184]. 
One goal in developing the foil fluorescence technique is simplicity and ease of automation.  




[185], but at the price of either having to add equipment to the machine that would require 
significant redesign or losing full automation by requiring a person to attach them for each 
calibration procedure. 
Future work will concentrate on optimizing the procedure.  Foil thickness, measurement 
geometry and simple collimation to reduce scatter will all be investigated. 
 
6.4 Conclusions 
Two viable techniques for creating a per-pixel energy calibration for MARS scanners were 
presented.  The broad spectrum energy offset technique is easily automated and requires no 
special equipment.  It measures the effective pixel area to eliminate noise unrelated to 
threshold dispersion and relies on the effective linearity of counts versus DAC step over very 
short threshold windows to quantify an energy offset for each pixel from the global energy 
correlated to a particular DAC value.  The oblique fluorescence technique requires the 
placement of monoatomic foils in the filter bar for the X-ray source, but is also easily 
automated and provides a direct map of photons of known energy onto the threshold DACs of 
each pixel. 
The broad spectrum technique reduced the FWHM of the molybdenum energy response for a 
group of 100 pixels by 28%.  It is a completed technique that could be implemented at any 
time if the reconstruction algorithm were modified to accept individual pixel calibrations.  
The broad spectrum offset technique provides the possibility of creating a fudge factor to 
correct count data that could be applied to the MARS reconstruction process as it currently 
exists.  However, because a simultaneous reconstruction and MD carried out on projection 
data is currently under development, that procedure will probably not be attempted. 
Foil fluorescence requires refinement to create a cleaner calibration for all pixels.  MARS 
team members are currently working to improve the procedure and its per-pixel energy 
calibration will also await modification to the reconstruction algorithm before 
implementation. 










This works most important results are the intrinsic and contrast enhanced images of 
biological samples scanned with an X-ray spectrum typical in actual human CT scans.  The 
clear identification and histologic confirmation of a lipid core and spotty calcifications in an 
excised carotid atheroma using material reconstruction illustrates the potential for spectral CT 
in noninvasively identifying not just atherosclerosis, but any disease with abnormal lipid or 
calcification distributions. Lipid and spotty calcifications identified in the presence of 
gadolinium contrast mean that the benefits of contrast enhanced vascular imaging may be 
attainable simultaneously with the material identification of intrinsic biomarkers of 
atherosclerosis.  Imaging and quantification of gold nanoparticle accumulation in a cancer 
tumour, the simultaneous identification of three contrasts, lipid and calcium in a mouse and 
MD of gold nanoparticle uptake by activated macrophages show the potential for contrast 
enhanced imaging of disease or injury with spectral CT; a potential that is limited only by the 
imagination of researchers in developing targeted and safe high-Z contrast agents. 
The conditions of these scans were close to those needed for human in vivo imaging.  
Medical imaging is used to enhance life outcomes by identifying disease or injury and 
directing treatment.  Spectral CT and material reconstruction will add improved and novel 
sources of information to the clinician’s toolbox and the work described in this thesis is 
helping bring spectral CT to commercial use. 
We have reached the above conclusions through two parallel lines of work that explored and 
improved the use of spectral CT with the MARS scanner to identify and quantify materials in 
biological samples.  We explored the potential for intrinsic and contrast material 
measurements in biological samples using the filtered, higher energy X-ray spectrum typical 
in human CT scanning.  Monitoring and refining the machine was performed in order to 
improve data and direct strategies for future improvements.  Sample imaging experiments 
refined protocols, especially energy threshold placement, and demonstrated the accuracy of 
material identification spatially and quantitatively.  The ability to quantify intrinsic and 
contrast materials in samples, simultaneously, has impacted Professor Steven Gieseg’s 
research group’s studies of macrophage activity in excised carotid atherosclerotic plaques 
[124] already and will impact clinical research and medical imaging in the future. 
My technical developments improved the raw data by masking faulty pixels, narrowing 
energy resolution with per-pixel energy calibration (yet to be applied in practice), identifying 
X-ray tube current limitations in CSM, and demonstrating the need for proper X-ray tube 
warm-up.  A simple graphing technique revealed the impact of the partial volume effect on 





Imaging experiments with whole mice and excised carotid atheromas demonstrated accurate 
material segmentation and quantification on a spatial scale of 90 um voxels.  Both intrinsic 
and contrast material identification was demonstrated.  The potential in identifying diseases 
based on spatial arrangements of lipid, calcium and contrast agents was demonstrated within 
an atherosclerosis and a cancer model. 
Spectral CT, in the form of the MARS small animal scanner, now, and soon, the MARS 
human scanner, measures the energy dependent attenuation patterns of a scanned volume and 
that data can be used to determine the spatial arrangement and concentrations of materials of 
interest.  Quite simply, material reconstruction presents a new and possibly revolutionary 
dataset in clinical imaging.    The diverse range of works described here in sample imaging 
and technical development encompass an overall goal of improved data quality and data 
assessment that leads to improved material imaging and demonstrations of the potential of 
material reconstructions in identifying disease states. 
 
7.2 Review of achievements reported in this thesis 
Chapters 1 and 2 provided a context for the research and development of spectral CT 
described in the thesis.  The concept and potential value of material reconstruction using 
spectral X-ray CT datasets was described.  Important specifics of the MARS scanner, MARS 
camera and MARS material reconstruction software were also detailed.  K-edge imaging 
within a spectral CT environment was outlined including the potential uses of targeted high-Z 
contrast agents in conjunction with material reconstruction.  Atherosclerosis and cancer were 
described briefly and their utility as testing models for intrinsic and contrast enhanced 
spectral CT was highlighted. 
The progression of intrinsic material imaging for the quantification of lipid- and calcium-rich 
regions as biomarkers of atherosclerosis was given in Chapter 3.  Studies presented there 
showed that using a filtered X-ray spectrum similar to that used in clinical human CT scans 
successfully identified necrotic lipid cores and spotty calcifications in excised carotid 
plaques.  Both are highly correlated with plaques that rupture and identifying them with a 
noninvasive imaging technique may help to diagnose this notoriously silent disease before it 
causes severe clinical ischaemic events.  Reconstruction at a (90 µm)
3
 voxel size is superior 
to current noninvasive imaging modalities and may allow detection of smaller and less 
advanced lesions before they are at risk of rupture.  The potentials of CdTe and GaAs as 
sensor layers were both confirmed.  SPM and CSM were both shown to provide sufficient 
spectral information for material identification of pathological lipid and calcium deposition.  
Issues were raised with respect to proper thresholding of lipid and calcium concentrations in 
viewing the MD data.  The limitations imposed by a two component MD that prevents a 
simultaneous lipid and calcium measurement in the same voxel were illustrated.  The 
importance of understanding the theoretical ability of MARS scanners to identify sub-voxel 
sized hydroxyapatite particle in atheromas was raised.  Initial steps in moving to live sample 




Chapter 4 added contrast agent quantification to continued intrinsic lipid and calcium 
measurements, again within the human relevant energy range over 30 keV.  Phantom studies 
were used to test K-edge imaging of multiple contrasts.  We showed that the K-factor and 
quantum signal proportion can be used to score various threshold combinations and that the 
scoring system was successful in choosing the optimal combination in the tested scenario.  
Various contrast enhanced scenarios were tested in biological samples.  The physical outline 
of an excised carotid plaque submerged in gadolinium contrast agent was visible using proper 
windowing of the MD gadolinium concentrations.  This important result highlights the 
potential uses of material reconstruction and the complex variety of viewing possibilities that 
may aid radiological assessment of disease and injury in contrast enhanced spectral CT.  
Furthermore, the lipid and calcium measurements were maintained in a contrast background 
compared to a scan of the plaque in air.  The ability to simultaneously image clinically 
important intrinsic material distributions and use contrast agents to reveal additional signs of 
disease has important implications in reducing patient dose, number of procedures and costs.  
A subcutaneous Lewis lung carcinoma tumour in a mouse was imaged using gold 
nanoparticle accumulation via the EPR effect.  Gold and bone are differentiated indicating 
that even tumours near bone could be viewed in detail with proper nanoparticle contrast 
targeting.  The tumour size could be measured and the accumulated gold quantified.  The 
ability to quantify spatial arrangements and concentrations opens myriad possibilities in 
assessing disease progression and regression over time, either with repeated procedures or 
contrasts designed to decay or be excreted in conjunction with physiologic changes.  Lipid, 
calcium and three contrast agents were quantified simultaneously in a whole mouse.  By 
proper compartmentalization of gadolinium to the gastrointestinal tract, gold to the 
vasculature and iodine to, predominantly, the kidneys and bladder, the accuracy of the spatial 
MD results for the contrasts and bone were easily verified.  Again, the ability to use multiple 
contrast agents simultaneously with only one imaging procedure opens up a realm of 
diagnostic and research possibilities such as monitoring multiple diseases or different aspects 
of just one. 
Contributions to machine functionality and data assessment are listed in Chapter 5.  A pixel 
masking technique was developed and added to the MARS scanner control software.  Two 
CT machines were commissioned with standardized testing that revealed faults in the X-ray 
source and camera while also providing information that lead to guidelines for scan protocols.  
A graphing technique comparing the Hounsfield unit values of voxels to the MD water 
concentration revealed the impact of the partial volume effect on MD segmentation and 
quantification of voxels near borders between materials of different density. 
Chapter 6 describes two techniques for per pixel energy calibration.  The broad spectrum 
energy offset technique uses the existing X-ray source to find an energy offset for each pixel 
from the global energy value at a given DAC and therefore, requires no special equipment or 
materials.  It achieved a 28% reduction in full width half maximum of a measured 
fluorescence peak for molybdenum.  The oblique fluorescence per-pixel energy calibration 
uses measures of off-axis fluorescence from monoatomic foils to directly map energy onto 




each pixel can be calculated and experimental results were similar to the global calibration, 
indicating the quality of the measurements. 
 
7.3 Opportunities and Issues for the Future 
This work establishes the potential of spectral CT and material reconstructions in intrinsic 
and contrast identification using the higher energy X-ray spectrum typical in human 
scanning.  But it also raises questions about how material reconstruction should be interpreted 
and points toward lines of research that can answer them.  The ability to detect sub-voxel 
sized particles of high density such as hydroxyapatite deposition in atherosclerotic plaques or 
calcifications in some cancers  and pseudogout could lead to much earlier diagnosis of these 
conditions and demands research establishing the confidence level of high Z measurements in 
the MD that are limited to single or small clusters of voxels.  The same is true of contrast 
agents.  As researchers develop sophisticated targeting mechanisms for high Z contrast agents 
like gold nanoparticles, spectral CT will develop in parallel with improving sensitivity.  The 
lowest concentrations detectable should be constantly lowered by threshold optimization like 
that described here along with improved sensor purity, sensor to chip bonding, and chip 
electronics. 
The known association of lipids and calcifications in atherosclerotic plaques that are 
highlighted in Chapter 3 also suggest that a 3 component MD should be a priority.  Multiple 
contrast scans that result in mixing of contrast in the same voxel also suggest that more than 
two materials should be measured.  Indeed MARS has a team of about six researchers 
investigating improved reconstruction methods, as are numerous teams worldwide.  Calcium 
measurements in the presence of lipid are almost surely incorrect or completely missed, as 
evidenced by the results in Section 3.4 and Section 5.4.  Alternatively, no lipid measurement 
is allowed currently when calcium is detected meaning that the true structure of calcified 
plaques cannot be assessed.  Voxel material concentrations for at least three materials could 
solve these issues. 
With superior spatial resolution to current clinical CT, the MARS scanner should be tested 
for imaging spatially important signs of disease.  For instance, this thesis did not attempt to 
measure the fibrous cap thickness of plaque samples. 
Material concentration thresholds will have to be established on a disease by disease basis.  
Lipid concentrations that are significant in atherosclerosis may mean little in assessing fatty 
liver disease.  The detection of sub-voxel sized particles, whether calcifications in plaques or 
concentrated contrast agents in macrophages is surely possible but confidence levels and 
thresholding strategies will need to be investigated. 
As we move into live animal scanning, dose measurements, which are not considered in this 
thesis, will be necessary.  Likewise, reconstruction methods for moving, breathing subjects 
will also become vital. It is likely that many such issues will need to be solved before my 
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